16.07.2013 Views

Vol 9 No1 - Journal of Cell and Molecular Biology - Haliç Üniversitesi

Vol 9 No1 - Journal of Cell and Molecular Biology - Haliç Üniversitesi

Vol 9 No1 - Journal of Cell and Molecular Biology - Haliç Üniversitesi

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />

•Notch in apoptosis<br />

<strong>Molecular</strong> <strong>Biology</strong><br />

<strong>Vol</strong>ume 9 · No 1 · June 2011<br />

http://jcmb.halic.edu.tr<br />

Xenobiotic genes <strong>and</strong> susceptibility to bladder cancer<br />

MMP1 <strong>and</strong> MMP2 polymorphisms in TMJ disorder<br />

Silencing suppressors <strong>of</strong> PVM<br />

Bio-database compression using enhanced suffix array


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />

<strong>Molecular</strong> <strong>Biology</strong><br />

<strong>Vol</strong>ume 9 · Number 1<br />

June 2011<br />

İstanbul-TURKEY


<strong>Haliç</strong> University<br />

Faculty <strong>of</strong> Arts <strong>and</strong> Sciences<br />

<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />

Founder<br />

Gündüz GEDİKOĞLU<br />

President <strong>of</strong> Board <strong>of</strong> Trustee<br />

Rights held by<br />

A. Sait SEVGENER<br />

Rector<br />

Correspondence Address:<br />

<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />

<strong>Haliç</strong> <strong>Üniversitesi</strong><br />

Fen-Edebiyat Fakültesi,<br />

Sıracevizler Cad. No:29 Bomonti 34394 Şişli<br />

İstanbul-Turkey<br />

Phone: +90 212 343 08 87<br />

Fax: +90 212 231 06 31<br />

E-mail: jcmb@halic.edu.tr<br />

<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> is<br />

indexed in ULAKBIM, EBSCO, DOAJ,<br />

EMBASE, CAPCAS, EM<strong>Biology</strong>, Socolar, Index<br />

COPERNICUS,Open J-Gate, Chemical<br />

Abstracts <strong>and</strong> Genamics <strong>Journal</strong>Seek<br />

ISSN 1303-3646<br />

Printed at MART Printing House<br />

Tuncay ALTUĞ, İstanbul, Turkey<br />

Canan ARKAN, Munich, Germany<br />

Aglaia ATHANASSIADOU, Patras, Greece<br />

Şehnaz BOLKENT, İstanbul, Turkey<br />

Nihat BOZCUK, Ankara, Turkey<br />

A. Nur BUYRU, İstanbul, Turkey<br />

Kemal BÜYÜKGÜZEL, Zonguldak, Turkey<br />

H<strong>and</strong>e ÇAĞLAYAN, İstanbul, Turkey<br />

İsmail ÇAKMAK, İstanbul, Turkey<br />

Adile ÇEVİKBAŞ, İstanbul, Turkey<br />

Beyazıt ÇIRAKOĞLU, İstanbul, Turkey<br />

Fevzi DALDAL, Pennsylvania, USA<br />

Zihni Demirbağ, Trabzon, Turkey<br />

Mustafa DJAMGÖZ, London, UK<br />

Aglika EDREVA, S<strong>of</strong>ia, Bulgaria<br />

Ünal EGELİ, Bursa, Turkey<br />

Advisory Board<br />

<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />

<strong>Molecular</strong> <strong>Biology</strong><br />

Published by<br />

<strong>Haliç</strong> University<br />

Faculty <strong>of</strong> Arts <strong>and</strong> Sciences<br />

Editor<br />

Nagehan ERSOY TUNALI<br />

Editorial Board<br />

M.Baki YOKEŞ<br />

M.Burcu IRMAK YAZICIOĞLU<br />

Kürşat ÖZDİLLİ<br />

Aslı BAŞAR<br />

Editorial Assistance<br />

Ozan TİRYAKİOĞLU<br />

Özlem KURNAZ<br />

Nermin GÖZÜKIRMIZI, İstanbul, Turkey<br />

Ferruh ÖZCAN, İstanbul, Turkey<br />

Füsun GÜMÜŞEL, İstanbul, Turkey<br />

C<strong>and</strong>an JOHANSEN, İstanbul, Turkey<br />

Asım KADIOĞLU, Trabzon, Turkey<br />

Maria V. KALEVITCH, Pennsylvania, USA<br />

Valentine KEFELİ, Pennsylvania, USA<br />

Meral KENCE, Ankara, Turkey<br />

Uğur ÖZBEK, İstanbul, Turkey<br />

Sevtap SAVAŞ, Toronto, Canada<br />

Müge TÜRET SAYAR, İstanbul, Turkey<br />

İsmail TÜRKAN, İzmir, Turkey<br />

Mehmet TOPAKTAŞ, Adana, Turkey<br />

Meral ÜNAL, İstanbul, Turkey<br />

Selma YILMAZER, İstanbul, Turkey<br />

Ziya ZİYLAN, İstanbul, Turkey


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />

CONTENTS <strong>Vol</strong>ume 9 · Number 1 · June 2011<br />

Review Articles<br />

Decision making mechanism influences the regulatory function <strong>of</strong> Notch in<br />

Apoptosis<br />

1<br />

A.NAIR<br />

Polymorphisms in the xenobiotic genes <strong>and</strong> susceptibility to bladder cancer<br />

5<br />

N.ERSOY TUNALI <strong>and</strong> N.O.TİRYAKİOĞLU<br />

Research Articles<br />

Identification <strong>of</strong> silencing suppressors <strong>of</strong> potato virus M<br />

R.KRYLDAKOV, R.AKBERGENOV, T.HOHN <strong>and</strong> B.ISKAKOV<br />

Identification <strong>of</strong> a novel dehydration responsive transcript from tossa jute<br />

(Corcohrus olitorius L.)<br />

S.SHARMIN, M.M.MOOSA, Md.S.ISLAM, I.KABIR, A.AKTER <strong>and</strong> H.KHAN<br />

Protective effects <strong>of</strong> curcumin on cadmium chloride induced colon toxicity in<br />

Swiss albino mice<br />

P.SINGH, P.MOGRA, V.SANKHLA <strong>and</strong> K.DEORA<br />

In vitro regeneration <strong>of</strong> Cleome viscosa – an important medicinal herb<br />

J.ANBURAJ, C.R.SINGH, S.SUNDARRAJ <strong>and</strong> S.KANNAN<br />

Bio-database compression using enhanced suffix array for pairwise sequence<br />

alignment<br />

A.KUNTHAVAI <strong>and</strong> S.VASANTHA RATHNA<br />

Cloning <strong>and</strong> expression <strong>of</strong> Lentinula edodes cellobiohydrolase gene in E. coli<br />

<strong>and</strong> characterization <strong>of</strong> the recombinant enzyme<br />

S.TAIPAKOVA, B.SMAILOV, G.STANBEKOVA <strong>and</strong> A.BISSENBAEV<br />

Investigation <strong>of</strong> the MMP1 <strong>and</strong> MMP3 promoter polymorphisms in<br />

temporom<strong>and</strong>ibular joint disorder<br />

N.TASKIN, K.ULUCAN, G.DEGIN, A.AKCAY, B.KARATAS <strong>and</strong> T.AKCAY<br />

Lead induced alterations in blood cell counts <strong>and</strong> hemoglobin during gestation<br />

<strong>and</strong> lactation in Swiss albino mice<br />

I. BARBER, R. SHARMA, S. MOGRA, K. PANWAR <strong>and</strong> U. GARU<br />

The effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> Vernonia amygdalina on<br />

some vital organs in adult Wistar rats<br />

S.NWANGWU, D.A.OFUSORI, S.JOSIAH, O.F.AMEGOR, H.NJOYA <strong>and</strong><br />

A.O.AYOKA<br />

Short Communication<br />

Investigation <strong>of</strong> the EGFR gene variations in bladder cancer patients using<br />

INFINITI TM Analyzer<br />

N.O.TİRYAKİOĞLU, Ö.KURNAZ, Ö.O.ÇAKIR <strong>and</strong> N.ERSOY TUNALI<br />

Instructions for Authors<br />

15<br />

21<br />

31<br />

37<br />

45<br />

53<br />

63<br />

69<br />

75<br />

83<br />

87


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 1-4, 2011 Review Article 1<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Decision making mechanism influences the regulatory function <strong>of</strong><br />

Notch in apoptosis<br />

Ajay NAIR*<br />

Laboratory for Evolution <strong>and</strong> Development, Department <strong>of</strong> Biochemistry, University <strong>of</strong> Otago, Dunedin<br />

9054, New Zeal<strong>and</strong><br />

(* author for correspondence; rudraaj14@gmail.com)<br />

Received: 24 January 2011; Accepted: 28 February 2011<br />

Abstract<br />

The anti-apoptotic role <strong>of</strong> Notch <strong>and</strong> its interactors has been cited by many in the recent past. This intriguing<br />

phenomenon however involves a non-canonical pathway that is independent <strong>of</strong> the usual nuclear-<br />

localization <strong>of</strong> the Notch intracellular domain (NICD) which is formed following a series <strong>of</strong> cleavage events<br />

set <strong>of</strong>f by the lig<strong>and</strong> dependent activation <strong>of</strong> the Notch receptor. This finding has in turn led to the general<br />

postulation that there is perhaps a membrane-tethered or cytoplasm localized form <strong>of</strong> NICD which is<br />

responsible for its non-canonical pathway. However, this notion has been a subject <strong>of</strong> scrutiny from the<br />

moment <strong>of</strong> its origin. This review will make an attempt to compile most <strong>of</strong> these current ambiguities <strong>and</strong> will<br />

furthermore try to substantiate, a likely evolutionary significance <strong>of</strong> the regulatory function <strong>of</strong> Notch on<br />

apoptosis, by using the theory <strong>of</strong> Natural Selection to intervene.<br />

Keywords: Notch, nuclear localization, Notch intracellular domain, apoptosis, natural selection.<br />

Karar verme mekanizması Notch'un apoptozdaki düzenleyici rolünü etkiler<br />

Özet<br />

Notch ve etkileşimde bulunduğu proteinlerin anti-apoptotik rollerinden yakın geçmişte fazlaca<br />

bahsedilmiştir. Ancak bu ilgi çekici fenomen, Notch reseptörünün lig<strong>and</strong> bağımlı aktivasyonuyla başlayan<br />

kesilme olayları sonucunda gerçekleşen Notch intrasellüler bölgesinin nükleer lokalizasyonundan bağımsız<br />

kanonik olmayan bir yolakla ilişkilidir. Bu bulgu kanonik olmayan bu yolaktan sorumlu NCID'nin<br />

membrana bağlı veya sitoplazmik bir formu olabileceği varsayımına yol açmıştır. Fakat bu görüş baştan<br />

itibaren detaylı incelemelere maruz kalmıştır. Bu derleme, bu konudaki belirsizlikleri toplamaya ve dahası<br />

doğal seleksiyon teorisi aracılığıyla Notch proteininin apoptozda düzenleyici işlevinin muhtemel evrimsel<br />

önemini göstermeye çalışacaktır.<br />

Anahtar Sözcükler: Notch, nükleer lokalizasyon, Notch intraselüler bölgesi, apoptoz, doğal seleksiyon.<br />

Introduction<br />

The Notch protein is a transmembrane receptor<br />

possessing distinct extracellular <strong>and</strong> intracellular<br />

domains. Specific lig<strong>and</strong> proteins (single pass<br />

transmembrane proteins belonging to the<br />

Delta/Serrate/ LAG-2 family <strong>of</strong> proteins) bind to<br />

the extracellular domain which in turn triggers<br />

successive proteolytic cleavage events starting with<br />

that <strong>of</strong> the extracellular domain, catalyzed by a<br />

metalloprotease, TACE (Tumor Necrosis Factor<br />

Alpha Converting Enzyme). This is then followed<br />

by the cleavage <strong>of</strong> the remaining notch protein<br />

catalyzed by γ-secretase (Perumalsamy et al.,<br />

2009). Once cleaved, it is referred as the Notch<br />

intracellular domain <strong>and</strong> migrates to the nucleus to<br />

influence gene expression. This is the conventional<br />

Notch signaling pathway. Apart from the canonical<br />

pathway <strong>of</strong> Notch signaling there also an


2 Ajar NAIR<br />

alternative pathway which culminates in the release<br />

<strong>of</strong> anti-apoptotic factors <strong>and</strong> the inactivation <strong>of</strong> proapoptotic<br />

proteins, especially in T cells (Sade et al.,<br />

2004). However, this unorthodox pathway avoids<br />

the usual nuclear localization. Recent research on<br />

the same has engendered the possibility <strong>of</strong> a<br />

membrane-tethered or cytoplasm- localized form,<br />

something that has been a subject <strong>of</strong> intense<br />

research since then. Now the question regarding the<br />

membrane or cytoplasmic localization <strong>of</strong> the Notch<br />

intracellular domain during its anti-apoptotic non<br />

canonical signal transduction is certainly puzzling.<br />

But what is utmost intriguing is that the structural<br />

composition <strong>of</strong> NICD doesn’t completely <strong>and</strong><br />

substantially support a membrane tethered or<br />

cytosolic form separately. This assertion can be<br />

made more explicit with the following findings<br />

from various works done in this regard:<br />

1. The existence <strong>of</strong> a nuclear localization sequence,<br />

intact in the NICD.<br />

2. Notch intracellular domain construct with a<br />

partially truncated PEST (P (Proline), E (Glutamic<br />

acid), S (Serine), T (Threonine)) domain is<br />

abbreviated as NIC (Figure 1); whereas the active,<br />

full-length Notch intracellular domain is<br />

abbreviated as NICD. While investigating the<br />

regulatory function <strong>of</strong> Notch-1 on apoptosis, one<br />

anti-apoptotic protein in particular is significantly<br />

upregulated in NICD-expressing Jurkat cells: the<br />

XIAP (X-linked inhibitor <strong>of</strong> apoptosis). A nearly<br />

three-fold increase <strong>of</strong> XIAP protein was detected in<br />

NICD-expressing T cells. Over expression <strong>of</strong> the<br />

full-length Notch intracellular domain also resulted<br />

in elevated levels <strong>of</strong> XIAP (Liu WH et al., 2007).<br />

3. Notch increases XIAP stability through<br />

downregulation <strong>of</strong> proteasome-mediated protein<br />

degradation <strong>and</strong> upregulation <strong>of</strong> XIAP by Notch<br />

activation is not Akt-dependent (Liu et al., 2007;<br />

Dan et al., 2004).<br />

4. NICD is composed <strong>of</strong> a RAM domain at the N<br />

terminal, then followed by six repeats <strong>of</strong> Ankyrin<br />

(ANK) followed by a NLS. This is ensued by a<br />

Transactivation domain (TAD) <strong>and</strong> the NICD<br />

structure ends at the C terminal, by a PEST domain<br />

(Figure 1). Deletions in the RAM or ANK repeat<br />

domains, do not affect the binding <strong>of</strong> NICD to<br />

XIAP. Truncation <strong>of</strong> the TAD from NICD on the<br />

other h<strong>and</strong> abolishes its association with His-XIAP,<br />

indicating that TAD is the XIAP binding region on<br />

NICD. NICD directly binds XIAP, where the Cterminal<br />

domain on NIC <strong>and</strong> the RING-finger<br />

domain <strong>of</strong> XIAP are critical for such interaction<br />

(Liu et al., 2007).<br />

5. NICD interacts with XIAP in the cytoplasm;<br />

which was confirmed by the finding that coexpression<br />

<strong>of</strong> XIAP decreases NIC-directed HES5<br />

(Hairy <strong>and</strong> enhancer <strong>of</strong> split5) trans-activation (Liu<br />

et al., 2007).<br />

6.TAD dictates the transcription activity <strong>of</strong> NICD.<br />

Partial deletion <strong>of</strong> TAD domain retains most <strong>of</strong> the<br />

NICD transcription activity, shown by activation <strong>of</strong><br />

the HES5 promoter, yet completely eliminating the<br />

capacity <strong>of</strong> NICD to bind XIAP (Figure 2) (Liu et<br />

al. 2007). If there is an independent membrane<br />

tethered form, then the canonical pathway must not<br />

get influenced by any means.<br />

Figure 1. Structural makeup <strong>of</strong> NICD. RAM<br />

domain at the N terminal is followed by six ANK<br />

repeats, a nuclear localization sequence, a TAD<br />

(Trans-activation domain) <strong>and</strong> a PEST domain at<br />

the C terminal. Truncation <strong>of</strong> the TAD affects<br />

NICD’s association with XIAP; altering NICD’s<br />

anti-apoptotic function.


The aforesaid, thus, strongly suggests that there<br />

is more to be added to complete the puzzle. From<br />

the above points it seems that there exists a<br />

decision making mechanism, within the cytoplasm<br />

which decides the fate <strong>of</strong> the NICD, which either<br />

complies with its usual nuclear retention or NCID<br />

gets stabilized in the cytoplasm. And certainly this<br />

point out to the possibility <strong>of</strong> an alternate<br />

modification <strong>of</strong> the NICD, other than those<br />

mentioned above, that perhaps answers for such a<br />

diversity seen in Notch, in terms <strong>of</strong> its action.<br />

Figure 2. Activation <strong>of</strong> transcription, via NICD’s<br />

usual nuclear retention in a cell. A) activated notch<br />

receptor. B) cleaved NICD with intact TAD. C)<br />

XIAP. D) NICD with truncated or deleted TAD;<br />

NICD fails to bind XIAP. E) HES5; NICD<br />

localizes to nucleus <strong>and</strong> associates with HES-5 to<br />

turn on transcription.<br />

An evolutionary rationale<br />

This perplexing behavioral change exhibited by<br />

Notch receptors <strong>and</strong> its signaling cascade may<br />

perhaps be explained in an alternate fashion, by<br />

observing it from an angle that concentrates on<br />

reasoning out the advantage <strong>of</strong> a T cell that may<br />

hold when urged to respond to an environmental<br />

stimulus like neglect or etoposide or DNA damage<br />

induced death signals. It’s recognized that energy is<br />

consumed for two central processes in any<br />

biological cell; one is for reproduction <strong>and</strong> the other<br />

for cell-maintenance. Although indirectly, the notch<br />

canonical pathway is responsible for meeting the<br />

requirements pertaining to development,<br />

Processing <strong>of</strong> Notch rescues cells from apoptosis 3<br />

reproduction etc. But a situation like neglect or<br />

other antagonist stimulus poses an unfavorable<br />

condition. Hence it is certainly in a cell’s interest to<br />

switch to a mode which would momentarily<br />

conserve much <strong>of</strong> the cells free energy for cell<br />

maintenance by promoting cell survival signaling<br />

pathways rather than promoting the customary<br />

transcriptional activities (developmental <strong>and</strong><br />

metabolic); for it is utterly uneconomical to spend<br />

the same energy on reproducing the cells in an<br />

attempt to revitalize the cell population. Therefore,<br />

notch signaling in entirety is bound to have a<br />

decision making mechanism from the time <strong>of</strong> its<br />

activation. But does notch directly respond to the<br />

dem<strong>and</strong> or the environmental stimulus. Perhaps<br />

there is more than a straight intrusion from Notch.<br />

Notch interactors, other than the canonical <strong>and</strong> noncanonical,<br />

are mostly playing a pivotal role in<br />

answering this question which still st<strong>and</strong>s<br />

challengeable inspite <strong>of</strong> the various breakthroughs<br />

made in the context <strong>of</strong> Notch <strong>and</strong> its regulatory<br />

function on apoptosis. The question that continues<br />

to seek an answer is, why does a mechanism like<br />

the Notch signaling pathway, which is one <strong>of</strong> the<br />

highly conserved cell signaling systems present in<br />

most multicellular organisms in terms <strong>of</strong> involving<br />

gene regulation mechanisms that control multiple<br />

cell differentiation processes, incorporate a<br />

different role such as anti apoptosis? Because notch<br />

holds the potential to influence cell fate decisions,<br />

it is imperative that there be a decision making<br />

mechanism that can modulate this omnipotent<br />

transmembrane protein <strong>and</strong> its actions, depending<br />

upon the need <strong>of</strong> the hour from a toll <strong>of</strong> billion<br />

deaths (Neglect or DNA damage induced).<br />

Probably cells have earned <strong>and</strong> evolved towards<br />

this non conventional Notch pathway, that rescues<br />

cells from self flattening. This postulation finds<br />

support from a concept called- The Selfish Gene<br />

Theory or Gene Selection Theory, according to<br />

which “adaptations are the phenotypic effects <strong>of</strong><br />

genes to maximize their own representation <strong>and</strong><br />

continued survival in the future generations”.<br />

Genes build vehicles to meet their mutual interests<br />

<strong>of</strong> jumping into the next generation <strong>of</strong> vehicles<br />

(Dawkins, 2006). <strong>Cell</strong>s are the survival machines <strong>of</strong><br />

genes. So it is important that there exist a sequential<br />

set <strong>of</strong> events which end up modulating the NICD in<br />

response to an apoptotic stimulus; this change will<br />

ensure cell survival <strong>and</strong> as a consequence, promote<br />

the perpetuation <strong>of</strong> genes.<br />

Neglect like situation, (known to activate antiapoptotic<br />

factors via Notch, in T cells (Sade et al.,


4 Ajar NAIR<br />

2004)) is extremely stressful; leading to a shift in<br />

the cell’s energy. The cell prepares itself for<br />

apoptosis; apoptosis promoting factors are<br />

activated. Such an event forces mitochondria<br />

towards an immediate fragmentation which marks<br />

the onset <strong>of</strong> apoptosis; fragmentation induces<br />

release <strong>of</strong> intrinsic pro-apoptotic factors (for e.g.<br />

cytochrome-c) (Suen et al., 2008). Perhaps an<br />

apoptotic distress signal, such as the one mentioned<br />

above, prevents the usual processing <strong>of</strong> NICD,<br />

which causes the partial or complete deletion <strong>of</strong> its<br />

trans-activation domain; in so doing prevent its<br />

nuclear localization <strong>and</strong> its ability to stimulate<br />

transcription by associating with transcription<br />

factors (for e.g. HES5). Possibly, a decision making<br />

mechanism in the form <strong>of</strong> an additional physical<br />

modification <strong>of</strong> NICD, in the cytoplasm, changes<br />

its typical course, so as to meet the need, which is<br />

to respond to the induced stress. Besides activating,<br />

anti-apoptotic factors like XIAP, this tailored NICD<br />

may well be acting upstream to the factors which<br />

promote mitochondrial connectivity (for e.g.<br />

Mit<strong>of</strong>usin (Mfn) 1&2), causing a delay in bax<br />

activation, cytochrome-c release <strong>and</strong> eventually halt<br />

cell demolition (Figure 3).<br />

Figure 3. Proposed alteration in notch activity<br />

during cell neglect. A) Notch receptor. B) Induced<br />

stress leads to, a shift in the energy metabolism,<br />

<strong>and</strong> the release pro-apoptotic factors (shown as<br />

blue circles); this results in mitochondrial<br />

fragmentation. C) This might act as an alarm<br />

upstream notch to stop its usual course to the<br />

nucleus; HES5 (shown in blue inside the nucleus)<br />

remains unbound to trigger transcription. D)<br />

Cleaved NICD binds to XIAP via its intact TAD.<br />

E) This interaction might activate other antiapoptotic<br />

factors <strong>and</strong> also release factors (for e.g.<br />

Mfn) to restore mitochondrial connectivity.<br />

Conclusion<br />

For each <strong>and</strong> every phenomenon or process that<br />

exists, there must in every case be a reason for its<br />

occurrence in terms <strong>of</strong> the benefit it provides to a<br />

cell. This leads to a specific adaptation with respect<br />

to the cell’s requirement at a particular instance<br />

(such as the long term survival <strong>of</strong> Memory T cells<br />

due to the regulatory function <strong>of</strong> Notch-1 on<br />

apoptosis). Through rigorous selective pressures on<br />

a cell, several individual molecular processes are<br />

scrutinized. The one that makes a cell evermore<br />

specialized with respect to the immediate dem<strong>and</strong>,<br />

is selected by natural selection. It is this long<br />

evolutionary history that, in all probabilities,<br />

endowed notch with this non-canonical<br />

mechanism. Hence, notions that speculate a<br />

discrete membrane localized form for Notch, do<br />

not seem to hold up.<br />

References<br />

Liu WH, Hsiao HW, Tsou WI <strong>and</strong> Lai MZ. Notch<br />

inhibits apoptosis by direct interference with<br />

XIAP ubiquitination <strong>and</strong> degradation. The<br />

EMBO <strong>Journal</strong>. 26: 1660–1669, 2007.<br />

Perumalsamy LR, Nagala M, Banerjee P <strong>and</strong> Sarin<br />

A. A hierarchical cascade activated by noncanonical<br />

Notch signaling <strong>and</strong> the mTOR–<br />

Rictor complex regulates neglect-induced death<br />

in mammalian cells. <strong>Cell</strong> Death <strong>and</strong><br />

Differentiation. 16: 879-889, 2009.<br />

Sade H, Krishna S <strong>and</strong> Sarin A. The Anti-apoptotic<br />

Effect <strong>of</strong> Notch-1 Requires p56lck-dependent<br />

Akt/PKB-mediated Signaling in T <strong>Cell</strong>s, The<br />

<strong>Journal</strong> <strong>of</strong> Biological Chemistry. 279: 2937–<br />

2944, 2004.<br />

Suen DF, Norris KL <strong>and</strong> Youle RJ. Mitochondrial<br />

dynamics <strong>and</strong> apoptosis. Genes & Development.<br />

22: 1577-1590, 2008.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 5-13, 2011 Review Article 5<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Polymorphisms in the xenobiotic genes <strong>and</strong> susceptibility to<br />

bladder cancer<br />

Nagehan ERSOY TUNALI* <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />

<strong>Haliç</strong> University, Department <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong> Genetics, Istanbul, TURKEY<br />

(* author for correspondence; nagehanersoy@halic.edu.tr)<br />

Received: 13 May 2011; Accepted: 20 June 2011<br />

Summary<br />

It is thought that the interaction between genetic <strong>and</strong> environmental factors accounts for the different levels<br />

<strong>of</strong> susceptibilities to the development <strong>of</strong> bladder cancer. The well known etiological risk factors <strong>of</strong> bladder<br />

cancer are occupational exposure to certain carcinogens <strong>and</strong> cigarette smoking. Therefore, polymorphisms in<br />

the genes coding for the xenobiotic-metabolizing enzymes may cause individual variations in metabolizing<br />

the exposed carcinogens. Here we aimed to review the metabolising genes <strong>and</strong> respective polymorphisms<br />

<strong>and</strong> to demonstrate the association between xenobiotic-metabolising gene polymorphisms <strong>and</strong> bladder<br />

cancer. Among metabolizing enzymes, we will introduce N-acetyltransferases (NAT), glutathione-Stransferases<br />

(GST), sulphotransferases (SULT), NAD(P)H dehydrogenase quinone 1 (NQO1),<br />

methylenetetrahydr<strong>of</strong>olate reductase (MTFR), cytochrome P-450 (CYP) <strong>and</strong> aldo-Ketoreductases (AKR)<br />

with special emphasis on the last two enzyme group.<br />

Keywords: Bladder cancer, xenobiotic metabolism, metabolising genes, genetic susceptibility, genetic<br />

polymorphism<br />

Ksenobiyotik genlerdeki polimorfizmler ve mesane kanserine yatkınlık<br />

Özet<br />

Genetik ve çevresel faktörler arasındaki etkileşimin mesane kanseri oluşumu için farklı seviyelerde<br />

yatkınlık oluşturduğu düşünülmektedir. En iyi bilinen etiyolojik risk faktörleri, meslek sebebi ile<br />

maruz kalınan kanserojenler ve sigara içimidir. Bu nedenle, ksenobiyotik-metabolize edici<br />

enzimlerdeki polimorfizmler maruz kalınan karsinojelerin metabolize edilmesinde kişisel<br />

varyasyonlara sebep olabilir. Biz burada metabolize edici genleri ve ilgili polimorfizmleri derlemeyi<br />

ve ksenobiyotik-metabolize edici gen polimorifzmleri ile mesane kanseri arasındaki bağlantıyı<br />

göstermeyi amaçladık. Metabolize edici genlerden N-asetiltransferazları (NAT), glutatyon-Stransferazları<br />

(GST), sulfotransfeazları, NAD(P)H dehidrogenaz kinon 1’i (NQO1),<br />

metilentetrahidr<strong>of</strong>olat redüktazı, sitokrom P-450’yi (CYP) ve aldo-ketoredüktazları (AKR), son iki<br />

enzim grubuna özel vurgu yaparak tanıtacağız.<br />

Anahtar kelimeler: Mesane kanseri, ksenobiyotik mekanizma, metabolize edici genler, genetik<br />

yatkınlık, genetik polimorfizm<br />

Introduction<br />

Cancer is regarded as a multifactorial disorder<br />

affected both by genetic <strong>and</strong> environmental factors,<br />

which culminate in dysregulated cell cycle.<br />

Although environmental risk factors are considered<br />

as the most important among others,<br />

epidemiological studies have shown that a certain<br />

part <strong>of</strong> the population is in fact more prone to<br />

develop cancers despite being exposed to the same<br />

type <strong>and</strong> amount <strong>of</strong> environmental risks. This


6 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />

finding has led the molecular epidemiology studies<br />

to focus on predisposition to cancer via genetic<br />

factors. It has been speculated that either the<br />

polymophisms in the DNA repair genes or those in<br />

carcinogen metabolizing genes should primarily be<br />

questioned as possible c<strong>and</strong>idates <strong>of</strong> genetic<br />

modifiers. The polymorphisms in the DNA repair<br />

genes may alter the function <strong>of</strong> the related enzyme<br />

<strong>and</strong> thereby affect the repair capacity <strong>of</strong> the<br />

individual. This kind <strong>of</strong> alteration in the DNA<br />

repair mechanism may get the individual more<br />

sensitive to carcinogens <strong>and</strong> more susceptible to<br />

cancer formation (Franekova et al., 2008).<br />

Likewise, polymorphisms in the genes coding for<br />

the xenobiotic-metabolizing enzymes may cause<br />

individual variations in metabolizing the exposed<br />

carcinogens (Longuemaux et al., 1999). As a result,<br />

individuals with a certain genetic background may<br />

become more susceptible to develop cancer.<br />

Xenobiotic metabolism<br />

Xenobiotic metabolism (from the Greek xenos<br />

"stranger" <strong>and</strong> biotic "related to living beings") is<br />

composed <strong>of</strong> several metabolic pathways that<br />

modify the chemical structure <strong>of</strong> xenobiotics, e.g.<br />

drugs, carcinogens, poisons. Upon their intake by<br />

an organism, xenobiotics undergo several metabolic<br />

Metabolising genes <strong>and</strong> susceptibility to bladder<br />

Cancer<br />

Polymorphisms in the xenobiotic-metabolising<br />

genes are pivotal to the above-mentioned<br />

alterations <strong>and</strong> therefore have been intensively<br />

investigated in many cancer types. Foremost <strong>of</strong><br />

Figure 1. Activation pathways <strong>of</strong> carcinogens<br />

conversions to facilitate their solubility in order to<br />

expedite their removal from the organism. These<br />

so-called biotransformation processes consists <strong>of</strong><br />

two consecutive steps; an initiation phase, where<br />

carcinogens are modified to accept reactive groups<br />

(Phase I) via the action <strong>of</strong> cytochrome P450<br />

oxidases; <strong>and</strong> a second phase where they are<br />

converted into more easily extractable molecules by<br />

conjugation reactions (Phase II) via transferase<br />

enzymes. The xenobiotic metabolism can be<br />

regarded as a detoxification mechanism consisting<br />

<strong>of</strong> two phases, however, conversion reactions<br />

catalyzed by xenobiotic-metabolising enzymes can<br />

also activate potential carcinogens (Figure 1.).The<br />

reason for this is the vastly diverse chemical<br />

structures <strong>of</strong> carcinogens which can not be<br />

compensated by the limited number <strong>of</strong> conversion<br />

reactions catalyzed by xenobiotic enzymes. The<br />

capability <strong>of</strong> the xenobiotic metabolism to either<br />

activate or detoxify carcinogens constitute a fragile<br />

balance between activation <strong>and</strong> detoxification <strong>of</strong><br />

carcinogens, which defines the amount <strong>of</strong> DNA<br />

damage accumulated in the cells. Alterations<br />

affecting enzyme activity shifts this balance<br />

towards either detoxification or activation <strong>of</strong><br />

carcinogens.<br />

these cancers is the bladder cancer, for which the<br />

well-known etiological risk factors are occupational<br />

exposure to certain carcinogens <strong>and</strong> cigarette<br />

smoking. In fact, smoking is proved to be the<br />

primary cause <strong>of</strong> approximately 70% <strong>of</strong> the bladder<br />

cancer cases (Parkin 2008). It is thought that the<br />

interaction between genetic <strong>and</strong> environmental


factors accounts for the different levels <strong>of</strong><br />

susceptibilities to the development <strong>of</strong> bladder<br />

cancer. Bladder cancer incidence varies highly<br />

between distinct regions worldwide, with<br />

developed countries having the highest incidence<br />

(Silverman et al., 1999; Parkin et al., 2002). Higher<br />

bladder cancer incidence in developed countries<br />

despite increased awareness against risk factors<br />

indicates the existence <strong>of</strong> genetic factors affecting<br />

bladder cancer susceptibility. Thereby,<br />

polymorphisms with possible association to bladder<br />

cancer have been widely investigated. Many<br />

metabolizing genes <strong>and</strong> their polymorphisms have<br />

been identified as responsible for individual<br />

susceptibility to cause BC.<br />

This review is written as an attempt to<br />

demonstrate the association between xenobioticmetabolising<br />

gene polymorphisms <strong>and</strong> bladder<br />

cancer. Among metabolizing enzymes, we will<br />

introduce N-acetyltransferases (NAT), Glutathione-<br />

S-transferases (GST), Sulphotransferases (SULT),<br />

NAD(P)H dehidrogenase Quinone 1 (NQO1),<br />

Methylenetetrahydr<strong>of</strong>olate reductase (MTFR),<br />

Cytochrome P-450 (CYP) <strong>and</strong> Aldo-Ketoreductases<br />

(AKR) with special emphasis on the last two<br />

enzyme group <strong>and</strong> related polymorphisms.<br />

N-acetyltransferases<br />

In humans, genetic locus for the two isoenzymes <strong>of</strong><br />

NAT, NAT1 <strong>and</strong> NAT2, resides at chromosome<br />

8p22. NAT1 <strong>and</strong> NAT2 are polymorphic <strong>and</strong> both<br />

catalyze N- <strong>and</strong> O-acetylation <strong>of</strong> aromatic <strong>and</strong><br />

heterocyclic amines (Franekova et al., 2008).<br />

NAT2, one <strong>of</strong> the Phase II enzymes, play roles in<br />

the bio-conversion <strong>of</strong> heterocyclic amines to<br />

electrophilic nitrenium ions. NAT2 catalyzes the<br />

activation <strong>and</strong> deactivation <strong>of</strong> various aromatic<br />

amines, heterocyclic amines <strong>and</strong> hydrazin drugs.<br />

Polymorphisms in the NAT2 gene have been<br />

strongly associated with bladder cancer. Based on<br />

the 13 SNPs, 30 different NAT2 alleles have been<br />

defined<br />

(http://louisville.edu/medschool/pharmacology/NA<br />

T.html). Depending on the effects <strong>of</strong> the<br />

polymorphisms, NAT2 alleles have been<br />

categorised in two groups as slow <strong>and</strong> fast<br />

acetylators. Individuals who lack both <strong>of</strong> the two<br />

functional NAT2 alleles have been designated as<br />

slow acetylators. A meta-analysis with combined<br />

results from 31 different studies has shown that<br />

NAT2 slow acetylation alleles increase the risk <strong>of</strong><br />

Genetic susceptibility to bladder cancer 7<br />

bladder cancer (OR=1,4; %95CI=1,2-1,7) (Garcia-<br />

Closas et al., 2005).<br />

NAT1 enzyme transfers one acetyl group from<br />

acetyl-coA to arylamine <strong>and</strong> hydrazin substrates.<br />

Many NAT1 variants have been defined to date<br />

(http://louisville.edu/medschool/pharmacology/NA<br />

T.html), however studies have revealed conflicting<br />

results (Hung et al., 2004) <strong>and</strong> their functional<br />

significance could not be fully identified yet.<br />

Since aromatic amines are present in cigarette<br />

smoke are the major risk factors for bladder cancer<br />

<strong>and</strong> are metabolized by NAT enzymes, it is for sure<br />

that the polymorphisms <strong>of</strong> the NAT genes have<br />

important roles in predisposing the individuals to<br />

bladder cancer (Franekova et al., 2008).<br />

Glutathione-S-transferases<br />

Cytosolic GSTs belong to a superfamily <strong>of</strong> Phase II<br />

enzymes, which contain sub-families <strong>and</strong><br />

polymorphic isoenzymes. The genetic<br />

polymorphisms <strong>of</strong> these enzymes affect the<br />

individual susceptibility to cancer, cardiovascular<br />

<strong>and</strong> respiratory diseases. GSTs facillitate the<br />

detoxification <strong>of</strong> electrophilic compounds by<br />

gluthathione conjugation. They interact with a wide<br />

variety <strong>of</strong> substrates including polycyclic aromatic<br />

hydrocarbon (PAH) epoxides <strong>and</strong> oxidative stress<br />

by-products. GSTM1 detoxifies carcinogenic PAHlike<br />

benzopyrene. A common deletion<br />

polymorphism in GSTM1 gene causes the loss <strong>of</strong><br />

enzyme activity <strong>and</strong> has been shown to be strongly<br />

associated with increased risk for bladder cancer<br />

(Jiang et al., 2011, Salinas-Sánchez et al., 2010)<br />

According to a meta-analysis conducted to show<br />

the overall effect <strong>of</strong> this polymorphism, an odds<br />

ratio (OR) <strong>of</strong> 1,5 has been calculated (%95CI=1,3-<br />

1,6) (Garcia-Closas et al., 2005). GSTT1 detoxifies<br />

smaller reactive hydrocarbons, like ethylene oxide.<br />

GSTT1 deletions, which have high frequency in<br />

Caucasians, have been associated with increased<br />

risk for bladder cancer (Abdel- Rahman et al.,1998;<br />

Srivastava et al., 2004). GSTP1 is involved in the<br />

conjugation <strong>and</strong> detoxification <strong>of</strong> many<br />

xenobiotics. The results <strong>of</strong> the studies investigating<br />

GSTT1 <strong>and</strong> GSTP1 gene polymorphisms are<br />

generally conflicting (Brockmoller et al., 1996;<br />

Lee et al., 2002.).<br />

In summary, polymorphisms <strong>of</strong> GSTM1,<br />

GSTT1 <strong>and</strong> GSTP1 constitute risk factors for many<br />

cancer types. Especially the null alleles <strong>of</strong> GSTM1


8 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİĞLU<br />

<strong>and</strong> GSTT1 are risk factors for bladder cancer in<br />

chain smokers.<br />

Sulphotransferases<br />

SULTs are encoded by a supergene family <strong>and</strong><br />

catalyze the sulphonation <strong>of</strong> many xenobiotic<br />

compounds, including drugs <strong>and</strong> carcinogens.<br />

SULT enzymes play role as one <strong>of</strong> the main<br />

detoxification systems in adults <strong>and</strong> in developing<br />

human fetuses. This gene family is not very<br />

polymorphic, except SULT1A1. SULT1A1<br />

Arg213His polymorphism, which causes a decrease<br />

in enzyme activity <strong>and</strong> thermal stability, has been<br />

suggested as a protective factor for bladder cancer<br />

(Zheng et al., 2003).<br />

NAD(P)H dehidrogenase, Quinone 1<br />

NQO1 enzyme protects the cell against<br />

electrophilic <strong>and</strong> oxidizing metabolites <strong>of</strong><br />

xenobiotic <strong>and</strong> endogenous quinone compounds.<br />

The gene coding for the NQO1 enzyme harbors<br />

several polymorphisms affecting enzyme activity.<br />

A187C transition results in the replacement <strong>of</strong><br />

proline with serine <strong>and</strong> decreases enzyme activity.<br />

Accordingly, Ser187 allele has been shown to<br />

increase bladder cancer risk (Franekova et al.,<br />

2008).<br />

Methylenetetrahydr<strong>of</strong>olate reductases<br />

MTHFR converts 5,10-methylenetetrahydr<strong>of</strong>olate<br />

(a methyl donor in deoxythymidine monophosphate<br />

synthesis) to 5-methyltetrahydr<strong>of</strong>olate. Folate<br />

deficiency is related to breakage <strong>of</strong> DNA str<strong>and</strong>s<br />

<strong>and</strong> binding <strong>of</strong> urasil to DNA. If an MTHFR variant<br />

causes a decrease in the folate levels by decreasing<br />

the enzyme activity; one can expect a tendency to<br />

DNA str<strong>and</strong> breakage <strong>and</strong> cancer formation. On the<br />

other h<strong>and</strong>, variant MTHFR activity alters the<br />

amount <strong>of</strong> methyl donors <strong>and</strong> thereby involves in<br />

bladder cancer formation by changing the status <strong>of</strong><br />

promotor methylation. MTHFR 677C>T <strong>and</strong><br />

1298A>C polymorphisms are proved to decrease<br />

enzyme activity. However, the relationship between<br />

the mentioned polymorphisms, enzyme activity <strong>and</strong><br />

susceptibility to bladder cancer should be more<br />

extensively studied to seek for confirming results<br />

(Karagas et al., 2005).<br />

Cytochrome P-450 genes<br />

CYP enzymes catalyze Phase I reactions <strong>and</strong><br />

belong to the microsomal enzyme super family.<br />

CYP enzyme system consists <strong>of</strong> over 20 highly<br />

polymorphic CYP enzymes<br />

(http://www.cypalleles.ki.se/). Human CYP1A1<br />

enzyme is expressed in epithelium <strong>and</strong> plays a key<br />

role in the activation <strong>of</strong> many procarcinogens<br />

including PAHs <strong>and</strong> aromatic amines arising from<br />

tobaccco-related products. Ile-Val (m2) mutation<br />

located in heme-binding domain <strong>and</strong> MspI (m1)<br />

mutation has been shown to increase enzyme<br />

activity. White blood cells <strong>of</strong> smokers harboring a<br />

Ile-Val mutation have been shown to contain more<br />

PAH-DNA adducts in comparison to non-smokers.<br />

Expression <strong>of</strong> CYP1A1 has been shown to elevate<br />

in bladder cancer patients in correlation with<br />

increased tumour stage (Bartsch et al., 2000). m1<br />

<strong>and</strong> m2 mutations, on the other h<strong>and</strong>, are directly<br />

associated with increased risk for lung cancer<br />

(Aynacioglu et al., 1998). CYP1A1 mutations<br />

exhibit variations among different ethnic groups. In<br />

contrast to Causians, prevalances <strong>of</strong> m1 <strong>and</strong> m2 are<br />

high among Asian populations. M3 mutation was<br />

identified only in Africans. In molecular <strong>and</strong><br />

epidemiologic studies, CYP1A1*2B allele,<br />

harboring m1 <strong>and</strong> m2 mutations, was found to be<br />

correlated with increased risk for lung cancer.<br />

Figure 2 shows the localisation <strong>of</strong> these four<br />

important mutations (m1, m2, m3, m4) on CYP1A1<br />

gene. Human CYP1B1 gene is located at<br />

chromosome 2p21 <strong>and</strong> contains three exons in a<br />

10kb region. It codes for the 543 amino acid long<br />

enzyme (Figure 3). It was found to be<br />

overexpressed in many cancer types including,<br />

colon, lung, skin, brain cancers in contrast to its<br />

lower expression in normal somatic tissues (Thier<br />

et al., 2002). CYP1B1 activates PAHs, aromatic<br />

<strong>and</strong> heterocyclic amines. It also catalyzes the<br />

conversion <strong>of</strong> benzo[a]pyrene to carcinogenic<br />

metabolite diol epoxide-2, which indicates its<br />

significant role in the activation <strong>of</strong> tobacco<br />

carcinogens. Studies conducted so far indicate that<br />

CYP1B1 polymorphisms, especially codon 432<br />

polymorphism, change enzyme activity <strong>and</strong><br />

contribute to carcinogenesis. CYP1B1 codon 432<br />

polymorphism increases risk for smokers for head<br />

<strong>and</strong> neck cancers (Thier et al., 2002).<br />

CYP2D6 gene codes for debrisoquine<br />

hydroxylase. Its subtrates include aromatic amines<br />

<strong>and</strong> tobacco nitrosamines. The existence <strong>of</strong><br />

homozygous recessive mutations in this gene<br />

results in the inability <strong>of</strong> metabolising certain<br />

compounds. Individuals with these mutations


compromise nearly 5-10% <strong>of</strong> the Caucasian<br />

population which are categorised as poor<br />

metabolizers (PM) because <strong>of</strong> their inability to<br />

metabolise certain compunds. The PM phenotype is<br />

Genetic susceptibility to bladder cancer 9<br />

associated with increased susceptibility to cancer,<br />

indicating a possible role for this enzyme in the<br />

conversion <strong>of</strong> procarcinogens to active carcinogens.<br />

Figure 2. m1, m2, m3 <strong>and</strong> m4 mutations in the CYP1A1 gene<br />

Most common mutations responsible for the PM<br />

phenotype have been identified. G/A transition<br />

located on exon3-intron4 conjunction creates an<br />

early stop codon resulting in defective mRNA. This<br />

CYP2E1 metabolizes many procarcinogens, e.g.<br />

N´-nitrosonornicotine, 4-methylnitrosamino-1,3pyridyl-1-butanone<br />

<strong>and</strong> other volatile nitrosamines,<br />

which are inhaled via cigarette smoking.<br />

Inter-individual expression variants <strong>of</strong> human<br />

CYP2E1 gene have been identified. The most<br />

frequently studied RFLPs on the CYP2E1 gene are<br />

those residing at the 5’ end <strong>of</strong> the gene which are<br />

proved to alter enzyme activity. Among them,<br />

PstI/RsaI (mutant allele: CYP2E1*5B) <strong>and</strong> DraI<br />

(mutant allele: CYP2E1*6) polymorphisms. These<br />

two polymorphisms together constitute the<br />

CYP2E1*5A allele. In addition to this, RsaI (G-<br />

1259C) <strong>and</strong> PstI (C-1091T) alleles are in complete<br />

linkage disequilibrium with eachother. CYP2E1*6<br />

allele variant is present in nearly 10% <strong>of</strong> the<br />

European population. Recently, Haufroid et al.<br />

(2002) have shown that people with at least one<br />

CYP2E1*6 allele have lower chlorzoxazone than<br />

homozygous wild type individuals. There are ethnic<br />

variations in CYP2E1*5A allele frequencies among<br />

Figure 3. Structure <strong>of</strong> the CYP1B1 gene (Thier et al., 2002)<br />

mutation accounts for 80% <strong>of</strong> the PM phenotype.<br />

While the deletion <strong>of</strong> the whole CYP2D6 gene<br />

accounts for the 15% <strong>of</strong> PM phenotypes (Sobti et<br />

al., 2005; Febbo et al., 1998).<br />

Asians <strong>and</strong> Europeans. Europeans are 5%<br />

heterozygous; Asians are 37% heterozygous <strong>and</strong><br />

6% homozygous for this allele. Because <strong>of</strong> the<br />

certain inter-ethnic variations <strong>of</strong> the CYP2E1*5A<br />

allele, genetic polymophisms, enzyme expression<br />

<strong>and</strong> alterations in the chemical metabolism are still<br />

not clear <strong>and</strong> the studies are conflicting each other<br />

(Bolt et al., 2003).<br />

Aldo-Ketoreductases<br />

AKRs catalyze the conversion <strong>of</strong> carbonyl groups<br />

to alcohol derivatives. Their most common<br />

endogenic substrates are lipid aldehydes, steroids<br />

<strong>and</strong> prostogl<strong>and</strong>ines. They also activate prodrugs<br />

<strong>and</strong> polycyclic aromatic hydrocarbons (PAHs). In<br />

addition, they have been shown to induce resistance<br />

against chemotherapeutic agents like cysplatine <strong>and</strong><br />

doxorubicin. The essential function <strong>of</strong> AKRs is to<br />

convert aldehydes to primary <strong>and</strong> secondary<br />

alcohols by reduction (Flynn <strong>and</strong> Green 1993;<br />

Penning et al., 2004). This conversion enables the


10 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />

conjugation reactions <strong>and</strong> therefore aldoketoreductases<br />

are considered as Phase I enzymes.<br />

Human AKRs interact with various substrates<br />

including drugs, carcinogens <strong>and</strong> reactive<br />

aldehydes. Their important role in the metabolism<br />

<strong>of</strong> these substrates signifies them as key enzymes in<br />

designating the carcinogenicity <strong>of</strong> these substrates.<br />

There are 15 AKR families discovered so far.<br />

Human AKRs are categorised into 3 families as<br />

AKR1, AKR6 <strong>and</strong> AKR7. 8 <strong>of</strong> the 13 discovered<br />

human AKRs belong to the AKR1 family<br />

(AKR1A1, AKR1B1, AKR1B10, AKR1C1,<br />

AKR1C2, AKR1C3, AKR1C4 <strong>and</strong> AKR1D1).<br />

Most <strong>of</strong> the AKR enzymes are 34-37 kDa<br />

monomeric proteins with a catalytic tetrade region,<br />

conserved among family members. Their substrate<br />

binding domains, on the other h<strong>and</strong>, show great<br />

variety, representing the diversity <strong>of</strong> their substrates<br />

(Jin <strong>and</strong> Penning, 2007).<br />

AKRs <strong>and</strong> activation <strong>of</strong> PAHs<br />

There are three different pathways <strong>of</strong> PAH<br />

activation. These are P-450 peroxidase induced<br />

formation <strong>of</strong> radical cations, P-450 induced<br />

formation <strong>of</strong> diol-epoxides <strong>and</strong> AKR induced<br />

formation <strong>of</strong> reactive o-quinones. The latter are<br />

highly reactive molecules which can bind to most<br />

macrobiomolecules including DNA, RNA <strong>and</strong><br />

proteins preemminently (Jin <strong>and</strong> Penning, 2007).<br />

The formation <strong>of</strong> o-quinones generates reactive<br />

oxygen species as by-products, which activate RAS<br />

targets by inducing the expression <strong>of</strong> antioxidant<br />

response element (ARE) containing genes. Since<br />

RAS pathway is responsible for transmitting the<br />

extracellular growth signals to nucleus, o-quinones<br />

produced by AKRs are considered to effect both the<br />

induction <strong>and</strong> progress <strong>of</strong> carcinogenesis (Jin <strong>and</strong><br />

Penning, 2007).<br />

Function <strong>and</strong> tissue specific expression <strong>of</strong> Aldo-<br />

Ketoreductases<br />

Human AKR1C family members; AKR1C1,<br />

AKR1C2, AKR1C3 <strong>and</strong> AKR1C4; show great<br />

homology to each other. They all contain 9 exons<br />

<strong>and</strong> are located on chromosome 10. The expression<br />

<strong>of</strong> AKR1C genes are regulated by AREs located in<br />

their promoters.<br />

AKR1C1 <strong>and</strong> AKR1C2 have been shown to be<br />

expressed 50-fold more in lung tumors (Hsu et al.<br />

2001). To confirm these results Palackal <strong>and</strong><br />

colleagues have measured the expression levels <strong>of</strong><br />

AKR1C1, AKR1C2 <strong>and</strong> AKR1C3 is<strong>of</strong>orms in lung<br />

adenocarcinoma cells <strong>and</strong> obtained similar results<br />

(Palackal et al., 2002). Furthermore a study<br />

conducted by Dozmorov et al. have shown that<br />

increased AKR1C3 expression induce angiogenesis<br />

<strong>and</strong> increase cell survival (Dozmorov et al., 2010)<br />

.AKR polymorphisms<br />

Even though the structural difference between<br />

AKR1C1 <strong>and</strong> AKR1C2 arises only from 7 different<br />

aminoacids, they have vastly different functions.<br />

Nonhomologous aminoacids are T38V, R47H,<br />

L54V, C87S, V151M, R170H <strong>and</strong> Q1721 which<br />

are highly polymorphic. Common polymorphisms<br />

in the AKR1C1 gene are T38A, T38I <strong>and</strong> R47H,<br />

whilst H47R, S87C, L172Q <strong>and</strong> V38A are common<br />

polymorphisms in AKR1C2. There have been 17<br />

polymorphisms identified in the coding regions <strong>of</strong><br />

AKR1C3. Nine <strong>of</strong> these polymorphisms results in<br />

amino acid changes while the other eight are<br />

synonymous (Table 1.).<br />

One <strong>of</strong> the nonsynonymous polymorphisms, the<br />

G106T polymorphism, has been shown to produce<br />

truncated protein; <strong>and</strong> another nonsynonymous<br />

polymorphism, A230G, has been associated with<br />

decreased cholesterol levels in the blood<br />

(Jakobsson et al., 2007). AKR1C4*5 (L311V)<br />

polymorphism is located on the C-terminal <strong>and</strong> has<br />

been shown to affect substrate binding specifity<br />

(Kume et al., 1999).<br />

There are a few studies conducted to investigate<br />

the association between the AKR polymorphisms<br />

<strong>and</strong> cancer. AKR polymorphisms have been<br />

investigated in Non-Hodgkin lymphoma <strong>and</strong><br />

AKR1A1 rs2088102 polymorphism has been<br />

shown to be associated with increased risk (Lan et<br />

al., 2004). Another study, where the association<br />

between prostate cancer <strong>and</strong> AKR1C3<br />

polymorphism have been investigated has shown an<br />

increased risk for rs7741 polymorphism<br />

(Cunningham et al., 2007).<br />

Studies concerning rs12529 polymorphism gave<br />

conflicting results. rs12529 has been shown to be<br />

associated with increased lung cancer (OR=1,84,<br />

%95CI= 0,98-3,45), while it has been shown to<br />

confer protection for bladder cancer (Lan et al.,<br />

2007; Figuerova et al., 2008; Tiryakioğlu, 2011).<br />

Figuerova et al.(2008) investigated 8<br />

polymorphisms located in two regions <strong>of</strong> AKR1C3<br />

gene, which are likely to affect bladder cancer risk<br />

(Table2).


Genetic susceptibility to bladder cancer 11<br />

Table 1. Exonic polymorphisms <strong>of</strong> AKR1C3 gene (http://www.med.upenn.edu/akr/polymorphisms.shtml)<br />

Exon Polymorphism Function Nucleotide change Aminoacid change Allele<br />

3 rs7741 synonymous G90A P30 AKR1C3*1A<br />

4 rs12387 synonymous G312A K104 AKR1C3*1B<br />

6 rs1131124 synonymous G495A V165 AKR1C3*1C<br />

3 rs1804061 synonymous A117G K39 AKR1C3*1D<br />

6 rs1937839 synonymous G459A K153 AKR1C3*1E<br />

8 rs7342072 synonymous C705T L235 AKR1C3*1F<br />

6 rs17849485 synonymous C546T L182 AKR1C3*1G<br />

3 rs28943574 synonymous A231G E77 AKR1C3*1H<br />

1 rs12529 nonsynonymous C15G Q5H AKR1C3*2<br />

6 rs1131132 nonsynonymous C525G M175I AKR1C3*3<br />

3 rs1804062 nonsynonymous G106T E36term AKR1C3*4<br />

9 rs1804059 nonsynonymous G879T M293I AKR1C3*5<br />

4 rs4987102 nonsynonymous G316A A106T AKR1C3*6<br />

3 rs11551177 nonsynonymous A230G E77G AKR1C3*7<br />

9 rs11551178 nonsynonymous G883T A295S AKR1C3*8<br />

5 rs28943579 nonsynonymous G434A C145Y AKR1C3*9<br />

5 rs28943580 nonsynonymous C772T R258C AKR1C3*10<br />

In this study, rs3763676, rs12775701 <strong>and</strong><br />

rs1937843 polymorphisms were found to be<br />

associated with increased bladder cancer risk;<br />

rs1937845, rs12529, rs4881400 <strong>and</strong> rs4641368<br />

polymorphisms were found to confer protection<br />

against bladder cancer. Recently, rs12529<br />

polymorphism has been shown to be associated<br />

with decreased bladder cancer risk (Tiryakioğlu,<br />

2011). According to this retrospective study,<br />

Conclusion<br />

homozygous GG variant genotype protects against<br />

bladder cancer (OR=0,255; %95CI=0,101-0,644),<br />

which supports the findings <strong>of</strong> Figuerova et<br />

al.(2008), where OR=0,78; %95CI= 0,52-1,18.<br />

Upon adjustment <strong>of</strong> these figures according to<br />

important risk factors in bladder cancer, namely,<br />

sex <strong>and</strong> cigarette smoking status, Tiryakioğlu<br />

(2001) have shown that rs12529 GG genotype still<br />

conserves its protective effect (OR=0,243).<br />

Table 2. AKR1C3 polymorphisms associated with bladder cancer<br />

Polymorphism Genotype Odds Ratio<br />

rs12529 GG OR= 0,78; %95CI= 0,52-1,18<br />

rs1937845 GG OR=0,74; %95CI= 0,57-0,96<br />

rs3763676 AG OR=1,28; %95CI= 1,05-1,55<br />

rs4881400 GG OR=0,53; %95CI= 0,33-0,85<br />

rs461368 TT OR=0,42; %95CI= 0,20-0,91<br />

rs127755701 GG OR=1,41; %95CI= 1,05-1,90<br />

The genetic variations in the human genome is truly<br />

a powerful source for the investigation <strong>of</strong> the<br />

complex disesases where genetic <strong>and</strong><br />

environmental factors interact to characterize the<br />

final outcome. Over the past ten years, researchers<br />

agreed on that rare genetic defects imputed to<br />

certain populations are not usually responsible for<br />

ever increasing cancer cases; rather polymorphic


12 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />

variations in the DNA sequences confer individual<br />

susceptibilities. This notion has been accepted for<br />

many cancer promoting mechanisms, including<br />

bladder cancer (Kim <strong>and</strong> Quan, 2005). Bladder<br />

cancer still conserves its importance regarding<br />

genetic <strong>and</strong> epidemiologic studies, since<br />

environmental factors, mainly cigarette smoking<br />

<strong>and</strong> occupational exposure to certain carcinogens<br />

play major roles in the formation <strong>of</strong> this cancer<br />

type. There are reasons for the high importance <strong>of</strong><br />

this cancer type in terms <strong>of</strong> molecular research. In<br />

the first place, genetic polymorphisms in the<br />

metabolizing genes may alter the functions <strong>of</strong> the<br />

related enzymes, which will result in abnormalities<br />

in the xenobiotic functions <strong>of</strong> the cell. As an<br />

outcome, the environmental carcinogens may not<br />

be detoxified properly <strong>and</strong> hence cause bladder<br />

cancer. Identification <strong>of</strong> the polymorphisms in the<br />

xenobiotic genes <strong>and</strong> their functional relevance to<br />

bladder cancer formation will certainly highlight<br />

the importance <strong>of</strong> inter-individual genetic<br />

variations <strong>and</strong> the phenomenon <strong>of</strong> genetic<br />

susceptibility, which can be adapted easily to other<br />

genetic conditions. Looking at the same view from<br />

another direction we can still come up with the<br />

importance <strong>of</strong> genetic polymorphisms in defining<br />

disease risks. Since bladder cancer is caused mainly<br />

by environmental factors, people living at the same<br />

st<strong>and</strong>ards in terms <strong>of</strong> cigarette smoking, diet <strong>and</strong><br />

other environmental exposures can be investigated<br />

for the frequency <strong>of</strong> occurrence <strong>of</strong> bladder cancer.<br />

Keeping the environmental factors constant, the<br />

only remaining factor will be the genetic variations.<br />

Comparing the frequencies <strong>of</strong> the genetic<br />

polymorphisms among bladder cancer cases <strong>and</strong><br />

healthy controls exposed to the same environments,<br />

genetic polymorphims responsible for the bladder<br />

cancer formation can be identified. There are for<br />

sure hundreds <strong>of</strong> genetic loci to investigate,<br />

however, it will be wise to begin with the genes<br />

coding for the xenobiotic-metabolizing enzymes.<br />

On the other h<strong>and</strong>, the above-mentioned studies<br />

should be performed for each ethnic <strong>and</strong><br />

geographic population in order to delineate<br />

genotypic distributions <strong>and</strong> to define genetic<br />

susceptibility loci. Using the accumulated data,<br />

researchers can establish diagnostic <strong>and</strong> even presymptomatic<br />

criteria on the basis <strong>of</strong> genetic<br />

polymorphisms. Until now, the prognostic <strong>and</strong><br />

diagnostic value <strong>of</strong> the current accumulated data<br />

prove to be problematic to utilize. The main reason<br />

for this is the conflicting results in addition to<br />

overlooked environmental <strong>and</strong> demographic<br />

factors. Another reason is the small scope <strong>of</strong> the<br />

most studies, focusing on a few genes instead <strong>of</strong><br />

taking the whole metabolic systems into account.<br />

Also, sample sizes <strong>of</strong> the studies are one <strong>of</strong> the<br />

major problems; wider retrospective research<br />

studies including hundreds <strong>of</strong> samples should be<br />

constructed. With the ever reducing time <strong>and</strong><br />

money costs <strong>of</strong> whole genome association studies,<br />

it becomes rapidly easier to perform wide-range<br />

studies, paving the way for more rewarding<br />

research.<br />

References<br />

Abdel-Rahman SZ, Anwar Wa, Abdel-Aal WE,<br />

Mostafa HM <strong>and</strong> Au WW. GSTM1 <strong>and</strong> GSTT1<br />

genes are potential risk modifiers for bladder<br />

cancer. Cancer Detection <strong>and</strong> Prevention<br />

22:129-138, 1998.<br />

Aynacıoglu AS, Cascorbi I, Mrozikiewicz PM <strong>and</strong><br />

Roots I. High frequency <strong>of</strong> CYP1A1 mutations<br />

in a Turkish population. Arch. Toxicol. 72: 215-<br />

218, 1998.<br />

Bartsch H, Nair U, Risch A, Rojas M, Wikman H<br />

<strong>and</strong> Alex<strong>and</strong>rov K. Genetic polymorphism <strong>of</strong><br />

CYP genes, alone or in combination, as a risk<br />

modifier <strong>of</strong> tobacco-related cancers. Cancer<br />

Epidemio. Biomarkers Prev. 9: 3-28, 2000.<br />

Bolt HM, Roos PH <strong>and</strong> Thier R. The cytochrome<br />

P-450 isoenzyme CYP2E1 in the biological<br />

processing <strong>of</strong> industrial chemicals:<br />

consequences for occupational <strong>and</strong><br />

environmental medicine. Int. Arch Occup<br />

Environ Health. 76: 174-185, 2003.<br />

Brockmoller J, Cascorbi I, Kerb R <strong>and</strong> Roots I.<br />

Combined analysis <strong>of</strong> inherited polymorphisms<br />

in arylamine N-acetyltransferase 2, glutathione<br />

S-transferase M1 <strong>and</strong> T1, microsomal epoxide<br />

hydrolase <strong>and</strong> cytochrome P450 enzymes as<br />

modulators bladder cancer risk. Cancer<br />

Research. 56: 3915-3925, 1996.<br />

Cascorbi I, Brockmoller J <strong>and</strong> Roots I. A C4887A<br />

polymorphism in exon 7 <strong>of</strong> human CYP1A1:<br />

population frequency, mutation linkages, <strong>and</strong><br />

impact on lung cancer susceptibility. Cancer<br />

Research. 4965-4969, 1996.


Cunningham JM. SJ Hebbring SJ, McDonnell SK,<br />

Cicek MS, Christensen GB, Wang L, Jacobsen<br />

SJ, Cerhan JR, Blute ML, Schaid DJ <strong>and</strong><br />

Thibodeau SN. Evaluation <strong>of</strong> genetic variations<br />

Dozmorov MG, Azzarello JT, Wren JD, Fung KM,<br />

Yang Q, Davis JS, Hurst RE, Culkin DJ,<br />

Penning TM <strong>and</strong> Lin HK. Elevated AKR1C3<br />

expression promotes prostate cancer cell<br />

survival <strong>and</strong> prostate cell-mediated endothelial<br />

cell tube formation: implications for prostate<br />

cancer progression. BMC Cancer.10: 672, 2010.<br />

Febbo PG, Kant<strong>of</strong>f PW, Giovannucci E, Brown M,<br />

Chang G, Hennekens CH <strong>and</strong> Stampfer M.<br />

Debrisoquine Hydroxylase (CYP2D6) And<br />

Prostate Cancer. Cancer Epidemiol Biomarkers<br />

Prev. 7: 1075-1078, 1998.<br />

Figuerova JD, Malats N, Garci-Closas M, Real FX,<br />

Silverman D, Kogevinas M, Chanock S, Welch<br />

R, Dosemeci M, Lan Q, Tardón A, Serra C,<br />

Carrato A, García-Closas R, Castaño-Vinyals G<br />

<strong>and</strong> Rothman N. Bladder cancer risk <strong>and</strong><br />

genetic variation in AKR1C3 <strong>and</strong> other<br />

metabolizing genes. Carcinogenesis.<br />

29(10):1955-1962, 2008.<br />

Flynn TG <strong>and</strong> Green NC. The aldo-keto reductases:<br />

an overview. Adv Exp Med Biol. 328:251-7,<br />

1993.<br />

Franekova M, Halasova E, Bukovska E, Luptak J<br />

<strong>and</strong> Dobrota D. Gene polymorphisms in bladder<br />

cancer. Urologic Oncology. 26(1):1-8, 2008.<br />

García-Closas M, Malats N, Silverman D,<br />

Dosemeci M, Kogevinas M, Hein DW, Tardón<br />

A, Serra C, Carrato A, García-Closas R, Lloreta<br />

J, Castaño-Vinyals G, Yeager M, Welch R,<br />

Chanock S, Chatterjee N, Wacholder S,<br />

Samanic C, Torà M, Fernández F, Real FX <strong>and</strong><br />

Rothman N. NAT2 slow acetylation, GSTM1<br />

null genotype, <strong>and</strong> risk <strong>of</strong> bladder cancer:<br />

results from the Spanish Bladder Cancer Study<br />

<strong>and</strong> meta-analyses. Lancet. 366(9486):649-59,<br />

2005.<br />

Hein DW, Boukouvala S, Grant DM, Minchin RF<br />

<strong>and</strong> Sim E. Human Arylamine N-<br />

Acetyltransferase Gene Nomenclature.<br />

Retrieved August 21, 2009 from<br />

http://louisville.edu/medschool/pharmacology/N<br />

AT.html<br />

Genetic susceptibility to bladder cancer 13<br />

in the <strong>and</strong>rogen <strong>and</strong> estrogen metabolic<br />

pathways as risk factors for sporadic <strong>and</strong><br />

familial prostate cancer. Cancer Epidemiology,<br />

Biomarkers <strong>and</strong> Prevention. 16: 969–978. 2007.<br />

Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS,<br />

Wang LS <strong>and</strong> Tsai CM. Overexpression <strong>of</strong><br />

dihydrodiol dehydrogenase as a prognostic<br />

marker <strong>of</strong> non-small cell lung cancer. Cancer<br />

Res. 61(6):2727-31, 2001.<br />

Hung RJ, B<strong>of</strong>fetta P, Brennan P, Malaveille C,<br />

Hautefeuille A, Donato F, Gelatti U, Spaliviero<br />

M, Placidi D, Carta A, Scotto di Carlo A <strong>and</strong><br />

Porru S. GST, NAT, SULT1A1, CYP1B1<br />

genetic polymorphisms, interactions with<br />

environmental exposures <strong>and</strong> bladder cancer<br />

risk in a high-risk population. International<br />

<strong>Journal</strong> <strong>of</strong> Cancer. 110(4):598-604, 2004.<br />

Hyndman D <strong>and</strong> Penning TM. Single Nucleotide<br />

Polymorphisms in Human AKR Genes.<br />

Retrieved October 19, 2010 from<br />

http://www.med.upenn.edu/akr/polymorphisms.<br />

shtml<br />

Jakobsson J. Palonek E, Lorentzon M, Ohlsson C,<br />

Rane A <strong>and</strong> Ekström L. A novel polymorphism<br />

in the 17beta-hydroxysteroid dehydrogenase<br />

type 5 (aldo-keto reductase 1C3) gene is<br />

associated with lower serum testosterone levels<br />

in caucasian men. The Pharmacogenomics<br />

<strong>Journal</strong>. 7: 282–289, 2007.<br />

Jiang Z, Li C <strong>and</strong> Wang X. Glutathione Stransferase<br />

M1 polymorphism <strong>and</strong> bladder<br />

cancer risk: a meta-analysis involving 33<br />

studies. Exp Biol Med. 236(6):723-8, 2011.<br />

Jin Y <strong>and</strong> Penning TM. Aldo-keto reductases <strong>and</strong><br />

bioactivation/detoxication. Annual Reviews<br />

Pharmacology <strong>and</strong> Toxicology. 47:263-92,<br />

2007.<br />

Karagas MR, Park S, Nelson HH, Andrew AS,<br />

Mott L, Schned A <strong>and</strong> Kelsey KT.<br />

Methylenetetrahydr<strong>of</strong>olate reductase (MTHFR)<br />

variants <strong>and</strong> bladder cancer: a population-based<br />

case-control study. Int J Hyg Environ Health.<br />

208: 321-327, 2005.<br />

Kim WJ <strong>and</strong> Quan C. Genetic <strong>and</strong> epigenetic<br />

aspects <strong>of</strong> bladder cancer. J <strong>Cell</strong> Biochem. 95:<br />

24-33, 2005.


14<br />

Kume T, Iwasa H, Shiraishi H, Yokoi T,<br />

Nagashima K, Otsuka M, Terada T, Takagi<br />

T, Hara A <strong>and</strong> Kamataki T. Characterization<br />

<strong>of</strong> a novel variant (S145C/L311V) <strong>of</strong><br />

3alpha-hydroxysteroid/dihydrodiol<br />

dehydrogenase in human liver.<br />

Pharmacogenetics. 9(6):763-71, 1999.<br />

Lan Q, Mumford JL, Shen M, Demarini DM,<br />

Bonner MR, He X, Yeager M, Welch R,<br />

Chanock S, Tian L, Chapman RS, Zheng T,<br />

Keohavong P, Caporaso N <strong>and</strong> Rothman N.<br />

Oxidative damage-related genes AKR1C3<br />

<strong>and</strong> OGG1 modulate risks for lung cancer<br />

due to exposure to PAH-rich coal<br />

combustion emissions. Carcinogenesis.<br />

25:2177–2181, 2004.<br />

Lan Q, Zheng T, Shen M, Zhang Y, Wang SS,<br />

Zahm SH, Holford TR, Leaderer B, Boyle P<br />

<strong>and</strong> Chanock S. Genetic polymorphisms in<br />

the oxidative stress pathway <strong>and</strong><br />

susceptibility to non-Hodgkin lymphoma.<br />

Human Genetics. 121:161–168, 2007.<br />

Lee SJ, Cho SH, Park SK, Kim SW, Park MS,<br />

Choi HY, Choi JY, Lee SY, Im HJ, Kim JY,<br />

Yoon KJ, Choi H, Shin SG, Park TW,<br />

Rothman N, Hirvonen A <strong>and</strong> Kang D.<br />

Combined effect <strong>of</strong> glutathione S-transferase<br />

M1 <strong>and</strong> T1 genotypes on bladder cancer<br />

risk. Cancer Letters. 177(2):173-9, 2002.<br />

Longuemaux S, Delomenıe C, Gallou C,<br />

Mejean A, Vincent-viry M, Bouvier R, Droz<br />

D, Krishnamoorthy R, Galteau MM, Junien<br />

C, Beroud C <strong>and</strong> Dupret JM. C<strong>and</strong>idate<br />

genetic modifiers <strong>of</strong> individual susceptibility<br />

to renal cell carcinoma: a study <strong>of</strong><br />

polymorphic human xenobioticmetabolizing<br />

enzymes. Cancer Res. 59:<br />

2903-2908, 1999.<br />

Palackal NT, Lee H, Harvey R, Blair I, <strong>and</strong><br />

Penning TM. Activation <strong>of</strong> polycyclic<br />

aromatic hydrocarbon trans-dihydrodiol<br />

proximate <strong>and</strong> their functional<br />

overexpression in human lung carcinoma<br />

(A549) cells. <strong>Journal</strong> <strong>of</strong> Biological<br />

Chemistry. 277(27):24799-24808, 2002.<br />

Parkin DM, Whelan S, Ferlay J, Leppo L <strong>and</strong><br />

Thomas DB. Cancer incidence in five<br />

continents. IARC Publication, Lyon, 2002.<br />

Parkin DM. The global burden <strong>of</strong> urinary<br />

bladder cancer. Sc<strong>and</strong>inavian <strong>Journal</strong> <strong>of</strong><br />

Urology <strong>and</strong> Nephrology. 218:12-20, 2008.<br />

Penning TM, Jin Y, Steckelbroeck S, Lanisnik<br />

Rizner T <strong>and</strong> Lewis M. Structure-function <strong>of</strong><br />

human 3 alpha-hydroxysteroid<br />

dehydrogenases: genes <strong>and</strong> proteins. Mol<br />

<strong>Cell</strong> Endocrinol. 215(1-2):63-72, 2004.<br />

Salinas-Sánchez AS, Sánchez-Sánchez F,<br />

Donate-Moreno MJ, Rubio-Del-Campo A,<br />

Gimenez-Bachs JM, Lorenzo-Romero JG,<br />

Serrano-Oviedo L <strong>and</strong> Escribano J.<br />

Polymorphic deletions <strong>of</strong> the GSTT1 <strong>and</strong><br />

GSTM1 genes <strong>and</strong> susceptibility to bladder<br />

cancer. BJU Int. 107(11):1825-32, 2011.<br />

Silverman DT, Rothman N, Devesa SS, Syrigos<br />

KN <strong>and</strong> Skinner DG. Bladder cancer:<br />

biology, diagnosis, <strong>and</strong> management.<br />

Oxford University Press, New York, 1999.<br />

Sobti RC, Al-badran, AI Sharma, S Sharma, SK<br />

Krishan A <strong>and</strong> Mohan H. Genetic<br />

polymorphisms <strong>of</strong> CYP2D6, GSTM1, <strong>and</strong><br />

GSTT1 genes <strong>and</strong> bladder cancer risk in<br />

North India. Cancer Genet. Cytogenet. 156:<br />

68-73, 2005.<br />

Srivastava DS, Kumar A, Mittal B <strong>and</strong> Mittal<br />

RD. GSTM1 <strong>and</strong> GSTT1 genes in bladder<br />

cancer: A study from North India. Archives<br />

<strong>of</strong> Toxicology 78:430-434, 2004.<br />

Thier R, Brüning T, Roos PH <strong>and</strong> Bolt HM.<br />

Cytochrome P450 1B1, a new keystone in<br />

gene-environment interactions related to<br />

human head <strong>and</strong> neck cancer? Toxicol. 76:<br />

249-256, 2002.<br />

Tiryakioğlu O. Investigation <strong>of</strong> aldoketoreductase<br />

1C3 rs12529 polymorphism in<br />

bladder cancer patients. MSc Thesis. <strong>Haliç</strong><br />

University, 2011.<br />

Zheng L, Wang Y, Schabath MB, Grossman<br />

H.B <strong>and</strong> Wu X. Sulfotransferase 1A1<br />

(SULT1A1) polymorphism <strong>and</strong> bladder<br />

cancer risk: A case-control study. Cancer<br />

Letters. 202:61-69, 2003.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 15-20, 2011 Research Article 15<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Identification <strong>of</strong> silencing suppressors <strong>of</strong> potato virus M<br />

Ruslan KRYLDAKOV 1* , Rashid AKBERGENOV 2 , Thomas HOHN 2 <strong>and</strong> Bulat<br />

ISKAKOV 1<br />

1<br />

Laboratory <strong>of</strong> Proteins <strong>and</strong> Nucleic Acids Research, M.A. Ajtkhozhin Institute <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong><br />

Biochemistry, Almaty, Kazakhstan<br />

2<br />

Laboratory <strong>of</strong> <strong>Molecular</strong> Plant Virology, Botanical Institute, University <strong>of</strong> Basel, Basel, Switzerl<strong>and</strong><br />

(* author for correspondence; kryldakov@yahoo.com)<br />

Received: 10 May 2010; Accepted: 20 January 2011<br />

Abstract<br />

Gene silencing is an important regulatory <strong>and</strong> defense mechanism in plants. Plant viruses evolved some<br />

proteins that suppress cellular RNA interference mechanism. In this work identification <strong>of</strong> silencing<br />

suppressors <strong>of</strong> potato virus M (PVM) is reported. The cDNA sequences <strong>of</strong> different PVM open reading<br />

frames were cloned into the Gateway-compatible binary T-DNA destination vector pMDC32, harboring a<br />

double 35S promoter. Each <strong>of</strong> these constructs was electroporated into Agrobacterium tumefaciens C58C1<br />

which then were agroinfiltrated into Nicotiana benthamiana 16C line. It was shown that viral coat protein<br />

(34K) as well as some other PVM proteins (12K, 11K) possessed suppressor properties <strong>of</strong> cellular silencing<br />

activity.<br />

Keywords: Gene silencing, suppressors <strong>of</strong> silencing, potato virus M, agroinfiltration, Nicotiana benthamiana<br />

16C line<br />

Patates virüsü M’nin susturucu baskılayıcılarının tayini<br />

Özet<br />

Gen susturma bitkilerde önemli bir düzenleme ve savunma mekanizmasıdır. Bitki virüsleri hücresel RNA<br />

müdehalesi mekanizmalarını baskılayan bazı proteinler evrimleştirmiştir. Bu çalışmada patates virüsü M’nin<br />

(PVM) susturucu baskılayıcılarının belirlenmesi rapor edilmiştir. Farklı PVM açık okuma çerçevesi olan<br />

cDNA dizileri çift 35S promotor içeren ikili T-DNA hedef vektörü pMDC32’ye klonl<strong>and</strong>ı. Bu düzeneklerin<br />

herbiri elektroporasyon ile Agrobacterium tumefaciens C58C1’e verilip daha sonra agroinfiltrasyon ile<br />

Nicotiana benthamiana 16C hattına süzdürüldü. Viral kılıf proteininin (34K) yanı sıra bazı diğer PVM<br />

proteinlerinin (12K, 11K) hücresel susturma aktivitesinin baskılayıcı özelliklerine sahip oldukları gösterildi.<br />

Anahtar Sözcükler: Gen susturma, susturmanın baskılayıcıları, patates virüsü M, agroinfiltrasyon, Nicotiana<br />

benthamiana 16C hattı<br />

Introduction<br />

Recently a new defense system was detected that<br />

does function in plants, namely post-transcriptional<br />

gene silencing (PTGS) or RNA interference<br />

(RNAi). In response to virus infection, this<br />

“adaptive immune-system” is induced based on the<br />

recognition <strong>of</strong> double-str<strong>and</strong>ed (ds) RNA or<br />

excessive quantities <strong>of</strong> RNA (Jorgensen, 2003).<br />

RNAi is an evolutionary conserved mechanism in<br />

many, if not all, eukaryotes, to target <strong>and</strong> degrade<br />

aberrant endogenous or exogenous RNA molecules<br />

(Sontheimer, 2005; Voinnet, 2005).<br />

Due to this silencing defense system, plant<br />

viruses are thought to need a counter defense<br />

mechanism to successfully infect a plant.<br />

Depending on the virus, such PTGS suppression<br />

can be a secondary function <strong>of</strong> almost any type <strong>of</strong><br />

viral protein. In plants, RNA silencing has been<br />

demonstrated to be one <strong>of</strong> the most important


16<br />

Ruslan KRYLDAKOV et al.<br />

antiviral mechanisms (Li <strong>and</strong> Ding, 2001; Ding et<br />

al., 2004). As a response to this highly efficient<br />

antiviral RNA silencing pathway, plant viruses<br />

have evolved specific suppressor proteins. Many <strong>of</strong><br />

these proteins were previously described as<br />

virulence factors or pathogenicity determinants. It<br />

has been reported that many plant viruses encode<br />

suppressor proteins to combat against RNA<br />

silencing (Voinnet, Pinto <strong>and</strong> Baulcombe, 1999; Li<br />

<strong>and</strong> Ding, 2001). Identification <strong>of</strong> silencing<br />

suppressors <strong>of</strong> different viruses is a crucial step in<br />

direction <strong>of</strong> development <strong>of</strong> resistance against viral<br />

infection (Ding <strong>and</strong> Voinnet, 2007).<br />

Silencing suppressors can interfere with several<br />

steps <strong>of</strong> the silencing pathway, i.e. dsRNA cleavage<br />

to produce siRNAs, destabilization <strong>of</strong> siRNAs,<br />

binding <strong>of</strong> siRNAs <strong>and</strong> siRNA usage as part <strong>of</strong><br />

RISC, which is required for target RNA<br />

elimination. Silencing suppressors are usually<br />

multifunctional viral proteins <strong>and</strong> in different virus<br />

families different viral proteins gain suppressor<br />

function as an additional property. Interference<br />

with suppressor function would inhibit the viral<br />

counter-defense system.<br />

The research <strong>and</strong> identification <strong>of</strong> silencing<br />

suppressors <strong>of</strong> PVM were carried out. Potato is one<br />

<strong>of</strong> the most important crops, <strong>and</strong> PVM, together<br />

with PVY, is responsible for 80% <strong>of</strong> all viruscaused<br />

losses <strong>of</strong> potato yields, especially in<br />

Kazakhstan (Sozinova et al., 2007). Thus the<br />

identification <strong>of</strong> PVM’s silencing suppressors<br />

points to the role <strong>of</strong> gene silencing as a natural<br />

antiviral defense system in plants.<br />

Materials <strong>and</strong> methods<br />

RNA isolation<br />

A PVM isolate was maintained in Nicotiana<br />

tabacum plants. Leaves <strong>of</strong> N. tabacum were<br />

harvested <strong>and</strong> frozen in liquid nitrogen, ground to a<br />

fine powder <strong>and</strong> mixed with Tri-reagent (“Sigma”),<br />

extracted once with 1/5 volume <strong>of</strong> chlor<strong>of</strong>orm.<br />

RNA was precipitated with the addition <strong>of</strong> an equal<br />

volume <strong>of</strong> isopropanol <strong>and</strong> incubated at +4°C for<br />

30 min. RNA was washed with 70% ethanol <strong>and</strong><br />

dissolved in water.<br />

Construction <strong>of</strong> PVM vectors<br />

The last 5 <strong>of</strong> 6 protein sequences <strong>of</strong> PVM were<br />

obtained with using SuperScript II Reverse<br />

Transcriptase according to manufacture protocol.<br />

PVM cDNA fragments encoding the 25kDa,<br />

12kDa, 7 kDa, coat protein (CP) <strong>and</strong> 11 kDa were<br />

PCR-amplified from cDNA <strong>and</strong> individually cloned<br />

using Gateway cloning kit (Invitrogen). First, the<br />

PCR products were cloned into pDONR207 vector<br />

using BP clonase, then they were re-cloned into<br />

pMDC32 destination vector harbouring double 35S<br />

promoter.<br />

Plant material <strong>and</strong> A. tumefaciens infiltration<br />

GFP transgenic 16C line <strong>of</strong> Nicotiana benthamiana<br />

plants were grown as described previously (Marano<br />

<strong>and</strong> Baulcombe, 1998; Voinnet et al. 1998).<br />

Recombinant Agrobacterium tumefaciens strain<br />

C58C1, carrying different constructs, were grown<br />

at 28°C in 2 ml <strong>of</strong> LB medium with 2,5 μg/ml<br />

tetracycline <strong>and</strong> 50 μg/ml kanamycin for two days,<br />

then transferred to 18 ml <strong>of</strong> fresh LB medium with<br />

appropriate antibiotics <strong>and</strong> were grown overnight at<br />

28°C. The bacteria were centrifuged at 4000 g for<br />

10 min. The pellet was resuspended in<br />

agroinfiltration solution (10mM MgCl2, 10 mM<br />

MES <strong>and</strong> 100 μM acetosyringone) up to desired<br />

optical density (OD600). The bacteria solution was<br />

left at room temperature for overnight before<br />

infiltration. Infiltration carried on underside leaves<br />

<strong>of</strong> 5-7-week-old N. benthamiana plants. For coinfiltration,<br />

equal volumes <strong>of</strong> indicated A.<br />

tumefaciens cultures (OD600=1) were mixed before<br />

infiltration. After 5-10 days post infiltration, plants<br />

were observed for silencing effect.<br />

GFP Imaging<br />

Visual detection <strong>of</strong> GFP fluorescence in whole<br />

plant was performed using a 100W h<strong>and</strong>-held longwave<br />

ultraviolet lamp. Plants were photographed<br />

with a yellow filter.<br />

Results<br />

Potato virus M belongs to the genus Carlavirus <strong>of</strong><br />

the Flexiviridae family. The PVM genome is a<br />

single positive-str<strong>and</strong> RNA <strong>of</strong> 8534 nucleotides.<br />

The sequence contains six open reading frames<br />

(ORFs) (Figure 1), <strong>and</strong> non-coding regions<br />

consisting <strong>of</strong> 75 nucleotides at the 5 ’ -end <strong>and</strong> 70<br />

nucleotides followed by a poly(A) tail at the 3 ’ -end<br />

(Zavriev et al., 1991).


Identification <strong>of</strong> silencing suppressors <strong>of</strong> PVM 17<br />

Figure 1. Scheme <strong>of</strong> PVM genome. Genes are shown as boxes <strong>and</strong> molecular masses <strong>of</strong> encoded proteins are<br />

indicated in kDa. (PRO: gene <strong>of</strong> polyprotein encoding for several peptides; CP: coat protein gene)<br />

The ORF beginning at the first initiation codon at nucleotide 74 encodes a polypeptide <strong>of</strong> 223K, virus<br />

RNA replicase (Table 1). The next coding block consists <strong>of</strong> three ORFs encoding polypeptides <strong>of</strong> 25K, 12K<br />

<strong>and</strong> 7K, which is responsible for viral cell-to-cell movement. The third block consists <strong>of</strong> two ORFs encoding<br />

polypeptides <strong>of</strong> 34K (coat protein) <strong>and</strong> 11K. The 11K polypeptide contains a pattern resembling the<br />

consensus for a metal-binding nucleic acid-binding zinc-finger motif.<br />

Table 1. Proteins <strong>of</strong> PVM <strong>and</strong> their sizes<br />

Symbol <strong>of</strong> protein Protein Start<br />

End<br />

Length<br />

(nt)<br />

(nt)<br />

(bp)<br />

ORF 1 polyprotein 74 5980 1968<br />

ORF 2 25kDa protein 6019 6708 229<br />

ORF 3 12kDa protein 6686 7015 109<br />

ORF 4 7kDa protein 7012 7203 63<br />

ORF 5 coat protein 7225 8139 304<br />

ORF 6 11kDa protein 8136 8462 108<br />

According to articles for last years (Chiba et al.,<br />

2006), the protein 11K is most putative silencing<br />

suppressor. The aim <strong>of</strong> our investigation was the<br />

check <strong>of</strong> suppressor activity <strong>of</strong> all PVM proteins<br />

except first one, largest polyprotein due to its size.<br />

The primers for cloning were designed using<br />

the GeneRunner programme version 3.0<br />

(ORF2sense 5 ’ -<br />

gggacaagtttgtacaaaaaagcaggctatggatgtgattgtagatttg-<br />

3 ’ <strong>and</strong> ORF2antisense 5 ’ -<br />

ggggaccactttgtacaagaaagctgggtctcaggcggcggtgtaagt<br />

gg-3 ’ for ORF2; ORF3sense 5 ’ -<br />

ggggacaagtttgtacaaaaaagcaggctatgccacttacaccgccgc<br />

c-3 ’ <strong>and</strong> ORF3antisense 5 ’ -<br />

ggggaccactttgtacaagaaagctgggtctcatgtgtgtgagcccgca<br />

c-3 ’ for ORF3; ORF4sense 5 ’ -<br />

ggggacaagtttgtacaaaaaagcaggctatgatagtgtatgtacttgta<br />

g-3 ’ <strong>and</strong> ORF4antisense 5 ’ -<br />

ggggaccactttgtacaagaaagctgggtcttatgacctaaaggaacca<br />

cac-3 ’ for ORF4; ORF5sense 5 ’ -<br />

ggggacaagtttgtacaaaaaagcaggctatgggagattcaacgaaga<br />

aag-3 ’ <strong>and</strong> ORF5antisense 5 ’ -<br />

ggggaccactttgtacaagaaagctgggtctcattttctattagactttac<br />

at-3 ’ for ORF5; ORF6sense 5 ’ -<br />

ggggacaagtttgtacaaaaaagcaggctatgaaggacgtaaccaag<br />

gtggctt-3 ’ <strong>and</strong> ORF6antisense 5 ’ -<br />

ggggaccactttgtacaagaaagctgggtcctactctcgcttgttgatga<br />

c-3 ’ for ORF6). The Gateway-kit (Invitrogen) was<br />

used for cloning. The DNA <strong>of</strong> the different PVM<br />

ORFs were obtained by RT-PCR, <strong>and</strong> cloned into<br />

the Gateway-compatible binary T-DNA destination<br />

vector pMDC32. Each <strong>of</strong> these constructs were<br />

electroporated into Agrobacterium tumefaciens<br />

C58C1 strain according to the manufacturer’s<br />

instructions. All constructs described above were<br />

verified by nucleotide sequencing.<br />

The Nicotiana benthamiana plant, constitutively<br />

expressing GFP transgene (line 16C; a gift from<br />

David Baulcombe), <strong>and</strong> the Agrobacterium<br />

infiltration operation have been described<br />

previously (Hamilton et al., 2002). The N.<br />

benthamiana line 16C were cultured in growth<br />

chambers at 22 to 24°C before <strong>and</strong> after infiltration.<br />

For coinfiltration, equal volumes <strong>of</strong> individual<br />

Agrobacterium cultures (OD600= 1) were mixed


18<br />

Ruslan KRYLDAKOV et al.<br />

prior to infiltration. HC-Pro <strong>of</strong> potato virus Y <strong>and</strong><br />

P19 <strong>of</strong> tombusviruses were used as a positive<br />

control. GFP fluorescence was observed under<br />

long-wavelength UV light <strong>and</strong> photographed using<br />

a digital camera with a yellow filter.<br />

GFP expression reached the highest level in all<br />

leaves infiltrated with GFP, as well as GFP plus<br />

other genes at 5 to 7 days postinfiltration (dpi), as<br />

shown by the enhanced green fluorescence in the<br />

infiltrated patches. The green fluorescence intensity<br />

remained strong in the patches coinfiltrated with<br />

ORF 3 <strong>and</strong> ORF 5 during the 7-9 dpi. Coinfiltration<br />

with ORF 6 also resulted in GFP fluorescence over<br />

a similar period <strong>of</strong> observations, but not as strong<br />

<strong>and</strong> clear as above described samples (Figure 2).<br />

On the other h<strong>and</strong>, GFP was silenced upon<br />

inoculation with OFR 2 <strong>and</strong> ORF 4.<br />

Figure 2. Effects <strong>of</strong> different ORFs <strong>of</strong> PVM on<br />

gene silencing in GFP transformants <strong>of</strong> Nicotiana<br />

benthamiana. Infiltrated leaves are shown.<br />

Silencing <strong>of</strong> GFP is manifested in red fluorescent.<br />

Green spots indicate suppression <strong>of</strong> silencing.<br />

Photographs were taken <strong>of</strong> UV-illuminated plants.<br />

1 <strong>and</strong> 2: HC-Pro <strong>and</strong> P19, respectively, are shown<br />

as control; 3: ORF2, 25K protein; 4: ORF3, 12K<br />

protein; 5: ORF4, 7K protein; 6: ORF5, coat<br />

protein; 7: ORF6, 11K protein<br />

According to these data the most promising<br />

c<strong>and</strong>idates as silencing suppressors are ORF 3 (12K<br />

protein; Table 1), ORF 5 (coat protein; Table 1)<br />

<strong>and</strong>, in lesser extent, ORF 6 (11K protein; Table 1),<br />

while ORF 2 <strong>and</strong> ORF 4 revealed no suppressor<br />

activity. We have repeated this experiment three<br />

times which yielded the same results.<br />

Discussion<br />

Most <strong>of</strong> the viruses have some sort <strong>of</strong> silencing<br />

suppressor system as an evolutionary counterresponse<br />

to the antiviral activity <strong>of</strong> the plant gene<br />

silencing defence. Gene silencing suppressors can<br />

inhibit silencing <strong>of</strong> transgenes or endogenous<br />

genes. Test for silencing suppression was based on<br />

a previously described experimental system<br />

(Brigneti et al., 1998). When leaves <strong>of</strong> N.<br />

benthamiana line 16C plants were agroinfiltrated<br />

with an A. tumefaciens C58C1 strain carrying the<br />

construct 35S GFP, the strong green fluorescent<br />

signal disappeared under UV light due to GFP<br />

silencing. However, if 35S-ds GFP <strong>and</strong> any strong<br />

silencing suppressor are co-agroinfiltrated, the<br />

fluorescent signal does not disappear <strong>and</strong> the area<br />

does not look dark under UV light. This is due to<br />

the inhibition <strong>of</strong> gene silencing caused by that<br />

suppressor.<br />

Thus, the result <strong>of</strong> experiments shows that<br />

ORF3 (12K protein; part <strong>of</strong> triple block, cell-to-cell<br />

movement), ORF5 (coat protein) <strong>and</strong> ORF6 (11K<br />

protein) <strong>of</strong> potato virus M has a suppressor activity.<br />

It corresponds to the results <strong>of</strong> recent articles about<br />

suppression activity <strong>of</strong> virus proteins responsible<br />

for long-distance movement (Voinnet, 2001), viral<br />

coat proteins (Roth, Pruss <strong>and</strong> Vance, 2004) <strong>and</strong><br />

10K-16K proteins with a conserved amino acid<br />

sequence motif encoded by diverse filamentous<br />

viruses (Chiba et al., 2006).<br />

The 12K protein encoded by the second ORF <strong>of</strong><br />

PVM triple gene block (TGB) which involved in<br />

the cell-to-cell <strong>and</strong> long-distance movement <strong>of</strong><br />

virus. This protein possesses conserved<br />

hydrophobic domain <strong>and</strong> plays significant role in<br />

TGB functions (Seppänen et al., 1997). TGBcontaining<br />

viruses have evolved special<br />

mechanisms to suppress RNA silencing (Voinnet et<br />

al., 2000; Morozov <strong>and</strong> Solovyev, 2003).<br />

The potex-like Carlavirus PVM requires the<br />

coat protein for virus cell-to-cell movement<br />

(Morozov <strong>and</strong> Solovyev, 2003; Verchot-Lubicz,<br />

2005). In RNA silencing assays, plant viral<br />

suppressors differ by their ability to suppress<br />

intracellular <strong>and</strong>/or intercellular silencing (Li <strong>and</strong><br />

Ding, 2001; Roth, Pruss <strong>and</strong> Vance, 2004).<br />

Spreading <strong>of</strong> silencing in plants occurs through<br />

plasmodesmata <strong>and</strong> results from a cell-to-cell<br />

movement <strong>of</strong> a short-range silencing signal, most<br />

probably 21-nt short interfering RNAs (siRNAs),<br />

that are produced by one <strong>of</strong> the plant Dicer<br />

enzymes (Kalantidis et al., 2008).<br />

11K protein had been shown to be a nonspecific<br />

nucleic acid-binding protein (Gramstat,<br />

Courtpozanis <strong>and</strong> Rohde, 1990), similar to p10<br />

which is silencing suppressor <strong>of</strong> Grapevine virus A<br />

(Zhou et al., 2006). Interestingly, 11K is supposed<br />

to be translated from the CP subgenomic RNA by a<br />

(-1) frameshift within the A-rich region


AAUAGAAAAUGA preceding the 12K AUG<br />

translational start codon (underlined) <strong>and</strong><br />

representing the 3’-terminus <strong>of</strong> the CP coding<br />

region (UGA stop codon in bold letters) (Gramstat,<br />

Courtpozanis <strong>and</strong> Rohde, 1990).<br />

This article describes the identification <strong>of</strong> viral<br />

suppressors <strong>of</strong> RNA silencing encoded by a natural<br />

pathogen. An exact role for any <strong>of</strong> the identified<br />

PVM suppressors in host infection remains to be<br />

established.<br />

The potential <strong>of</strong> using viral suppressors to help<br />

underst<strong>and</strong> the mechanism <strong>of</strong> RNA silencing in<br />

plants is largely unexplored, <strong>and</strong> these studies<br />

promise to be a fertile area <strong>of</strong> research. Viral<br />

suppressors <strong>of</strong> silencing also provide unique tools<br />

to underst<strong>and</strong> the mechanism <strong>of</strong> RNA silencing as<br />

well as interaction between virus <strong>and</strong> their hosts.<br />

Moreover, it became an extremely useful technique<br />

for molecular biology <strong>and</strong> very powerful<br />

biotechnological tool.<br />

Acknowledgement<br />

This work has been supported by funds from<br />

INTAS, Young Scientist Fellowship Nr. 06-<br />

1000014-6200.<br />

References<br />

Brigneti C, Voinnet O, Li WX, Ji LH, Ding SW<br />

<strong>and</strong> Baulcombe DC. Viral pathogenicity<br />

determinants are suppressors <strong>of</strong> transgene<br />

silencing in Nicotiana benthamiana. The<br />

EMBO <strong>Journal</strong>. 17: 6739-6746, 1998.<br />

Chiba M, Reed JC, Prokhnevsky AI, Chapman EJ,<br />

Mawassi M, Koonin EV, Carrington JC <strong>and</strong><br />

Dolja VV. Diverse suppressors <strong>of</strong> RNA<br />

silencing enhance agroinfection by a viral<br />

replicon. Virology. 346: 7-14, 2006.<br />

Ding SW, Li H, Lu R, Li F <strong>and</strong> Li WX. RNA<br />

silencing: a conserved antiviral immunity <strong>of</strong><br />

plants <strong>and</strong> animals. Virus Research. 102: 109-<br />

115, 2004.<br />

Ding SW <strong>and</strong> Voinnet O. Antiviral Immunity<br />

Directed by Small RNAs. <strong>Cell</strong>. 130: 413-426,<br />

2007.<br />

Gramstat A, Courtpozanis A <strong>and</strong> Rohde W. The 12<br />

kDa protein <strong>of</strong> potato virus M displays<br />

properties <strong>of</strong> a nucleic acid-binding regulatory<br />

protein. FEBS Letters. 276: 34-38, 1990.<br />

Identification <strong>of</strong> silencing suppressors <strong>of</strong> PVM 19<br />

Hamilton A, Voinnet O, Chappell L <strong>and</strong> Baulcombe<br />

D. Two classes <strong>of</strong> short interfering RNA in<br />

RNA silencing. The EMBO <strong>Journal</strong>. 21: 4671-<br />

4679, 2002.<br />

Jorgensen RA. RNA silencing in plants:<br />

mechanisms, methods, <strong>and</strong> applications. Plant<br />

& Animal Genomes XI Conference, USA.<br />

2003.<br />

Kalantidis K, Schumacher HT, Alexiadis T <strong>and</strong><br />

Helm JM. RNA silencing movement in plants.<br />

<strong>Biology</strong> <strong>of</strong> the <strong>Cell</strong>. 100: 13-26, 2008.<br />

Li WX <strong>and</strong> Ding SW. Viral suppressors <strong>of</strong> RNA<br />

silencing. Current Opinion in Biotechnology.<br />

12: 150-154, 2001.<br />

Marano MR <strong>and</strong> Baulcombe D. Pathogen-derived<br />

resistance targeted against the negative-str<strong>and</strong><br />

RNA <strong>of</strong> tobacco mosaic virus: RNA str<strong>and</strong>specific<br />

gene silencing? Plant <strong>Journal</strong>. 13:<br />

537-546, 1998.<br />

Morozov SYu <strong>and</strong> Solovyev AG. Triple gene block:<br />

modular design <strong>of</strong> a multifunctional machine<br />

for plant virus movement. <strong>Journal</strong> <strong>of</strong> General<br />

Virology. 84: 1351-1366, 2003.<br />

Roth BM, Pruss GJ <strong>and</strong> Vance VB. Plant viral<br />

suppressors <strong>of</strong> RNA silencing. Virus Research.<br />

102: 97-108, 2004.<br />

Seppдnen P, Puska R, Honkanen J, Tyulkina LG,<br />

Fedorkin O, Morozov SYu <strong>and</strong> Atabekov JG.<br />

Movement protein-derived resistance to triple<br />

gene block-containing plant viruses. <strong>Journal</strong> <strong>of</strong><br />

General Virology. 78: 1241-1246, 1997.<br />

Sontheimer EJ. Assembly <strong>and</strong> function <strong>of</strong> RNA<br />

silencing complexes. Nature Reviews. 6: 127-<br />

138, 2005.<br />

Sozinova L, Abay A, Ramankulov E, Nachmias A<br />

<strong>and</strong> Loebenstein G. Reducing Virus Incidence<br />

in Potato Seed Tubers by Rapid Propagation: A<br />

Pilot Scheme in Kazakhstan, The 28 th Congress<br />

<strong>of</strong> the Israeli Phytopathological Society, The<br />

<strong>Vol</strong>cani Center, Israel. 2007.<br />

Verchot-Lubicz J. A New <strong>Cell</strong>-to-<strong>Cell</strong> Transport<br />

Model for Potexviruses. <strong>Molecular</strong> Plant-<br />

Microbe Interactions <strong>Journal</strong>. 18: 283-290,<br />

2005.<br />

Voinnet O, Vain P, Angell S <strong>and</strong> Baulcombe DC.<br />

Systemic spread <strong>of</strong> sequence-specific transgene<br />

RNA degradation is initiated by localized


20<br />

Ruslan KRYLDAKOV et al.<br />

introduction <strong>of</strong> ectopic promoterless DNA.<br />

<strong>Cell</strong>. 95: 177-187, 1998.<br />

Voinnet O, Pinto YM <strong>and</strong> Baulcombe DC.<br />

Suppression <strong>of</strong> gene silencing: A general<br />

strategy used by diverse DNA <strong>and</strong> RNA<br />

viruses <strong>of</strong> plants. Proceedings <strong>of</strong> the National<br />

Academy <strong>of</strong> Sciences. 86: 14147-14152, 1999.<br />

Voinnet O, Lederer C <strong>and</strong> Baulcombe DC. A viral<br />

movement protein prevents spread <strong>of</strong> the gene<br />

silencing signal in Nicotiana benthamiana.<br />

<strong>Cell</strong>. 103: 157-167, 2000.<br />

Voinnet O. RNA silencing as a plant immune<br />

system against viruses. Trends in Genetics. 17:<br />

449-459, 2001.<br />

Voinnet O. Induction <strong>and</strong> suppression <strong>of</strong> RNA<br />

silencing: insights from viral infections. Nature<br />

Reviews Genetics. 6: 206-220, 2005.<br />

Zavriev SK, Kanyuka KV <strong>and</strong> Levay KE. The<br />

genome organization <strong>of</strong> potato virus M RNA.<br />

<strong>Journal</strong> <strong>of</strong> General Virology. 72: 9-14, 1991.<br />

Zhou ZSh, Dell’Orco M, Saldarelli P, Turturo C,<br />

Minafra A <strong>and</strong> Martelli GP. Identification <strong>of</strong> an<br />

RNA-silencing suppressor in the genome <strong>of</strong><br />

Grapevine virus A. <strong>Journal</strong> <strong>of</strong> General<br />

Virology. 87: 2387-2395, 2006.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 21-29, 2011 Research Article 21<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Identification <strong>of</strong> a novel dehydration responsive transcript from<br />

tossa jute (Corcohrus olitorius L.)<br />

Sazia SHARMIN 1,δ , Mahdi Muhammad MOOSA 1,δ , Md. Shahidul ISLAM 1,2 , Inamul<br />

KABIR 3 , Arzuba AKTER 1 1, *<br />

<strong>and</strong> Haseena KHAN<br />

1<br />

University <strong>of</strong> Dhaka, Department <strong>of</strong> Biochemistry & <strong>Molecular</strong> <strong>Biology</strong>, Dhaka 1000, Bangladesh<br />

2<br />

Bangladesh Jute Research Institute, Dhaka 1207, Bangladesh<br />

3<br />

University <strong>of</strong> Dhaka, Department <strong>of</strong> Genetic Engineering & Biotechnology, Dhaka 1000, Bangladesh<br />

δ<br />

Contributed equally to the study.<br />

(* author for correspondence; haseena@univdhaka.edu)<br />

Received: 18 January 2011; Accepted: 23 April 2011<br />

Abstract<br />

Water deficit stress is one <strong>of</strong> the major environmental stress conditions faced by sessile l<strong>and</strong> plants.<br />

Acquisition <strong>of</strong> resistance to this stress enabled plants to settle into terrestrial habitats. Dehydration stress is a<br />

specific form <strong>of</strong> water deficit stress. A number <strong>of</strong> functionally characterized genes are involved in<br />

dehydration response pathway. Here we report a novel dehydration responsive transcript from tossa jute<br />

(Corcohrus olitorius L.) which shows reduced expression under dehydration stress. Study <strong>of</strong> tissue specific<br />

expression revealed that the transcript is expressed in root, shoot <strong>and</strong> leaf under normal conditions. Search for<br />

known homologues <strong>of</strong> the transcript failed to identify functionally characterized counterparts in any other<br />

plant species.<br />

Keywords: Drought, stress tolerance, water deficit stress, dehydration responsive transcript, drp.<br />

Tossa jute‘den (Corcohrus olitorius L.) yeni bir dehidrasyon cevap transkripti<br />

tanımlanması<br />

Özet<br />

Su eksikliği stresi sapsız kara bitkilerince karşılaşılan en büyük çevresel stress koşullarından biridir. Bu<br />

strese dirençlilik kazanmak bitkilerin karasal yetişme ortamına yerleşmesini sağlamıştır. Dehidrasyon stresi<br />

su eksikliği stresinin özgün bir formudur. Birçok fonksiyonel olarak karakterize edilmiş gen dehidrasyon<br />

tepki yolağıyla ilişkilidir. Bu makalede hint kenevirinden (Corcohrus olitorius L.) dehidrasyon stresinde<br />

azalmış ifade gösteren yeni bir dehidrasyona cevap transkripti rapor etmekteyiz. Dokuya özgün ifade<br />

çalışması transkriptin kök, budak ve yaprakta ifade edildiğini ortaya koymuştur. Transkriptin bilinen<br />

homologlarının araştırılması sonucunda diğer başka bitkilerde fonksiyonel olarak karakterize edilmiş bir eşi<br />

bulunamamıştır.<br />

Anahtar Sözcükler: Kuraklık, stres toleransı, su eksikliği stresi, dehidrasyon cevap transkripti, drp<br />

Introduction<br />

Unlike their mobile animal counterparts, sessile<br />

plants have to adjust their gene expression pattern<br />

as well as metabolite pr<strong>of</strong>ile to cope with altered<br />

local environmental conditions (Kulheim et al.<br />

2002). A number <strong>of</strong> genes are involved in these<br />

pathways which can either be up-regulated (Hannah<br />

et al. 2005; Holappa <strong>and</strong> Walker-Simmons, 1995;<br />

Yan et al. 2005.) or down-regulated (Hannah et al.


22 Sazia SHARMIN et al.<br />

2005; Yan et al. 2005) based on their mode <strong>of</strong><br />

function. Identification <strong>of</strong> these genes may lead to<br />

the development <strong>of</strong> commercial crops, which are<br />

better suited to grow in a particular unfavourable<br />

condition. Due to cross-species transferability <strong>of</strong><br />

gene functions, this improvement can be achieved<br />

in non-source plant species as well.<br />

Jute (Corchorus olitorius L.) is the most<br />

important bast fibre producing plant (Kundu, 1956).<br />

It is the major fibre producing plant <strong>of</strong> Bangladesh<br />

(Hossain et al. 2003) <strong>and</strong> one <strong>of</strong> the major fibre<br />

crops <strong>of</strong> the Indian subcontinent (Basu et al. 2004).<br />

The production quality <strong>and</strong> yield <strong>of</strong> this<br />

economically important crop is affected by several<br />

biotic e.g. fungi, pest, insect, nematode, virus, mite<br />

(BBS, 2004; Ghosh, 1983; Keka et al. 2008) <strong>and</strong><br />

abiotic factors e.g. salinity, submergence <strong>and</strong> low<br />

temperature (Hossain et al. 2003; Samira et al.<br />

2010). Thus, development <strong>of</strong> jute varieties with<br />

increased resistance to both biotic <strong>and</strong> abiotic stress<br />

conditions have considerable economic importance.<br />

In spite <strong>of</strong> its enormous commercial value, only<br />

a few genes or part <strong>of</strong> genes from jute have been<br />

identified or sequenced (Ahmed et al. 2009; Alam<br />

et al. 2010; Islam et al. 2005; Mahmood et al.<br />

2010; Samira et al. 2010; Wazni et al. 2007). Here<br />

we report a novel transcript from Corchorus<br />

olitorus var. 9897 responsive to dehydration stress.<br />

Search for known homologues failed to identify<br />

functionally characterized counterparts in any other<br />

plant species.<br />

Materials <strong>and</strong> methods<br />

Stress treatment <strong>of</strong> plant seedlings<br />

Plant seeds were incubated at room temperature in<br />

the absence <strong>of</strong> light for two days in petri dishes in<br />

the presence <strong>of</strong> water only. Germinated plant<br />

seedlings were subjected to different stress<br />

conditions such as low temperature, dehydration,<br />

fungus <strong>and</strong> abscisic acid (ABA) beginning third<br />

day <strong>of</strong> their germination according to methods<br />

described by Alam <strong>and</strong> co-workers (Alam et al.<br />

2010). Fungus treatment was done by spraying<br />

suspension <strong>of</strong> Macrophomina phaseolina on the<br />

plate with germinated seedlings (Alam et al. 2010;<br />

Mahmood et al. 2010). For dehydration treatment,<br />

the seedlings were treated with 50 mM manitol to<br />

create an environment similar to water deficit<br />

condition. The concentration <strong>of</strong> manitol was<br />

increased to 100 mM on day 5 (Alam et al. 2010).<br />

Salt stress was applied by adding 50 mM NaCl to<br />

the plate on day 3. The concentration was increased<br />

by 50 mM per day, reaching to 150 mM NaCl on<br />

day 5 (Alam et al. 2010). Low temperature<br />

treatment was carried out by growing the seedlings<br />

at 14 O C in an incubator from day 3 (Alam et al.<br />

2010).<br />

Isolation <strong>of</strong> DNA <strong>and</strong> RNA<br />

Genomic DNA from different Corchorus species<br />

was isolated using the CTAB method (Murray <strong>and</strong><br />

Thompson, 1980). RNA was isolated using<br />

TRIZOL reagent (Invitrogen) according to the<br />

provided manual. For tissue specific RNA isolation,<br />

leaf, stem <strong>and</strong> root was cut into pieces, ground in<br />

liquid N2. RNA was isolated from ground tissue<br />

using TRIZOL reagent (Invitrogen) as per<br />

manufacturer’s instruction<br />

Identification <strong>of</strong> the dehydration responsive<br />

transcript<br />

The transcript was identified as an additional b<strong>and</strong><br />

while carrying out RT (Reverse Transcriptase)-<br />

PCR <strong>of</strong> a cold stress responsive gene, LDLP (Low<br />

density lipoprotein like protein) from C. olitorius<br />

using the primer RevP (unpublished result). RT-<br />

PCR was carried out using RNA isolated from C.<br />

olitorius grown under normal condition. This<br />

additional b<strong>and</strong> was extracted from agarose gel<br />

using QIAGEN MinElute Gel Extraction Kit <strong>and</strong><br />

sequenced (1 st Base PTE Singapore) using ForP<br />

<strong>and</strong> RevP as primers. Gene specific primers<br />

(GSPF1, GSPR1 <strong>and</strong> GSPR2) for the transcript was<br />

designed using Primer3Plus (Untergasser et al.<br />

2007). Sequences <strong>of</strong> primers are given in Table 1.<br />

These primers were used to sequence partial CDS<br />

(coding sequence) <strong>of</strong> drp from C. capsularis, C.<br />

tridens, C. aestuans, C. pseudo-olitorius, C.<br />

trilocularis.<br />

Table 1. Primers used in the study<br />

Primer Sequence<br />

ForP 5’- ATACTTATGGGAGAATGAAAG -3’<br />

RevP 5’- TACAGGTAAAATGTCACCAA -3’<br />

GSP-R1 5’- GAGGCTTTTCTTGGAAC -3’<br />

GSP-R2 5’- GTCCCGATCCCTTGAATTAC -3’<br />

GSP-F1 5’- CTTAATCGGAGCAGGGTGAG -3’


Semiquantitative RT-PCR<br />

Total RNA was isolated from jute seedlings <strong>and</strong><br />

quantified using a nanodrop (ND-1000). Poly (A)<br />

RNA was isolated from total RNA using mRNA<br />

extraction kit (SIGMA, MRN 10KT, 046k6879)<br />

<strong>and</strong> quantified. First str<strong>and</strong> cDNA was synthesized<br />

from 50 ng <strong>of</strong> mRNA using gene specific primer<br />

GSP-R2. PCR amplification <strong>of</strong> the cDNA was<br />

carried out for 25 cycles using primers GSP-F1 <strong>and</strong><br />

GSP-R2 (95°C for 40 s, 58°C for 40 s, <strong>and</strong> 72°C<br />

for 50 s). The housekeeping gene β-actin was used<br />

as the internal st<strong>and</strong>ard for reverse transcriptase<br />

polymerase chain reaction (Alam et al. 2010).<br />

5′ RACE<br />

277 bp sequence at the 5′ end <strong>of</strong> the transcript was<br />

determined by 5′- Rapid Amplification <strong>of</strong> cDNA<br />

Ends (RACE) protocol. The first str<strong>and</strong> cDNA was<br />

prepared from mRNA using the primer GSPR1.<br />

Purification <strong>of</strong> first str<strong>and</strong> cDNA <strong>and</strong> TdT tailing<br />

was carried out as recommended by the<br />

manufacturer (5′ RACE system, Invitrogen<br />

Corporation, Carlsbad, CA). First round PCR <strong>of</strong><br />

target cDNA was carried out using the primer<br />

GSPR2 for 35 cycles (95°C for 1 min, 55°C for 1<br />

min, <strong>and</strong> 72°C for 2 min).<br />

Southern blot<br />

15 μg DNA was digested with EcoRI <strong>and</strong> SacI <strong>and</strong><br />

size-fractionated on 1% agarose gel <strong>and</strong> then<br />

transferred onto a positively charged nylon<br />

membrane (Amersham Hybond-N). Probe was<br />

synthesized from RT-PCR product using primer<br />

GSP-F1 <strong>and</strong> GSPR2 <strong>and</strong> Dig nucleic acid labeling<br />

<strong>and</strong> detection kit (Roche, IN). Manufacturer’s<br />

guideline for highly stringent hybridization <strong>and</strong><br />

detection conditions was followed (probe 10<br />

ng/mL, stringency washes with 0.5X SSC, 0.1%<br />

SDS).<br />

Northern blot<br />

10 μg RNA was separated by electrophoreses in 1X<br />

MOPS <strong>and</strong> transferred to a positively charged<br />

nylon membrane (Amersham Hybond-N). Probe<br />

was synthesized from RT-PCR product by using<br />

primer GSPF <strong>and</strong> GSPR2 <strong>and</strong> Dig nucleic acid<br />

labelling <strong>and</strong> detection kit (Roche, Cat No.<br />

11175033910). Manufacturer’s guideline for highly<br />

stringent hybridization <strong>and</strong> detection conditions<br />

Novel dehydration responsive transcript from jute 23<br />

was followed (probe 10 ng/mL, stringency washes<br />

with 0.1X SSC, 0.1% SDS).<br />

Sequence assembly <strong>and</strong> analysis<br />

Sequences from gel extracted b<strong>and</strong> <strong>and</strong> 5′ RACE<br />

was assembled using CAP3 (Huang <strong>and</strong> Madan,<br />

1999) from PBIL web-server (Perriere et al. 2003).<br />

Coding sequences were identified using ESTScan2<br />

(Iseli et al. 1999). Phylogenetic tree was<br />

constructed using MEGA4 by UPGMA method<br />

with default parameters (Tamura et al. 2007).<br />

Multiple sequence alignment was done using<br />

Clustalx (Larkin et al. 2007). Protein secondary<br />

structure was predicted from NPS@ webserver<br />

(Combet et al. 2000).<br />

Results<br />

Identification <strong>of</strong> the transcript<br />

The dehydration responsive transcript was<br />

identified by sequencing <strong>of</strong> additional b<strong>and</strong><br />

obtained from RT-PCR <strong>of</strong> LDLP gene. The 396 bp<br />

sequenced transcript failed to show significant<br />

similarity to any <strong>of</strong> the so far functionally<br />

characterized proteins in blast search at NCBI<br />

database. An additional 277 bp sequence at the 5′<br />

end was determined by 5′ RACE. Partial CDS <strong>of</strong><br />

drp from five other Corchorus spp (C. capsularis,<br />

C. tridens, C. aestuans, C. pseudo-olitorius, C.<br />

trilocularis) were obtained using gene specific<br />

primer (GSP) pairs. Sequence information was<br />

deposited to DDBJ (Accession numbers<br />

AB571589-AB571594).<br />

Copy number determination<br />

To determine the copy number <strong>of</strong> the gene within<br />

the C. olitorius genome, isolated genomic DNA<br />

was digested EcoRI <strong>and</strong> SacI. Southern blot with<br />

both enzyme digests showed four distinct b<strong>and</strong>s<br />

(Figure 1). Thus, it is likely that C. olitorius<br />

genome has four copies <strong>of</strong> drp.<br />

Expression study: Tissue <strong>and</strong> stress specific<br />

expression<br />

Reverse transcriptase PCR (RT-PCR) from RNA<br />

isolated from leaf, stem <strong>and</strong> root suggested that drp<br />

was expressed in all three tissues (Figure 2).<br />

Semiquantitative RT-PCR showed reduced<br />

expression under dehydration stressed condition


24 Sazia SHARMIN et al.<br />

(Figure 3). Similar expression pattern was observed<br />

in Northern blot <strong>of</strong> C. olitorius transcript with a<br />

cDNA probe specific for the sequence (Figure 4).<br />

The transcript also showed somewhat reduced<br />

Figure 1. Southern blot <strong>of</strong> drp after EcoRI (a) <strong>and</strong><br />

SacI (b) digestion. Arrows indicate b<strong>and</strong>s to which<br />

probe was hybridized.<br />

Figure 3. Semiquantitative RT-PCR <strong>of</strong> drp (top)<br />

<strong>and</strong> actin control (bottom) under different stress<br />

conditions (N, L, S, D, F <strong>and</strong> A st<strong>and</strong>s for Normal,<br />

Experimental, Low temperature, Salt, Dehydration,<br />

Fungal <strong>and</strong> ABA treatment, respectively).<br />

Comparative analysis <strong>of</strong> drp from different<br />

Corchorus spp.<br />

Translated protein sequence alignment showed a<br />

highly conserved segment <strong>of</strong> 32 amino acid<br />

expression in low temperature <strong>and</strong> fungus treated<br />

plants (Figures 3 <strong>and</strong> 4).<br />

Figure 2. RT-PCR <strong>of</strong> RNA isolated from stem, root<br />

<strong>and</strong> leaf (S, R <strong>and</strong> L st<strong>and</strong>s for stem, root <strong>and</strong> leaf,<br />

respectively).<br />

Figure 4. Northern blot <strong>of</strong> drp under different<br />

stress conditions (N, L, S, D, F, A st<strong>and</strong>s for<br />

Normal, Experimental, Low temperature, Salt,<br />

Dehydration, Fungal <strong>and</strong> ABA treatment,<br />

respectively). rRNA is shown below as a control<br />

for equal loading.<br />

residues (Figure 5a). Secondary structure prediction<br />

suggested that the region is mainly composed <strong>of</strong><br />

R<strong>and</strong>om Coils (Figure 5b <strong>and</strong> Table 2). A<br />

phylogenetic tree (Figure 6) <strong>of</strong> drp nucleotide<br />

sequence from different Corchorus species was<br />

constructed using MEGA4 (Tamura et al. 2007).


A<br />

Corchorus_olitorius SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />

Corchorus_capsularis SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />

Corchorus_tridens SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />

Corchorus_pseudo-olitorius SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />

Corchorus_trilocularis SAPKARQRCVADGKLVNIPAPSYSAMGGRIAE<br />

Corchorus_aestuans SAPKARQRCVADGKQVNIPAPSYNAMGGRIAE<br />

************** ********.********<br />

B<br />

10 20 30<br />

| | |<br />

UNK_136050 SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />

DPM ctchhhhhhehtcccecccccccchhcchhcc<br />

DSC ccccceeeeecccccccccccccccccccccc<br />

GOR1 hhhhhheeeeettteeeeeeceeeehhhhhhh<br />

GOR3 cccchhheehhccceecccccccccccceehh<br />

HNNC cccccccccccccccccccccccccccccccc<br />

MLRC cccccceeeecccccecccccccccccccccc<br />

PHD ccccccchhhhccccccccccccccccccccc<br />

Predator ccchhhhhhhcccccccccccccccccccccc<br />

SOPM ccccccheeecttccccccccccchhtchhhh<br />

Sec.Cons. ccccc?heeecccccccccccccccccccccc<br />

Sequence length : 32<br />

Novel dehydration responsive transcript from jute 25<br />

Figure 5. A) Highly conserved segment <strong>of</strong> the translated protein sequence <strong>of</strong> drp gene from different<br />

Corchorus spp; B) Predicted secondary structure <strong>of</strong> the conserved segment. The last line shows consensus<br />

secondary structure from different methods <strong>of</strong> prediction.<br />

Table 2. Summary <strong>of</strong> predicted secondary structures from different prediction tools. The last row is for<br />

consensus secondary structure.<br />

S<strong>of</strong>tware R<strong>and</strong>om coil (c) Alpha helix (h) Extended str<strong>and</strong> (e)<br />

DPM (Deléage <strong>and</strong> Roux, 1987) 53.12 % 34.38% 6.25%<br />

DSC (King <strong>and</strong> Sternberg, 1996) 84.38% 0.00% 15.62%<br />

GOR1 (Garnier et al. 1978) 3.12% 40.62% 46.88%<br />

GOR3 (Gibrat et al. 1987) 59.38% 21.88% 18.75%<br />

HNNC (Guermeur, 1997) 100.00% 0.00% 0.00%<br />

MLRC (Guermeur et al. 1999) 84.38% 0.00% 15.62%<br />

PHD (Rost <strong>and</strong> S<strong>and</strong>er, 1993) 87.50% 12.50% 0.00%<br />

Predator (Frishman <strong>and</strong> Argos, 1996) 78.12% 21.88% 0.00%<br />

SOPM (Geourjon <strong>and</strong> Deléage, 1994) 59.38% 21.88% 9.38%<br />

Sec.Cons. (Consensus) 84.38% 3.12% 9.38%


26 Sazia SHARMIN et al.<br />

Figure 6. Evolutionary relationship <strong>of</strong> 6 Corchorus species, poplar <strong>and</strong> rice. The percentage <strong>of</strong> replicate trees<br />

in which the associated taxa clustered together in the bootstrap test (10000 replicates) is shown next to the<br />

branches. The rate variation among sites was modelled with a gamma distribution (shape parameter = 1).<br />

Discussion<br />

Acquisition <strong>of</strong> dehydration tolerance is one <strong>of</strong> the<br />

traits that enabled l<strong>and</strong>-plants to settle into<br />

terrestrial habitats (Richardt et al. 2007).<br />

Dehydration stress is a specific form <strong>of</strong> water<br />

deficit stress that results in alteration <strong>of</strong> plants at<br />

the cellular, morphological <strong>and</strong> developmental<br />

levels (Bray, 1993). At the molecular level, the<br />

pathway can be classified into two broad categories<br />

viz. ABA dependent <strong>and</strong> ABA independent<br />

pathway (Ramanjulu <strong>and</strong> Bartels, 2002). Individual<br />

pathways are discussed in detail elsewhere<br />

(Agarwal <strong>and</strong> Jha, 2010; Ingram <strong>and</strong> Bartels, 1996;<br />

Nakashima et al. 2009; Umezawa et al. 2006;<br />

Yamaguchi-Shinozaki <strong>and</strong> Shinozaki, 2006).<br />

The newly identified transcript, namely drp,<br />

was found to be expressed in all three tissues tested<br />

(root, stem <strong>and</strong> leaf) in normal condition (Figure 2).<br />

Analysis <strong>of</strong> the expression pattern after stress<br />

treatments suggests decreased expression in<br />

dehydration stress, but increased expression in<br />

ABA stress condition (Figures 3 <strong>and</strong> 4).<br />

Comparative analyses <strong>of</strong> water deficit stressed<br />

transcriptome <strong>of</strong> a number <strong>of</strong> plants identified plant<br />

genes showing altered expression in either<br />

dehydration stress alone or in combination with any<br />

other water deficit stress or ABA treatment (Bray,<br />

2004; Rabbani et al. 2003; Seki et al. 2002; Talame<br />

et al. 2007). Nevertheless, none <strong>of</strong> the studies<br />

identified single transcript showing opposite<br />

expression patterns in water deficit stress <strong>and</strong> ABA<br />

treatment as shown by drp. It is to be noted that the<br />

transcript also shows somewhat reduced expression<br />

in low temperature treated plants. Previous studies<br />

on dehydration stress responsive genes also found<br />

similar correlation with low temperature response<br />

pathways (Shinozaki <strong>and</strong> Yamaguchi-Shinozaki,<br />

2000).<br />

Comparative analysis <strong>of</strong> different experimental<br />

methods <strong>of</strong> water deficit stress treatment revealed<br />

that three transcripts (At2g06850, At1g72610 <strong>and</strong><br />

At5g20630) are down-regulated in Arabidopsis<br />

irrespective <strong>of</strong> the method (filter paper, mannitol or<br />

soil water deficit) applied (Bray, 2004).<br />

Interestingly all the three genes are either known or<br />

hypothesized to function in plant cell wall<br />

modification pathways that control growth (Bray,<br />

2004). Both semi-quantitative RT (reverse<br />

transcriptase) -PCR <strong>and</strong> northern blot suggests<br />

reduced expression <strong>of</strong> drp in fungus treated plants.<br />

Study by Schenk <strong>and</strong> co-workers (Schenk et al.<br />

2000) revealed that a significant portion <strong>of</strong> fungal<br />

inoculation responsive genes in Arabidopsis are<br />

associated with cell wall synthesis <strong>and</strong><br />

modification. Thus, drp might also play a role in<br />

defence pathways against fungal infection in jute<br />

by playing a role in cell wall synthesis <strong>and</strong>/or<br />

modification.<br />

Southern blot <strong>of</strong> the transcript suggests that C.<br />

olitorius genome has four copies <strong>of</strong> drp gene<br />

(Figure 1). Thus, it is also possible that different<br />

copies <strong>of</strong> the drp gene are under different<br />

regulatory mechanisms <strong>and</strong> the observed<br />

expression patterns are <strong>of</strong> different drp genes which


are indistinguishable in the region selected for<br />

analyses.<br />

The newly identified transcript failed to show<br />

significant similarity to any <strong>of</strong> the so far<br />

functionally characterized proteins. It is to be noted<br />

that plant specific nucleotide blast in NCBI<br />

database shows significant similarity to a<br />

hypothetical Poplus trichocarpa protein<br />

(XM_002337327.1) <strong>and</strong> other plant transcripts.<br />

Paralogues <strong>of</strong> the gene were found to be present in<br />

all tested Corchorus species. Phylogenetic analysis<br />

<strong>of</strong> drp gene <strong>and</strong> its homologues suggests that C.<br />

capsularis is the closest neighbour <strong>of</strong> C. olitorius in<br />

terms <strong>of</strong> drp. It is to be noted that all considered<br />

dicots grouped into same clade in the tree (Figure<br />

6).<br />

Multiple sequence alignment <strong>of</strong> protein<br />

sequences from different Corchorus spp. identified<br />

a highly conserved segment <strong>of</strong> 32 amino acid<br />

residues. Secondary structure prediction at NPS@<br />

webserver (Combet et al. 2000) suggested these<br />

amino acids are most likely to form r<strong>and</strong>om coils<br />

(Figure 5b <strong>and</strong> Table 2). R<strong>and</strong>om coils or more<br />

specifically coils add flexibility to the protein<br />

structure (Buxbaum, 2007). Our literature survey<br />

revealed an interesting relationship between<br />

r<strong>and</strong>om coils <strong>and</strong> their possible role in dehydration<br />

response. It has been long known that different<br />

organisms release osmolytes when subjected to<br />

water stresses (Yancey et al. 1982). Study by Qu<br />

<strong>and</strong> co-workers (1998) identified that osmolytes<br />

cause contraction <strong>of</strong> r<strong>and</strong>om coils leading to<br />

decrease <strong>of</strong> conformational entropy <strong>and</strong> subsequent<br />

stabilization <strong>of</strong> protein folding.<br />

The present study has identified a novel<br />

dehydration responsive transcript from different<br />

jute (Corchorus) species. Further studies are<br />

required to elucidate the detailed mechanism <strong>of</strong><br />

action <strong>of</strong> this transcript.<br />

Acknowledgement<br />

This research was supported by the United States<br />

Department <strong>of</strong> Agriculture (USDA). We are<br />

thankful to Bangladesh Jute Research Institute<br />

(BJRI) for providing seeds <strong>of</strong> different jute species.<br />

References<br />

Agarwal P <strong>and</strong> Jha B. Transcription factors in<br />

plants <strong>and</strong> ABA dependent <strong>and</strong> independent<br />

abiotic stress signalling. Biol Plant. 54:201-212,<br />

2010.<br />

Novel dehydration responsive transcript from jute 27<br />

Ahmed S, Nabi MZ, Alam MM, Islam MS, Samira<br />

R, Moosa MM <strong>and</strong> Khan H. A computational<br />

<strong>and</strong> experimental approach for developing jute<br />

ESTs from genomic clones. Aust J Crop Sci.<br />

3:322-328, 2009.<br />

Alam M, Sharmin S, Nabi Z, Mondal S, Islam M,<br />

Nayeem S, Shoyaib M <strong>and</strong> Khan H. A Putative<br />

Leucine-Rich Repeat Receptor-Like Kinase <strong>of</strong><br />

Jute Involved in Stress Response. Plant Mol<br />

Biol Rep. 28:394-402, 2010.<br />

Basu A, Ghosh M, Meyer R, Powell W, Basak SL<br />

<strong>and</strong> Sen SK. Analysis <strong>of</strong> genetic diversity in<br />

cultivated jute determined by means <strong>of</strong> SSR<br />

markers <strong>and</strong> AFLP pr<strong>of</strong>iling. Crop Science.<br />

44:678-685, 2004.<br />

Buxbaum E. Protein structure. Fundamentals <strong>of</strong><br />

protein structure <strong>and</strong> function. Springer<br />

ScienceBusiness Media, LLC, New York. 12-<br />

37, 2007.<br />

BBS. Statistical pocket book <strong>of</strong> Bangladesh<br />

statistics division, Bangladesh Bureau <strong>of</strong><br />

Statistics, Ministry <strong>of</strong> Planning, the People's<br />

Republic <strong>of</strong> Bangladesh. 2004.<br />

Bray EA. <strong>Molecular</strong> responses to water deficit.<br />

Plant Physiol. 103:1035-1040, 1993.<br />

Bray EA. Genes commonly regulated by waterdeficit<br />

stress in Arabidopsis thaliana. J Exp Bot.<br />

55:2331-2341, 2004.<br />

Combet C, Blanchet C, Geourjon C, <strong>and</strong> Deléage<br />

G. NPS@: Network Protein Sequence Analysis.<br />

Trends in Biochemical Science. 25:147-150,<br />

2000.<br />

Deléage G <strong>and</strong> Roux B. An algorithm for protein<br />

secondary structure prediction based on class<br />

prediction. Protein Eng. 1:289-294, 1987.<br />

Frishman D <strong>and</strong> Argos P. Incorporation <strong>of</strong> nonlocal<br />

interactions in protein secondary structure<br />

prediction from the amino acid sequence.<br />

Protein Eng. 9:133-142, 1996.<br />

Garnier J, Osguthorpe DJ <strong>and</strong> Robson B. Analysis<br />

<strong>of</strong> the accuracy <strong>and</strong> implications <strong>of</strong> simple<br />

methods for predicting the secondary structure<br />

<strong>of</strong> globular proteins. J Mol Biol. 120:97-120,<br />

1978.<br />

Geourjon C <strong>and</strong> Deléage G. SOPM: a selfoptimized<br />

method for protein secondary


28 Sazia SHARMIN et al.<br />

structure prediction. Protein Eng. 7:157-164,<br />

1994.<br />

Ghosh T. H<strong>and</strong> book on jute. Food <strong>and</strong> Agriculture<br />

Organization <strong>of</strong> the United Nations (FAO):115-<br />

116, 1983.<br />

Gibrat JF, Garnier J <strong>and</strong> Robson B. Further<br />

developments <strong>of</strong> protein secondary structure<br />

prediction using information theory: New<br />

parameters <strong>and</strong> consideration <strong>of</strong> residue pairs. J<br />

Mol Biol. 198:425-443, 1987.<br />

Guermeur Y. Combinaison de classifieurs<br />

statistiques, Application a la prediction de<br />

structure secondaire des proteines., p 169,<br />

Paris: University <strong>of</strong> Paris 06, 1997.<br />

Guermeur Y, Geourjon C, Gallinari P <strong>and</strong> Deléage<br />

G. Improved performance in protein secondary<br />

structure prediction by inhomogeneous score<br />

combination. Bioinformatics. 15:413-421, 1999.<br />

Hannah MA, Heyer AG <strong>and</strong> Hincha DK. A Global<br />

Survey <strong>of</strong> Gene Regulation during Cold<br />

Acclimation in Arabidopsis thaliana. PLoS<br />

Genetics. 1:e26, 2005.<br />

Holappa LD <strong>and</strong> Walker-Simmons MK. The Wheat<br />

Abscisic Acid-Responsive Protein Kinase<br />

mRNA, PKABA1, Is Up-Regulated by<br />

Dehydration, Cold Temperature, <strong>and</strong> Osmotic<br />

Stress. Plant Physiol. 108:1203-1210, 1995.<br />

Hossain MB, Awal A, Rahman MA, Haque S <strong>and</strong><br />

Khan H. Distinction between cold-sensitive <strong>and</strong><br />

-tolerant Jute by DNA polymorphism. <strong>Journal</strong><br />

<strong>of</strong> Biochemistry <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong>.<br />

36:427-432, 2003.<br />

Huang X <strong>and</strong> Madan A. CAP3: A DNA Sequence<br />

Assembly Program. Genome Research. 9:868-<br />

877, 1999.<br />

Ingram J <strong>and</strong> Bartels D. The molecular basis <strong>of</strong><br />

dehydration tolerance in plants. Annual Review<br />

<strong>of</strong> Plant Physiol <strong>and</strong> Plant <strong>Molecular</strong> <strong>Biology</strong>.<br />

47:377-403, 1996.<br />

Iseli C, Jongeneel CV <strong>and</strong> Bucher P. ESTScan: a<br />

program for detecting, evaluating, <strong>and</strong><br />

reconstructing potential coding regions in EST<br />

sequences. In: Proceedings / International<br />

Conference on Intelligent Systems for<br />

<strong>Molecular</strong> <strong>Biology</strong> pp 138-148, 1999.<br />

Islam AS, Taliaferro M, Lee CT, Ingram C,<br />

Montalvo RJ, Ende Gvd, Alam S, Siddiqui J<br />

<strong>and</strong> Sathasivan K. Preliminary progress in Jute,<br />

Corchorus species. genome analysis. Plant<br />

Tissue Cult Biotechnol. 15:145-156, 2005.<br />

Keka SI, Shamsuzzaman M, Pahloan MU, Pervin<br />

S, Rahman MM <strong>and</strong> Khan H. Identifying simple<br />

sequence repeat (SSR) marker linked to mite<br />

tolerance in jute species. Bangladesh <strong>Journal</strong> <strong>of</strong><br />

Botany. 37:161-171, 2008.<br />

King RD <strong>and</strong> Sternberg MJE. Identification <strong>and</strong><br />

application <strong>of</strong> the concepts important for<br />

accurate <strong>and</strong> reliable protein secondary structure<br />

prediction. Protein Sci. 5:2298-2310, 1996.<br />

Kulheim C, Agren J <strong>and</strong> Jansson S. Rapid<br />

Regulation <strong>of</strong> Light Harvesting <strong>and</strong> Plant<br />

Fitness in the Field. Science, 297:91-93, 2002.<br />

Kundu B. Jute — world’s foremost bast fibre, II.<br />

Technology, marketing, production <strong>and</strong><br />

utilization. Economic Botany. 10:203-240,<br />

1956.<br />

Larkin MA, Blackshields G, Brown NP, Chenna R,<br />

McGettigan PA, McWilliam H, Valentin F,<br />

Wallace IM, Wilm A, Lopez R, Thompson JD,<br />

Gibson TJ <strong>and</strong> Higgins DG. Clustal W <strong>and</strong><br />

Clustal X version 2.0. Bioinformatics. 23:2947-<br />

2948, 2007.<br />

Mahmood N, Azam MS, Islam MS, Sharmin S,<br />

Moosa MM, Hossain MA <strong>and</strong> Khan H.<br />

Differentially expressed transcripts <strong>of</strong> wild <strong>and</strong><br />

cultivated jute (Corchorus spp.) varieties upon<br />

fungal, Macrophomina phaseolina. infection.<br />

Annals <strong>of</strong> Biological Research. 1:120-127,<br />

2010.<br />

Murray MG <strong>and</strong> Thompson WF. Rapid isolation <strong>of</strong><br />

high molecular weight plant DNA. Nucleic<br />

Acids Res. 8:4321-4326, 1980.<br />

Nakashima K, Ito Y <strong>and</strong> Yamaguchi-Shinozaki K.<br />

Transcriptional Regulatory Networks in<br />

Response to Abiotic Stresses in Arabidopsis <strong>and</strong><br />

Grasses. Plant Physiol. 149:88-95, 2009.<br />

Perriere G, Combet C, Penel S, Blanchet C,<br />

Thioulouse J, Geourjon C, Grassot J, Charavay<br />

C, Gouy M, Duret L <strong>and</strong> Deleage G. Integrated<br />

databanks access <strong>and</strong> sequence/structure<br />

analysis services at the PBIL. Nucleic Acids<br />

Res. 31:3393-3399, 2003.<br />

Qu Y, Bolen CL, <strong>and</strong> Bolen DW. Osmolyte-driven<br />

contraction <strong>of</strong> a r<strong>and</strong>om coil protein.<br />

Proceedings <strong>of</strong> the National Academy <strong>of</strong><br />

Sciences <strong>of</strong> the United States <strong>of</strong> America.<br />

95:9268-9273,1998.


Rabbani MA, Maruyama K, Abe H, Khan MA,<br />

Katsura K, Ito Y, Yoshiwara K, Seki M,<br />

Shinozaki K <strong>and</strong> Yamaguchi-Shinozaki K.<br />

Monitoring Expression Pr<strong>of</strong>iles <strong>of</strong> Rice Genes<br />

under Cold, Drought, <strong>and</strong> High-Salinity<br />

Stresses <strong>and</strong> Abscisic Acid Application Using<br />

cDNA Microarray <strong>and</strong> RNA Gel-Blot Analyses.<br />

Plant Physiol. 133:1755-1767, 2003.<br />

Ramanjulu S <strong>and</strong> Bartels D. Drought- <strong>and</strong><br />

desiccation-induced modulation <strong>of</strong> gene<br />

expression in plants. Plant, <strong>Cell</strong> &<br />

Environment. 25:141-151, 2002.<br />

Richardt S, Timmerhaus G, Lang D, Qudeimat E,<br />

Corrêa L, Reski R, Rensing S <strong>and</strong> Frank W.<br />

Microarray analysis <strong>of</strong> the moss Physcomitrella<br />

patens reveals evolutionarily conserved<br />

transcriptional regulation <strong>of</strong> salt stress <strong>and</strong><br />

abscisic acid signalling. Plant <strong>Molecular</strong><br />

<strong>Biology</strong>. 72:27-45, 2007.<br />

Rost B <strong>and</strong> S<strong>and</strong>er C. Prediction <strong>of</strong> Protein<br />

Secondary Structure at Better than 70%<br />

Accuracy. J Mol Biol. 232:584-599, 1993.<br />

Samira R, Moosa MM, Alam MM, Keka SI <strong>and</strong><br />

Khan H. In silico analysis <strong>of</strong> jute SSR library<br />

<strong>and</strong> experimental verification <strong>of</strong> assembly.<br />

Plant Omics <strong>Journal</strong>. 3:57-65, 2010.<br />

Schenk PM, Kazan K, Wilson I, Anderson JP,<br />

Richmond T, Somerville SC <strong>and</strong> Manners JM.<br />

Coordinated plant defense responses in<br />

Arabidopsis revealed by microarray analysis.<br />

Proceedings <strong>of</strong> the National Academy Science<br />

<strong>of</strong> the United States <strong>of</strong> America. 97:11655-<br />

11660, 2000.<br />

Seki M, Ishida J, Narusaka M, Fujita M, Nanjo T,<br />

Umezawa T, Kamiya A, Nakajima M, Enju A,<br />

Sakurai T, Satou M, Akiyama K, Yamaguchi-<br />

Shinozaki K, Carninci P, Kawai J, Hayashizaki<br />

Y <strong>and</strong> Shinozaki K. Monitoring the expression<br />

pattern <strong>of</strong> around 7,000 Arabidopsis genes<br />

under ABA treatments using a full-length<br />

cDNA microarray. Functional & Integrative<br />

Genomics. 2:282-291, 2002.<br />

Shinozaki K <strong>and</strong> Yamaguchi-Shinozaki K.<br />

<strong>Molecular</strong> responses to dehydration <strong>and</strong> low<br />

temperature: differences <strong>and</strong> cross-talk between<br />

two stress signalling pathways. Current Opinion<br />

in Plant <strong>Biology</strong>. 3:217-223, 2000.<br />

Talame V, Ozturk NZ, Bohnert HJ <strong>and</strong> Tuberosa R.<br />

Barley transcript pr<strong>of</strong>iles under dehydration<br />

shock <strong>and</strong> drought stress treatments: a<br />

Novel dehydration responsive transcript from jute 29<br />

comparative analysis. J Exp Bot. 58:229-240,<br />

2007.<br />

Tamura K, Dudley J, Nei M <strong>and</strong> Kumar S.<br />

MEGA4: <strong>Molecular</strong> Evolutionary Genetics<br />

Analysis, MEGA. S<strong>of</strong>tware Version 4.0. Mol<br />

Biol Evol. 24:1596-1599, 2007.<br />

Umezawa T, Fujita M, Fujita Y, Yamaguchi-<br />

Shinozaki K <strong>and</strong> Shinozaki K. Engineering<br />

drought tolerance in plants: discovering <strong>and</strong><br />

tailoring genes to unlock the future. Curr Opin<br />

Biotechnol. 17:113-122, 2006.<br />

Untergasser A, Nijveen H, Rao X, Bisseling T,<br />

Geurts R <strong>and</strong> Leunissen JAM. Primer3Plus, an<br />

enhanced web interface to Primer3. Nucleic<br />

Acids Res. 35:W71-74, 2007.<br />

Wazni MW, Islam AS, Taliaferro JM, Anwar N<br />

<strong>and</strong> Sathasivan K. Novel ESTs from a Jute,<br />

Corchorus olitorius L). cDNA library. Plant<br />

Tissue Cult Biotechnol. 17:173-182, 2007.<br />

Yamaguchi-Shinozaki K <strong>and</strong> Shinozaki K.<br />

Transcriptional regulatory netwirks in cellular<br />

responses <strong>and</strong> tolerance to dehydration <strong>and</strong> cold<br />

stress. Annu Rev Plant Biol, 57:781-803, 2006.<br />

Yan S, Tang Z, Su W <strong>and</strong> Sun W. Proteomic<br />

analysis <strong>of</strong> salt stress-responsive proteins in rice<br />

root. Proteomics. 5:235-244, 2005.<br />

Yancey P, Clark M, H<strong>and</strong> S, Bowlus R <strong>and</strong> Somero<br />

G. Living with water stress: evolution <strong>of</strong><br />

osmolyte systems. Science. 217:1214-1222,<br />

1982.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 31-36, 2011 Research Article 31<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Protective effects <strong>of</strong> curcumin on cadmium chloride induced colon<br />

toxicity in Swiss albino mice<br />

Preeti SINGH * , Priya MOGRA, V<strong>and</strong>ana SANKHLA <strong>and</strong> Kanchan DEORA<br />

Department <strong>of</strong> Zoology, College <strong>of</strong> Science, M.L.S. University, Udaipur-Rajasthan, 313001 India.<br />

(* author for correspondence; priti1960@yahoo.co.in )<br />

Received: 26 October 2010; Accepted: 29 April 2011<br />

Abstract<br />

Cadmium, an omnipresent, hazardous, heavy metal, is recognized to produce severe toxic effects in humans.<br />

The Agency for Toxic Substances <strong>and</strong> Disease Registry (ATSDR) in Atlanta, Georgia has listed cadmium as<br />

number 7 in its top 20 list <strong>of</strong> hazardous substances. In contrast to the toxic activity <strong>of</strong> cadmium chloride,<br />

curcumin derived from Curcuma longa (Turmeric) is attributed with numerous beneficial properties <strong>and</strong> is<br />

supposed to possess multifaceted healing properties. The purpose <strong>of</strong> the present study was to elucidate the<br />

protective efficacy <strong>of</strong> curcumin against cadmium chloride induced colon toxicity in Swiss albino mice. Four<br />

batches <strong>of</strong> Swiss-albino mice, each batch comprising six mice, were treated with cadmium chloride <strong>and</strong><br />

curcumin. Comparative observations <strong>of</strong> colon in cadmium-treated groups clearly showed induction <strong>of</strong><br />

histopathological damage as evidenced by emptied goblet cells, lacerated <strong>and</strong> suppressed mucosa, destruction<br />

<strong>of</strong> surface epithelium, marked decline in mucin production <strong>and</strong> hemorrhagic colon, which were not seen in<br />

control <strong>and</strong> curcumin treated group. In animals pretreated with curcumin <strong>and</strong> subsequently treated with<br />

cadmium chloride, the histopathology <strong>of</strong> colon clearly delineates the protection accorded by curcumin, as the<br />

induced damage by cadmium chloride was negligible <strong>and</strong> the number <strong>of</strong> empty goblet cells, hemorrhagic<br />

areas, suppression <strong>of</strong> mucosa was significantly reduced.<br />

Keywords: Curcumin, cadmium chloride, colon, goblet cells, mucosa<br />

Swiss albino farelerde zerdeçalın kadmiyum klorür ile indüklenmiş kolon<br />

toksisitesine koruyucu etkileri<br />

Özet<br />

Her yerde bulunan, tehlikeli bir ağır metal olan kadmiyumun ins<strong>and</strong>a şiddetli toksik etkiler yarattığı fark<br />

edilmiştir. Atlanta, Georgia’daki Toksik Maddeler ve Hastalık Kayıt Acentası (ATSDR) kadmiyumu ilk 20<br />

tehlikeli maddeler listesinde 7. sırada listelemiştir. Kadmiyum kloridin toksik aktivitesine karşın, Curcuma<br />

longa’dan (Turmeric) elde edilen zerdeçala çok sayıda yararlı özellikler atfedilmiş ve iyileştirici özelliklere<br />

sahip olduğu tahmin edilmiştir. Bu çalışmanın amacı Swiss albino farelerde zerdeçalın kadmiyum klorid ile<br />

indüklenmiş kolon toksisitesine karşı koruyucu etkisini açıklamaktır. Her birinde altı fare bulunan dört grup<br />

Swiss albino fare kadmiyum klorid ve zerdeçal ile muamele edilmiştir. Kadmiyum ile muamele edilmiş<br />

grupta kolonunun karşılaştırmalı gözlemi açıkça boşalmış goblet hücreleri, yırtılmış ve bastırılmış mukoza,<br />

yüzey epitelin yıkımı, müsin üretimindeki belirgin düşüş, kolon kanaması gibi durumlarla kanıtlanan<br />

histopatolojik hasar indüklenmesi göstermiştir. Öncelikle zerdeçal ve daha sonra kadmiyum klorid ile<br />

muamele edilmiş hayvanların kolon histopatolojisi, kadmiyum klorid ile indüklenen hasarın gözardı edilebilir<br />

olması ve boş goblet hücreleri ve kanama alanlarının sayısı ile mukoza baskılanmasının önemli derecede<br />

azalması ile zerdeçalın koruyucu rolünü anlaşılır bir biçimde açıklar.<br />

Anahtar Sözcükler: Curcumin, kadmiyum klorür, kolon, goblet hücreleri, mukoza


32 Preeti SINGH et al.<br />

Introduction<br />

Cadmium, an omnipresent, hazardous, heavy metal<br />

is recognized to produce severe toxic effects in<br />

humans (Lee et al., 1980; Jarup et al., 1998a;<br />

ATSDR, 1999 <strong>and</strong> Singh et al., 2007). The Agency<br />

for Toxic Substances <strong>and</strong> Disease Registry<br />

(ATSDR, 1989) in Atlanta, Georgia has listed<br />

cadmium as number 7 in its top 20 list <strong>of</strong> hazardous<br />

substances. Cadmium will invariably be present in<br />

our society, either in useful products in the form <strong>of</strong><br />

nickel-cadmium batteries, dyes, plastics,<br />

electrochemistry, paint pigments or in controlled<br />

wastes as a major source <strong>of</strong> pollution, in water <strong>and</strong><br />

as constituent <strong>of</strong> food material (Friberg et al., 1975;<br />

Goyer et al., 1984; Friberg et al., 1985a; Jarup et<br />

al., 1998 <strong>and</strong> Ikeda et al., 2000). In humans it has<br />

been found to produce wide range <strong>of</strong> biochemical<br />

<strong>and</strong> physiological dysfunctions as manifested in the<br />

forms <strong>of</strong> various diseases viz. Itai-itai, kidney<br />

malfunction, inflammation, Parkinsons disorder,<br />

liver malfunction etc. (Friberg et al., 1974; Nogawa<br />

et al.,1977; RAIS ,1991; Jarup et al., 1998; <strong>and</strong><br />

Ikeda et al.,2000).Various modes <strong>and</strong><br />

methodologies are being devised to combat<br />

cadmium-induced toxicity with a focus on herbal<br />

formulations. The use <strong>of</strong> herbal medicine increases<br />

every day <strong>and</strong> still finds a wide use worldwide.<br />

Traditional herbs have more acceptance than<br />

prescription drugs in many cultures. One <strong>of</strong> such<br />

drug is curcumin derived from Curcuma longa the<br />

dried powered form <strong>of</strong> which is known as Turmeric<br />

<strong>and</strong> is a m<strong>and</strong>atory condiment <strong>of</strong> every Indian<br />

kitchen. Turmeric extract containing the ingredient<br />

curcumin is marked widely in the western world as<br />

a dietary supplement for the treatment <strong>and</strong><br />

prevention <strong>of</strong> a variety <strong>of</strong> disorder, including<br />

inflammation, arthritis <strong>and</strong> other proposed uses <strong>of</strong><br />

curcumin is in Alzheimer's Disease, cancer<br />

prevention, cataract prevention, chronic, high<br />

cholesterol, liver protection, menstrual pain,<br />

multiple sclerosis, osteoarthritis, rheumatoid<br />

arthritis etc. (Deodhar et al., 1980; Chen et al.,<br />

1996; Eigner <strong>and</strong> Scholz, 1999). Curcumin is also<br />

reported to have antibacterial, antiamoebic,<br />

antifungal, antiviral <strong>and</strong> anti HIV activities<br />

(Ammon, 1992; Azuine, 1992; Ruby, 1995 <strong>and</strong><br />

Mortellini et al., 2000). In some experiments it has<br />

been shown to be 300 times more potent than<br />

vitamin E. However no concrete evidence in<br />

scientific field is available pertaining to the colonic<br />

protective effects <strong>of</strong> curcumin on cadmium chloride<br />

induced toxicity. Hence, the aim <strong>of</strong> the present<br />

research was to fulfill this lacuna <strong>and</strong> to determine<br />

the efficacy <strong>of</strong> curcumin in rendering protection<br />

against cadmium chloride induced colonic toxicity<br />

at the cellular level.<br />

Materials <strong>and</strong> methods<br />

In the present experiment the following chemical<br />

reagents were used. Cadmium chloride: CdCl2.<br />

H2O was procured from Glaxo company (India),<br />

with following features: <strong>Molecular</strong> Weight =<br />

201.32, Minimum assay (ex Cl) 95%. Curcumin<br />

Crystalline: C21H20O6 was procured from Loba<br />

Chem. Pvt. Ltd., with following features: <strong>Molecular</strong><br />

Weight = 368.39 Minimum assay (acidimetric)<br />

99%, Melting point= 170- 180°C.<br />

The present study was conducted after taking<br />

prior approval by Indian Animal Ethical Committee<br />

(No .CS\Res\07\759), on twenty four adult male<br />

Swiss albino mice 32-50 days old <strong>and</strong> weighing<br />

around to 30-40g were maintained in plastic cages<br />

under controlled lighting conditions (12:12 light:<br />

dark cycle) relative humidity (50 ± 5%) <strong>and</strong><br />

temperature (37 ± 2°C), fed with mice feed <strong>and</strong><br />

were given ad libitum access to water. A group <strong>of</strong> 6<br />

mice per experiment were taken <strong>and</strong> treated with<br />

CdCl2 <strong>and</strong> curcumin. The doses were prepared<br />

daily in distilled water <strong>and</strong> were administered by<br />

gastric gavage method.<br />

The dose protocol was as follows: Group-I<br />

Control group (a) were treated with only vehicle<br />

(water) for a day; Group-II Control groups (b) were<br />

treated with only curcumin 10mg/animal/day for 16<br />

days; Group-III Experimental batch were<br />

administered CdCl2 50mg/kg/animal for a single<br />

day; Group-IV Experimental batch with were pretreated<br />

with curcumin 10mg/animal/day for 15 days<br />

<strong>and</strong> on the 16 th day a single oral dose <strong>of</strong> CdCl2<br />

50mg/kg/day/animal was administered. After<br />

administration <strong>of</strong> the last dose, the control <strong>and</strong> the<br />

experimental animal were sacrificed. Their colon<br />

was excised <strong>and</strong> subsequently fixed in Bouins<br />

solutions. After fixation, wax block <strong>and</strong> paraffin<br />

sections <strong>of</strong> the colons were prepared, processed <strong>and</strong><br />

differentially stained in hematoxyline <strong>and</strong> eosin for<br />

general histopathological assessment. The sections<br />

were stained in bromophenol blue for assessment <strong>of</strong><br />

protein pr<strong>of</strong>ile, <strong>and</strong> in Schiff’s for the study <strong>of</strong><br />

glycoproteins. They were then observed under a<br />

light microscope <strong>and</strong> the gross histopathological<br />

pr<strong>of</strong>ile was assessed.


Results<br />

The colonic histopathological pr<strong>of</strong>ile <strong>of</strong> control<br />

group mice revealed no aberrations the colonic<br />

mucosa was distinct with no lacerations <strong>and</strong> the<br />

goblet cells present were filled. Mucin production<br />

was distinctly evident (Figure 1a <strong>and</strong> 1b).<br />

Similarly, no significant variations were observed<br />

in curcumin treated mice, which showed a similar<br />

structural pr<strong>of</strong>ile as that <strong>of</strong> control group mice<br />

(Figure 1c <strong>and</strong> 1d). The histopathology <strong>of</strong> colon in<br />

animals treated with CdCl2 was blunt <strong>and</strong><br />

suppressed, clearly delineating histopathological<br />

Protective effects <strong>of</strong> curcumin on colon toxicity 33<br />

damage. Emptied goblet cells, lacerated mucosa,<br />

destruction <strong>of</strong> surface epithelium, marked decline<br />

in mucin production <strong>and</strong> hemorrhagic areas in<br />

colon were also visible (Figure 1g <strong>and</strong> 1h). In<br />

animals pretreated with curcumin <strong>and</strong> subsequently<br />

treated with CdCl2 the histopathology <strong>of</strong> colon<br />

clearly delineates the protection accorded by<br />

curcumin as the induced damage by CdCl2 was<br />

negligible <strong>and</strong> the number <strong>of</strong> empty goblet cells,<br />

hemorrhagic areas, suppression <strong>of</strong> mucosa was<br />

significantly reduced (Figure 1e <strong>and</strong> 1f).<br />

Figure 1. (a) Photomicrograph showing the colonic surface <strong>of</strong> control group. Prominent mucosa <strong>and</strong> filled<br />

goblet cells is distinctly visible. (10X magnification), (b) Photomicrograph showing the colonic surface <strong>of</strong><br />

control group. Filled goblet cells are clearly visible. (40X magnification), (c) Photomicrograph <strong>of</strong> colon <strong>of</strong><br />

cur cumin treated group. Mucosa is similar to that <strong>of</strong> control group. (10X magnification), (d)<br />

Photomicrograph <strong>of</strong> colon <strong>of</strong> cur cumin treated group showing distinct goblet cells (40X magnification), (e)<br />

Photomicrograph <strong>of</strong> colon <strong>of</strong> group which was pretreated with cur cumin <strong>and</strong> subsequently treated with<br />

cadmium. Suppression <strong>of</strong> colonic mucosal surface is less as compared to mucosa <strong>of</strong> only cadmium chloride<br />

treated group. (10X magnification), (f) Photomicrograph <strong>of</strong> colon <strong>of</strong> group which was pretreated with cur<br />

cumin <strong>and</strong> subsequently treated with cadmium. Filled <strong>and</strong> empty goblet cells are clearly visible. (40X<br />

magnification), (g) Photomicrograph <strong>of</strong> colon <strong>of</strong> cadmium treated experimental group. Emptied goblet cells,<br />

suppressed mucosa, <strong>and</strong> destruction <strong>of</strong> surface epithelium are evident. (10X magnification), (h)<br />

Photomicrograph <strong>of</strong> colon <strong>of</strong> cadmium treated experimental group. Empty goblet cells are visible. (40X<br />

magnification).


34 Preeti SINGH et al.<br />

Discussion<br />

Cadmium is an omnipresent heavy metal which<br />

enters the biological systems from natural sources,<br />

such as volcanic emissions, weathering <strong>of</strong> rocks,<br />

mining processes as well as from industrial<br />

applications, agricultural practices <strong>and</strong> human<br />

usages. Cadmium emissions into the environment<br />

are normally continuous between the three main<br />

environmental compartments air, water <strong>and</strong> soil.<br />

The majority <strong>of</strong> cadmium exposure arises from<br />

ingestion <strong>of</strong> food substances due to uptake <strong>of</strong><br />

cadmium by plants from fertilizers, sewage sludge,<br />

manure <strong>and</strong> atmospheric deposition (Lee <strong>and</strong><br />

White, 1980; Anderson et al 1988; Hotz et al.,<br />

1989; Lauwerys et al., 1991; Iwata et al., 1992;<br />

Bernard et al 1992, Ikeda et al., 2000). Human<br />

uptake <strong>of</strong> cadmium is mainly through cigarette<br />

smoking <strong>and</strong> food intake. In vegetarian diet,<br />

mushrooms, cocoa powder, potatoes, fruits, wheat,<br />

grains, bran, sugerbeet fiber, carrot, dried seaweeds<br />

etc. are the source <strong>of</strong> cadmium intake. Similarly, in<br />

non-vegetarian diets shellfish, mussel, meat <strong>and</strong><br />

fish are rich in cadmium. These cadmium rich<br />

foods can greatly increase cadmium concentration<br />

in the human body (Friberg et al., 1985b; Vahter et<br />

al., 1996 <strong>and</strong> WHO, 2000). In humans cadmium<br />

has a long half life, which is reported to be <strong>of</strong> 10-30<br />

years in kidney, <strong>and</strong> 4.7-9.7 years in liver (Chen<br />

<strong>and</strong> Wang, 1990). On average, 5% <strong>of</strong> the total<br />

orally ingested cadmium is absorbed in the<br />

intestines, but individual values range from less<br />

than 1% to more than 20%.This reflects the fact<br />

that humans do not have effective pathways for<br />

cadmium elimination, hence cadmium shows the<br />

phenomenon <strong>of</strong> bioaccumulation. Once absorbed<br />

by an organism, it remains resident for many years.<br />

Where cadmium toxicity is concerned, colon is <strong>of</strong><br />

prime importance, for <strong>of</strong> the total cadmium that<br />

enters the gastrointestinal tract 90-95% is excreted<br />

out <strong>and</strong> hence colonic cells are exposed to cadmium<br />

in fecal matter as well as to cadmium present in the<br />

circulation. Hence in the present experiment we<br />

aimed to assess the toxic effects <strong>of</strong> cadmium<br />

chloride as well as to monitor the protective effects<br />

<strong>of</strong> curcumin in colon <strong>of</strong> Swiss albino mice on the<br />

basis <strong>of</strong> histopathological observations. The<br />

integrity <strong>of</strong> colon depends upon the balance<br />

between the hostile factors, one <strong>of</strong> them being<br />

cadmium, which damages the mucosa ,goblet cells<br />

etc. <strong>and</strong> the protective factors such as certain<br />

internal secretions like mucin <strong>and</strong> certain external<br />

agents like curcumin which render protection<br />

against cadmium toxicity. Pertaining to cadmium<br />

toxicity our results are similar to the results <strong>of</strong><br />

various studies where cadmium has been reported<br />

to cause variations in histoarctecture <strong>of</strong> colon.<br />

These reports revealed that oral exposure to<br />

cadmium caused severe necrosis, hemorrhage <strong>and</strong><br />

ulcers in the colonic epithelium as well induced<br />

decreased body weight <strong>and</strong> muscle atrophy (Barret<br />

et al., 1947; Stawe et al., 1972; Richardson et al.,<br />

1974 <strong>and</strong> ATSDR, 1999). These reports give<br />

validity to our experiment, where we have also<br />

discerned similar cadmium induced aberrations in<br />

colon. In contrast to the injurious activity <strong>of</strong><br />

cadmium, curcumin serves as protective agent<br />

where it has been shown to decrease congestion <strong>and</strong><br />

inflammation in stagnant mucus membranes <strong>and</strong> no<br />

negative side effects have been associated with<br />

curcumin supplementation (Mukhopadhyay et<br />

al.,1982; Rao et al., 1982; Dikshit et al., 1995;<br />

Shukla et al., 2002 <strong>and</strong> Egan et al., 2004).<br />

Curcumin has also been reported to have proposed<br />

uses in ulcerative colitis (Deodhar et al., 1980 <strong>and</strong><br />

Chen et al., 1996). Curcumin has been shown to<br />

protectively coat esophagus, stomach, intestinal<br />

mucus membrane <strong>and</strong> reduce acid secretion.<br />

However no information is available pertaining to<br />

protective effect <strong>of</strong> curcumin in relation to<br />

cadmium induced toxicity. Hence, this study clearly<br />

delineates the protective effect <strong>of</strong> curcumin against<br />

CdCl2 induced colonic toxicity.<br />

References<br />

Anderson O, Nielsen JB <strong>and</strong> Svendsen E. Oral<br />

cadmium chloride intoxication in mice: Effects<br />

<strong>of</strong> dose on tissue damage, intestinal absorption<br />

<strong>and</strong> relative organ distribution. Toxicology.<br />

48:225-236, 1988.<br />

ATSDR (Agency for Toxic Substances <strong>and</strong> Disease<br />

Registry). Toxicological pr<strong>of</strong>ile for cadmium.<br />

ATSDR/U.S. Public Health Service,<br />

Atlanta/TP-88/08, 1989.<br />

ATSDR (Agency for Toxic Substances <strong>and</strong> Disease<br />

Registry). Toxicological pr<strong>of</strong>ile for Cadmium.<br />

ATSDR / US department <strong>of</strong> Health <strong>and</strong> Human<br />

Services, Atlanta/, US, 1999.<br />

Ammon HPT, Anazodo M I, Safayhi H <strong>and</strong><br />

Dhawan BN. Curcumin a potent inhibitor <strong>of</strong><br />

leukotriene B4 formation in rat


polymorphonuclear neutrophils (PMNL).<br />

Planta Med. 67: 1-6, 1992.<br />

Azuine M <strong>and</strong> Bhide S. Chemo preventive effect <strong>of</strong><br />

turmeric against stomach <strong>and</strong> skin tumors<br />

induced by chemical carcinogens in Swiss mice.<br />

Nutr Cancer. 17: 77-83, 1992.<br />

Barret HM, Irwin DA <strong>and</strong> Semmons E. Studies on<br />

the toxicity <strong>of</strong> inhaled cadmium. The acute<br />

toxicity <strong>of</strong> cadmium oxide by inhalaltion. J Ing<br />

Hyg Toxicol. 29: 279, 1947.<br />

Bernard A, Lauwery R, <strong>and</strong> Amor AO. Loss <strong>of</strong><br />

glomerular polyanion correlated with<br />

albuminuria in experimental cadmium<br />

nephropathy. Arch Pathol. 66:272-278, 1992.<br />

Chen CJ <strong>and</strong> Wang CJ. Ecological correlation<br />

between arsenic level in well water <strong>and</strong> age<br />

adjusted mortality from malignant neoplasms.<br />

Cancer Res. 50: 5470 - 5474, 1990.<br />

Chen YC, Kuo TC, Lin-Shiau SY <strong>and</strong> Lin J K.<br />

Induction <strong>of</strong> HSP70 gene expression by<br />

modulation <strong>of</strong> Ca(+2) ion <strong>and</strong> cellular p53<br />

protein by curcumin in colorectal carcinoma<br />

cells. Mol Carcinogen. 17: 224-234, 1996.<br />

Deodhar SD, Sethi R <strong>and</strong> Srimal RC. Preliminary<br />

study on antirheumatic activity <strong>of</strong> curcumin<br />

(diferuloyl methane). Indian J Med Res. 71:632-<br />

634, 1980.<br />

Dikshit M, Rastogi L, Shukla R <strong>and</strong> Srimal RC.<br />

Prevention <strong>of</strong> ischaemia-induced biochemical<br />

changes by curcumin <strong>and</strong> quinidine in the cat<br />

heart. Indian J Med Res. 101: 31 - 35, 1995.<br />

Friberg L, Piscator MA, Nordberg G <strong>and</strong><br />

Kjellstrom T. Cadmium in the Environment,<br />

<strong>Vol</strong>. II: A Toxicological <strong>and</strong> Epidemiological<br />

Appraisal, Exposure, Dose <strong>and</strong> Metabolism,<br />

Clevel<strong>and</strong>, OH, CRC Press. 1974.<br />

Friberg L, Piscator MA, Nordberg G <strong>and</strong><br />

Kjellstrom T. Cadmium in Environment. 2nd.Ed<br />

CRC Press, Boca Raton, Florida, 1975.<br />

Friberg L, Kjellstrom T, Nordberg G <strong>and</strong> Piscator<br />

A. Cadmium <strong>and</strong> Health: Toxicological <strong>and</strong><br />

Epidemiological Appraisal, US Environment<br />

Protection Agency, Washington DC, 1985a.<br />

Protective effects <strong>of</strong> curcumin on colon toxicity 35<br />

Friberg L, Elinder CG, Kjellstrom T <strong>and</strong> Nordberg<br />

G. Cadmium <strong>and</strong> Health: A Toxicological <strong>and</strong><br />

Epidemiological Appraisal, CRC Press, Baca<br />

Raton, Florida. 23 – 63, 1985b.<br />

Eigner D <strong>and</strong> Scholz D. Ferula asafetida <strong>and</strong><br />

Curcuma longa in traditional medicinal<br />

treatment <strong>and</strong> diet in Nepal. J Ethnopharmacol.<br />

67: 1-6, 1999.<br />

Egan ME, Pearson M, Weiner SA, Rajendran V,<br />

Rubin D, Glockner-Pagel J, Canny S, Du K,<br />

Lukacs GL <strong>and</strong> Caplan MJ. Curcumin a major<br />

constituent <strong>of</strong> turmeric, corrects cystic fibrosis<br />

defects. Science. 23; 304 (5670): 600-2, 2004.<br />

Goyer R, Amdur MO, Doull JD <strong>and</strong> Klaassen CD.<br />

Toxicology: Toxic effects <strong>of</strong> metals. 4th ed. Eds.<br />

Casarett <strong>and</strong> Doull's. Progamone Press, New<br />

York. 623 -680, 1991.<br />

Hotz P, Buchet JP, Bernard A, Lison D <strong>and</strong><br />

Lauwerys R. Renal effects <strong>of</strong> low-level<br />

environmental cadmium exposure: 5-year<br />

follow-up <strong>of</strong> a subcohort from the Cadmibel<br />

Study, Lancet. 354:1508, 1989.<br />

Iwata K, Saito H, Moryiama M <strong>and</strong> Nakano A.<br />

Follow up study <strong>of</strong> renal tubular dysfunction<br />

<strong>and</strong> mortality in residents <strong>of</strong> an area polluted<br />

with cadmium. B r J Ind Med. 49: 736 - 737,<br />

1992.<br />

Ikeda M, Zang Z W, Moon C S, Shimbo S,<br />

Watanabe T, Nakatsuka H, MatsudaInoguchi N<br />

<strong>and</strong> Higashikawa K. Possible effects <strong>of</strong><br />

environmental cadmium exposure on kidney<br />

function in the Japanese general population. Int<br />

Arch Occup Environ Health. 73: 15 - 25, 2000.<br />

Jarup L, Alfven T, Persson B, Toss G <strong>and</strong> Elinder<br />

CG. Cadmium may be a risk factor for<br />

osteoporosis. Occup Environ Med. 55: 435-<br />

439, 1998a.<br />

Lee JS <strong>and</strong> White KL. A review <strong>of</strong> health effects <strong>of</strong><br />

cadmium. Am J Ind Med. 1: 307-317, 1980.<br />

Lauwerys R, Bernard A <strong>and</strong> Buchet JP. Does<br />

environmental exposure to cadmium represent a<br />

health risk? Conclusions from the Cadmibel<br />

Study. Acta Clin Belg. United States<br />

Environmental Protection Agency. 46: 219 -<br />

225, 1991.


36 Preeti SINGH et al.<br />

Mukhopadhyay A, Basu N <strong>and</strong> Ghatak N. Antiinflammatory<br />

<strong>and</strong> irritant activities <strong>of</strong> curcumin<br />

analogues in rats. Agents Actions. 12: 508 - 515,<br />

1982.<br />

Mortellini R, Foresti R, Bassi R <strong>and</strong> Green CJ.<br />

Curcumin, an antioxidant <strong>and</strong> anti-inflammatory<br />

agent, induces heme oxygenase-1 <strong>and</strong> protects<br />

endothelial cells against oxidative stress. Free<br />

Radic Biol Med. 28:1303-1312, 2000.<br />

Nogawa K, Ishizaki A <strong>and</strong> Evrin PE. Urinary<br />

beta2-microglobulin excretion among people<br />

exposed to cadmium in the general<br />

environment: An epidemiological study in<br />

cooperation between Japan <strong>and</strong> Sweden.<br />

Environ Res. 13(2):318-344, 1977.<br />

Richardson ME, Fox MRS, <strong>and</strong> Fry BE.<br />

Pathological changes produced in Japanese<br />

quail by ingestion <strong>of</strong> cadmium. J Nutr. 104:323,<br />

1974.<br />

Rao TS, Basu N <strong>and</strong> Siddiqui H. Antiinflammatory<br />

activity <strong>of</strong> curcumin analogues.<br />

Indian J Med Res. 75:574-8, 1982.<br />

Risk Assessment Information System (RAIS).<br />

Toxicity summary for cadmium. Chemical<br />

Hazard Evaluation <strong>and</strong> Communication Group,<br />

Biomedical <strong>and</strong> Environmental Information<br />

Analysis Section, Health <strong>and</strong> Safety Research<br />

Division. 1991.<br />

Ruby A J <strong>and</strong> Kuttan G. Anti-tumour <strong>and</strong><br />

antioxidant activity <strong>of</strong> natural curcuminoids.<br />

Cancer Lett .94: 79 - 80, 1995.<br />

Singh P, Chaudhary S, Patni A <strong>and</strong> Sankhla V.<br />

Effect <strong>of</strong> cadmium chloride induced<br />

genotoxicity in bone marrow chromosomes <strong>of</strong><br />

Swiss albino mice <strong>and</strong> subsequent protective<br />

effects <strong>of</strong> Emblica <strong>of</strong>ficinalis <strong>and</strong> vitamin C. J<br />

<strong>of</strong> Herbal Medicine <strong>and</strong> Toxicology. 1 (2): 67-<br />

71, 2007.<br />

Stawe H D, Wilson M <strong>and</strong> Goyer R A. Clinical <strong>and</strong><br />

morphological effects <strong>of</strong> oral cadmium toxicity<br />

in rabbits. Arch Pathol. 94: 389 - 405, 1972.<br />

Shukla Y, Arora A <strong>and</strong> Taneja P. Antimutagenic<br />

potential <strong>of</strong> curcumin on chromosomal<br />

aberrations in Wistar rats. Mutat Res. 515: 197-<br />

202, 2002.<br />

Vahter M, Bergl<strong>and</strong> M, Nermall B <strong>and</strong> Akesson A.<br />

Bioavailability <strong>of</strong> cadmium from shellfish <strong>and</strong><br />

mixed diet in women. Toxicol Appl Pharmacol.<br />

136: 332 -341, 1996.<br />

World Health Organization (WHO). Environmental<br />

Health Criteria 134. Cadmium International<br />

Programme on Chemical Safety (IPCS)<br />

Monograph, 2000.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 37-44, 2011 Research Article 37<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

In vitro regeneration <strong>of</strong> Cleome viscosa – an important medicinal<br />

herb<br />

Jeyaraj ANBURAJ *,1 , Chinnappan Ravinder SINGH 1 , Shenbagamoorthy SUNDARRAJ 2<br />

Soundarap<strong>and</strong>ian KANNAN 2<br />

1<br />

Ayya Nadar Janaki Ammal College, Department <strong>of</strong> Biotechnology, Sivakasi, India.<br />

2<br />

Bharathiar University, Proteomics <strong>and</strong> <strong>Molecular</strong> <strong>Cell</strong> Physiology Lab, Department <strong>of</strong> Zoology,<br />

Coimbatore, India.<br />

(* author for correspondence; geneanbu@yahoo.co.in)<br />

Received: 30 August 2010; Accepted: 26 May 2011<br />

Abstract<br />

Cleome viscosa is an important medicinal herb. Mass collection <strong>of</strong> the plant from natural habitats has led to<br />

its depletion. We have established a protocol for its mass propagation through in vitro organogenesis using<br />

leaf explants. For callus induction it was found that Indole-3acetic acid (2mg/l) has a significant effect on the<br />

callus induction, callus index <strong>and</strong> callus physical appearance. The moderate response was observed with<br />

Indole-3butyric acid (2mg/l), <strong>and</strong> a low response was observed with 2-Napthalene acetic acid (2mg/l). 2mg/l<br />

concentration <strong>of</strong> Benzyl aminopurine significantly influenced shoot proliferation. Optimum response was<br />

observed with Benzyl aminopurine + Kinetin (5+2.5mg/l), <strong>and</strong> low response was observed with Kinetin<br />

(1mg/l). About 91% <strong>of</strong> rooting response was observed with NAA (0.1mg/l). Moderate response was observed<br />

from Indole-3butyric acid (0.1mg/l) <strong>and</strong> low response observed from IAA (0.1mg/l). After two weeks <strong>of</strong><br />

acclimatization 90% <strong>of</strong> survival rate have been observed. The present study describes a well-documented <strong>and</strong><br />

reliable protocol for Cleome viscosa from leaf explants with a high rate <strong>of</strong> multiplication. This protocol could<br />

be used as a basic tool for commercial cultivation <strong>of</strong> this medicinally important plant Cleome viscosa.<br />

Keywords: Cleome viscosa, organogenesis, medicinal plants, in vitro regeneration, auxins<br />

Önemli bir tıbbi bitki olan Cleome viscosa’nın in vitro rejenerasyonu<br />

Özet<br />

Cleome viscosa önemli bir tıbbi bitkidir. Bitkinin doğal ortamından toplu halde toplanması tükenmesine<br />

sebep olmuştur. Yaprak eksplantları kullanarak in vitro organogenez ile toplu üretimini sağlayacak bir<br />

protokol oluşturduk. İndol- 3-asetik asitin (2mg/l) kallus oluşumunda, kallus indeksinde ve kallus fiziksel<br />

görünümünde önemli derecede etkili olduğu belirlenmiştir. İndol-3-butirik asitin (2mg/l) orta derecede, 2naptalen<br />

asetik asitin de (2mg/ml) düşük derecede etki gösterdiği belirlenmiştir. 2mg/ml konsantrasyonda<br />

benzil aminopürin ise filiz proliferasyonunu önemli derecede arttımıştır. Benzil aminopürin + Kinetin (5+2<br />

mg/l) ile optimum cevap, Kinetin (1mg/ml) ile de düşük dereceli cevap gözlemlenmiştir. İndol-3-bütirik<br />

asitin (0,1mg/l) orta derecede, İAA' nın ise düşük derecede cevaba sebep olduğu gözlemlenmiştir.<br />

İklimlendirmenin iki hafta sonrasında %90 hayatta kalma oranı gözlemlenmiştir. Bu çalışmada Cleome<br />

viscosa yaprak eksplantlarından yüksek or<strong>and</strong>a çoğaltım sağlayan güvenilir ve iyi belgelenmiş bir protokol<br />

tarif edilmektedir. Bu protokol tıbbi önemi olan bir bitki olan Cleome viscosa'nın ticari amaçlı kültürünün<br />

yapılabilmesi için temel bir araç olarak kullanılabilir.<br />

Anahtar Sözcükler: Cleome viscosa ,organogenez, tıbbi bitkiler, in vitro rejenerasyon, oksinler.


38 Jeyaraj ANBURAJ et al.<br />

Introduction<br />

Cleome viscosa Linn. (Capparidaceae) is<br />

commonly known as Tickweed, wild mustard or<br />

Spider plant (English), Hurhur (Hindi) <strong>and</strong><br />

Hurhuria (Bengali). It occurs in woodl<strong>and</strong> <strong>and</strong><br />

grassl<strong>and</strong>, <strong>and</strong> is a weed <strong>of</strong> fallow l<strong>and</strong>, fields,<br />

roadsides <strong>and</strong> wastel<strong>and</strong>, <strong>of</strong>ten occurring on s<strong>and</strong>y<br />

soils, but sometimes on calcareous <strong>and</strong> rocky soils.<br />

It is a widely distributed herb with yellow flowers<br />

<strong>and</strong> long slender pods containing seeds. The whole<br />

plant is sticky in nature <strong>and</strong> has a strong odour<br />

resembling asafoetida. It is found in both seasonal<br />

dry <strong>and</strong> humid conditions, from mean sea level up<br />

to an altitude <strong>of</strong> 1000 m. The seeds have no<br />

dormancy <strong>and</strong> germinate readily after shedding.<br />

Plants start flowering 3–4 weeks after germination<br />

<strong>and</strong> the lifecycle is about 3 months. Cleome viscosa<br />

Linn (Capparidaceae), also called “Dog mustard”,<br />

is a herb that grow up to 1m height in India<br />

(Parimala et al., 2004). Cleome is a large genus<br />

included in the Capparaceae family, which<br />

comprises 427 species occurring in tropical <strong>and</strong><br />

subtropical regions <strong>of</strong> the world (Brummit, 1992).<br />

In Asia <strong>and</strong> Africa the leaves <strong>and</strong> seeds are used<br />

as a rubefacient <strong>and</strong> vesicant <strong>and</strong> to treat infections,<br />

fever, rheumatism <strong>and</strong> headache. The whole herb is<br />

used in the treatment <strong>of</strong> ringworm, flatulence, colic,<br />

dyspepsia, constipation, cough, bronchitis, cardiac<br />

disorders (Kirtikar <strong>and</strong> Basu, 1975; Saxena et al.,<br />

2000). Leaves are used as the external application<br />

to inflammation <strong>of</strong> the middle ear <strong>and</strong> applied on<br />

wounds <strong>and</strong> ulcers (Chopra et al., 1986),<br />

hepatoprotective activity (Gupta <strong>and</strong> Dixit, 2009).<br />

Traditionally, this plant is used in various disorders<br />

such as diarrhoea, fever, inflammation, liver<br />

diseases, bronchitis, skin diseases, <strong>and</strong> malarial<br />

fever. Its juice is useful in piles, lumbago <strong>and</strong><br />

earache (Rukmini, 1978). The analgesic, antipyretic<br />

<strong>and</strong> anti-diarrhoeal activities <strong>of</strong> the extract have<br />

been reported by researchers. A decoction is used<br />

as an expectorant <strong>and</strong> digestive stimulant <strong>and</strong> the<br />

vapour from a steaming decoction <strong>of</strong> the whole<br />

plant is inhaled to treat headache (CSIR, 1950). The<br />

seeds <strong>and</strong> its oil have anti-helminthic properties but<br />

they are ineffective in treating roundworm<br />

infections (Saxena et al., 2000). They also have<br />

anti-convulsant effect in Swiss albino mice (Mishra<br />

et al., 2010). The root is a remedy for scurvy <strong>and</strong><br />

rheumatism (Rukmini, 1978). An aqueous seed<br />

extract displayed significant analgesic activity in<br />

mice <strong>and</strong> local anaesthetic activity in guinea pigs<br />

(Singh <strong>and</strong> West, 1991; Parimaladevi et al., 2003).<br />

In tests with rats, the anti-diarrhoeal (Devi et al.,<br />

2002) <strong>and</strong> anti-pyretic (Devi et al., 2003) activities<br />

<strong>of</strong> the extracts have been confirmed. Leaves <strong>and</strong><br />

young shoots are cooked as a vegetable<br />

(Man<strong>and</strong>har, 2002). It has a sharp mustard like<br />

flavor (Facciola, 1990). The pungent seed can be<br />

pickled or used as a mustard substitute in curries<br />

(Man<strong>and</strong>har, 2002; Facciola, 1990). The juice <strong>of</strong><br />

the plant is used as a condiment (Facciola, 1990).<br />

Oil obtained from the seeds is used for cooking<br />

(Man<strong>and</strong>har, 2002). All parts <strong>of</strong> the plant are used<br />

in liver diseases, chronic painful joints <strong>and</strong> mental<br />

disorders (Chatterjee <strong>and</strong> Pakrashi, 1991).<br />

The induction <strong>of</strong> callus growth <strong>and</strong> subsequent<br />

differentiation <strong>and</strong> organogenesis is accomplished<br />

by the differential application <strong>of</strong> growth regulators<br />

<strong>and</strong> the control conditions in the culture medium.<br />

With the stimulus <strong>of</strong> endogenous growth substances<br />

or by addition <strong>of</strong> exogenous growth regulators to<br />

the nutrient medium cell division, cell growth <strong>and</strong><br />

tissue differentiation are induced (Tripathi <strong>and</strong><br />

Tripathi 2003). Organogenesis permits the<br />

manipulation <strong>of</strong> large numbers <strong>of</strong> high quality plant<br />

material within a short period <strong>of</strong> time. The vast<br />

usage <strong>of</strong> the Cleome viscosa in medicinal purpose,<br />

based on the above reason, it is increasing<br />

commercial dem<strong>and</strong> <strong>of</strong> Cleome viscosa. The<br />

present study was undertaken to develop a more<br />

efficient protocol for rapid in vitro multiplication <strong>of</strong><br />

Cleome viscosa using leaf explants as an initial<br />

plant material.<br />

Materials <strong>and</strong> methods<br />

The plants were collected from in <strong>and</strong> around<br />

Virudhunagar district, Tamil Nadu, India (Figure<br />

1). Small young leaves were collected from healthy<br />

plants <strong>of</strong> Cleome viscosa L defoliated <strong>and</strong> sectioned<br />

into many segments. They were washed under<br />

continuous flashing <strong>of</strong> running tap water for 30<br />

minutes <strong>and</strong> then with distilled water three times.<br />

Leaves were treated with 0.1% mercury chloride<br />

for 1.5 minutes <strong>and</strong> washed with sterilized double<br />

distilled water for 3 times. The small washed<br />

explants were treated with 3% hydrogen peroxide<br />

for 1.5 minutes <strong>and</strong> then washed with sterilized<br />

double distilled water for 3 times. At final the<br />

explants were treated with 70% ethanol for 0.5<br />

minutes <strong>and</strong> then washed with sterilized double<br />

distilled water for 3 times in laminar air flow<br />

cabinet.


Figure 1. Natural habitat <strong>of</strong> Cleome<br />

(Linn.).<br />

Culture media <strong>and</strong> growth condition<br />

viscosa<br />

The medium comprised <strong>of</strong> macro <strong>and</strong><br />

micro<br />

elements according to Murashige <strong>and</strong> Skoog (1962)<br />

with myoinositol (100mg/l), thamine<br />

HCl<br />

(0.1mg/l), pyridoxine (0.5mg/l), nicotinic acid<br />

(0.5mg/l) <strong>and</strong> sucrose (30g/l), solidified with 0.8%<br />

agar. The plant growth regulators used were<br />

Kinetin (Kn), Indole-3butyric acid (IBA), Indole-<br />

3acetic acid (IAA), 2-Napthalene acetic acid<br />

(NAA) <strong>and</strong> Benzyl aminopurine (BAP). All<br />

experiments were carried out in culture tubes<br />

(25×150mm) containing 10ml <strong>of</strong> culture medium.<br />

The pH <strong>of</strong> the medium was adjusted to 5.8 prior to<br />

autoclaving at 121ºC for 20 minutes. Cultures were<br />

incubated under 16 hours/8 hours light/dark cycles.<br />

Callus induction <strong>and</strong> shoot regeneration<br />

The small segments <strong>of</strong> leaf explants were cultured<br />

on MS medium fortified with different<br />

concentration <strong>of</strong> auxins such as, IAA, NAA <strong>and</strong><br />

IBA ranging from 0.5 – 4.0mg/l for callus<br />

initiation. Explants were found to give pr<strong>of</strong>use<br />

callusing <strong>and</strong> when callusing was observed in entire<br />

explant, the callus was transferred to MS medium<br />

supplemented with various concentrations <strong>of</strong> BAP<br />

(0.5-4.0mg/l), Kinetin (0.5-4.0mg/l) <strong>and</strong> BAP (1.0-<br />

5.0mg/l) in combinations with Kinetin (0.5-<br />

2.5mg/l). All the cultures were maintained at 25 ± 2<br />

ºC for a photoperiod <strong>of</strong> 16h light per day. A total <strong>of</strong><br />

40 explants was used for each experiment <strong>and</strong> was<br />

repeated 5 times. Data on percent <strong>of</strong> response,<br />

number <strong>of</strong> shoots <strong>and</strong> shoot length formation per<br />

explant was recorded after 30 days <strong>of</strong> culture.<br />

Callus Growth Measurement<br />

In order to minimize the differences in growth that<br />

may have been the result <strong>of</strong> variation in inoculum<br />

Regeneration <strong>of</strong> Cleome viscosa 39<br />

size, a growth index was used to evaluate the callus<br />

growth after 30 days <strong>of</strong> culture. Dry weight <strong>of</strong> calli<br />

was evaluated by drying fresh calli in an air forced<br />

oven at 60ºC for 36 hrs. The growth index was<br />

determined according to the formula:<br />

Regeneration <strong>of</strong> roots <strong>and</strong> development <strong>of</strong> complete<br />

plantlets<br />

For rooting individual microshoots (1.5-2.5mm<br />

length) were isolated from callus clumps <strong>and</strong><br />

cultured on MS medium containing 0.1-1.0mg/l <strong>of</strong><br />

different auxins such as, IBA, IAA <strong>and</strong> NAA to<br />

induce <strong>of</strong> root formation. A total <strong>of</strong> 40 plantlets<br />

were taken for each experiment <strong>and</strong> were repeated<br />

5 times. Percent <strong>of</strong> rooting, number <strong>of</strong> root<br />

formations <strong>and</strong> root length was recorded 40 days<br />

after root initiation. All the rooted plants were<br />

carefully removed from culture tubes <strong>and</strong> washed<br />

in tap water to remove agar gels <strong>and</strong> transferred to<br />

plastic pots containing soil mixture (sterile soil,<br />

vermicompost <strong>and</strong> s<strong>and</strong>) in the ratio <strong>of</strong> 1:2:1. In<br />

vitro regenerated plants covered with polythene<br />

bags to maintain high humidity. These were<br />

acclimatized at 25 ± 3ºC less than 16/8 hours<br />

photoperiod <strong>and</strong> watered regularly. After 3 – 4<br />

weeks, the polythene bags were removed <strong>and</strong><br />

established plantlets were transplanted to earthen<br />

pots in a greenhouse.<br />

Statistical analysis<br />

All results reported are the means <strong>of</strong> five replicate.<br />

The result are expressed as mean values ± st<strong>and</strong>ard<br />

deviation (n=5). Data were statistically analyzed at<br />

P≤0.05 levels using one way analysis <strong>of</strong> variance<br />

(ANOVA). Mean comparisons were carried out by<br />

Duncan's multiple ran test was used as a post hoc<br />

analysis (SPSS package, Version 17).<br />

Results<br />

The fresh smaller size <strong>of</strong> explants provide less<br />

chance <strong>of</strong> contamination, as well as, longer leaves<br />

showed, total loss <strong>of</strong> morphogenic potential. 3%<br />

hydrogen peroxide, 0.1% mercuric chloride <strong>and</strong><br />

70% ethanol was used to sterilize the leaves.


40 Jeyaraj ANBURAJ et al.<br />

Surface <strong>of</strong> the leaves were sterilized with 0.1%<br />

mercuric chloride for 1.5minutes, 3% hydrogen<br />

peroxide for 1.5minutes <strong>and</strong> 70% ethanol for<br />

0.5minutes reported the maximum growth without<br />

contamination.<br />

Interactive effects <strong>of</strong> culture medium <strong>and</strong><br />

explant type were statistically significant (P≤0.05)<br />

for calli fresh weight, <strong>and</strong> calli growth index (Table<br />

1). Calli were initiated from leaf explants <strong>of</strong><br />

Cleome viscosa (Figure 2A&B). After two weeks<br />

<strong>of</strong> culture on MS medium fortified with different<br />

concentrations <strong>of</strong> auxins IBA (0.5-4 mg/l), NAA<br />

(0.5-4 mg/l) <strong>and</strong> IAA (0.5-4 mg/l). The highest<br />

mean for calli growth index, <strong>and</strong> calli fresh weight<br />

<strong>of</strong> leaf explant belonged to the MS culture medium,<br />

supplemented with 2mg/L IAA. Leaf explant was<br />

superior to the nodal explants regarding the growth<br />

index, <strong>and</strong> calli fresh weight. About 81% callusing<br />

response with maximum <strong>of</strong> 178±0.71mg (P≤0.05)<br />

fresh mass <strong>and</strong> calli growth index 2.3±0.07<br />

(P≤0.05) was observed. The optimum concentration<br />

<strong>of</strong> IBA (2mg/l) showed 70% callusing response<br />

with 122±0.54mg fresh mass was observed in leaf<br />

explants. Here IBA (2mg/l) was more effective<br />

callusing response <strong>and</strong> callus growth index<br />

compare with IBA (1mg/l) (P=0.526). Low<br />

callusing response (55%) with 107±0.57mg fresh<br />

mass was observed in leaf explants cultured on<br />

NAA (2mg/l) fortified medium (Figure 2C, D & E).<br />

The callus cultured on MS medium with 3.0%<br />

sucrose <strong>and</strong> 0.8% agar medium supplemented with<br />

hormones such as, BAP, KN <strong>and</strong> BAP+KN<br />

produced microshoots. High frequency (95%)<br />

multiple shoot induction with 7.6±0.54 (P≤0.05)<br />

number <strong>of</strong> shoots <strong>and</strong> an average length <strong>of</strong><br />

4.10±0.18cm shoots in MS medium supplemented<br />

with 2.0mg/l BAP. On the other h<strong>and</strong>, the callus<br />

cultured on cytokinin combination BAP <strong>and</strong> KN<br />

(5+2.5mg/l) containing medium promoted the<br />

microshoots. About 85% moderate shooting<br />

response with 7.2±0.83 number <strong>of</strong> shoots <strong>and</strong> an<br />

average length <strong>of</strong> 3.62±0.15cm shoots from leaf<br />

callus. Low frequency (69%) multiple shoot<br />

induction with 5.6±0.55 (P=0.149) number <strong>of</strong><br />

shoots <strong>and</strong> an average length <strong>of</strong> 3.15±0.28cm<br />

shoots in MS medium supplemented with 1.0mg/l<br />

Kn (Table 2, Figure 2F, G & H).<br />

The healthy shoots with two to three leaves<br />

were isolated from shoot clumps <strong>and</strong> cultured on<br />

root induction medium to induce adventitious<br />

rooting. MS medium fortified with different<br />

concentration <strong>of</strong> auxins IBA (0.1-1.0mg/l), NAA<br />

(0.1-1.0mg/l) <strong>and</strong> IAA (0.1-1.0mg/l). The<br />

individual plantlets cultured on MS medium<br />

supplemented with NAA (0.1mg/l) fortified<br />

medium induced high frequency (91%) rooting<br />

with 3.4±0.89 (P≤0.05) number <strong>of</strong> microroots <strong>and</strong><br />

an average length <strong>of</strong> 3.00±0.25cm roots. There is<br />

no significant compared with concentration <strong>of</strong><br />

0.2mg/l NAA (P=0.6). When cultured on the MS<br />

medium containing other hormones such as IBA<br />

(0.1mg/l) <strong>and</strong> IAA (0.1mg/l) both explants showed<br />

low response than 0.1mg/l <strong>of</strong> NAA (Table 3, Figure<br />

2 I). The healthy rooted plants were carefully<br />

removed from the culture tubes <strong>and</strong> washed in<br />

running tap water to remove agar gels <strong>and</strong><br />

transferred to plastic pots containing soil mixture.<br />

Finally, the regenerated plants were successfully<br />

transferred to earthen pot containing soils. Almost<br />

all (90%) the in vitro regenerated plants<br />

successfully survived in green house condition<br />

(Figure 2J, K, L & M).<br />

Figure 2. A) Callus initiation in Cleome viscosa<br />

from leaf explants in MS media containing 2mg/l<br />

IBA. B) Callus initiation in Cleome viscosa from<br />

leaf explants in MS media containing 2mg/l NAA.<br />

C) Callus induction in Cleome viscosa from leaf<br />

explants in MS media containing 2mg/l IAA. D)<br />

Kinetin MS media. H) Shoot regeneration from<br />

callus on BAP + KN (4+2mg/l) MS media. I)<br />

Rooting generation on 0.5mg/l IAA & NAA. J) In<br />

vitro regeneration <strong>of</strong> complete plantlets <strong>of</strong> Cleome<br />

viscosa from leaf explants. K) Plants growing in<br />

Callus induction in Cleome viscosa from leaf<br />

explants in MS media containing 2mg/l NAA. E)<br />

Callus induction in Cleome viscosa from leaf<br />

explants in MS media containing 2mg/l IBA. F)<br />

Shoot regeneration from callus on 2mg/l BAP MS<br />

media. G) Shoot regeneration from callus on 2mg/l<br />

earthen pots containing soil under green house<br />

condition.


Regeneration <strong>of</strong> Cleome viscosa 41<br />

Table 1. Effects <strong>of</strong> different concentration <strong>of</strong> auxins on callus growth index from leaf <strong>of</strong> Cleome viscosa after<br />

30days.<br />

Growth regulators Callusing Callus growth Callus growth<br />

Callus<br />

(mg/l)<br />

IAA<br />

response % (mg fresh mass) index (Mean ±SE) morphology<br />

0.5 60 129±0.83a 1.2±0.09ac Green nodular calli<br />

1 65 140±0.89a 1.4±0.09b Green nodular calli<br />

2 81 178±0.71a 2.3±0.07abc Green nodular calli<br />

3 80 156±0.55a 1.8±0.07ab Green nodular calli<br />

4<br />

IBA<br />

75 147±0.45a 1.6±0.09c Green nodular calli<br />

0.5 65 114±0.84ab 1.3±0.05a White green compact calli<br />

1 60 109±0.71b 1.2±0.03b White green compact calli<br />

2 70 122±0.54a 1.6±0.04c White green compact calli<br />

3 60 110±0.57ab 1.2±0.04abc White green compact calli<br />

4<br />

NAA<br />

60 80±0.99ab 1.0±0.03abc White green compact calli<br />

0.5 45 100±0.45a 1.4±0.02a White yellow friable calli<br />

1 50 103±0.83a 1.8±0.11ab White yellow friable calli<br />

2 55 107±0.57a 2.1±0.12ab White yellow friable calli<br />

3 40 84±0.55a 1.4±0.05b White yellow friable calli<br />

4 15 39±0.89a 1.0±0.06ab White yellow friable calli<br />

Values followed by the same letter within each column are not significantly different.<br />

Table 2. Effects <strong>of</strong> different concentration <strong>of</strong> cytokinins <strong>and</strong> cytokinins combinations on multiple shoot<br />

induction from leaf <strong>of</strong> Cleome viscosa.<br />

Growth regulators Callusing<br />

Number <strong>of</strong><br />

Shoot length<br />

(mg/l)<br />

Bap<br />

response % total shoots)<br />

(cm)<br />

0.5 60<br />

5.4±0.54ac<br />

3.50±0.24a<br />

1 80<br />

6.2±0.83bd<br />

3.60±0.16b<br />

2 95<br />

7.6±0.54ac<br />

4.10±0.18abc<br />

3 55<br />

2.6±0.89ab<br />

3.20±0.25c<br />

4 50<br />

2.2±0.45cd<br />

3.10±0.18b<br />

Kn<br />

Bap+Kn<br />

0.5<br />

1<br />

2<br />

3<br />

4<br />

60<br />

69<br />

54<br />

45<br />

40<br />

5.2±0.45a<br />

5.6±0.55b<br />

5.1±0.84c<br />

4.8±0.95d<br />

4.2±0.84e<br />

2.85±0.21a<br />

3.15±0.28b<br />

3.08±0.15c<br />

3.20±0.25d<br />

3.00±0.13e<br />

0.5<br />

1<br />

2<br />

3<br />

4<br />

60<br />

45<br />

75<br />

80<br />

85<br />

5.4±0.89a<br />

4.2±0.84bc<br />

6.0±0.71c<br />

4.4±0.89d<br />

7.2±0.83abd<br />

2.95±0.31a<br />

2.63±0.18b<br />

3.25±0.15bc<br />

2.80±0.14c<br />

3.62±0.15abc<br />

Values followed by the same letter within each column are not significantly different.


42 Jeyaraj ANBURAJ et al.<br />

Table 3. Effects <strong>of</strong> different concentration <strong>of</strong> auxins on efficient rooting from shooted callus <strong>of</strong> Cleome<br />

viscosa.<br />

Growth regulators<br />

(mg/l)<br />

NAA<br />

0.1<br />

0.2<br />

0.5<br />

1<br />

IBA<br />

IAA<br />

0.1<br />

0.2<br />

0.5<br />

1<br />

0.1<br />

0.2<br />

0.5<br />

1<br />

Callusing<br />

response %<br />

91<br />

80<br />

55<br />

40<br />

85<br />

70<br />

40<br />

35<br />

65<br />

40<br />

35<br />

25<br />

Number <strong>of</strong><br />

total shoots)<br />

3.4±0.89ac<br />

3.2±0.45bd<br />

2.6±0.89ab<br />

2.4±0.54cd<br />

3.2±0.83a<br />

3.0±0.71b<br />

2.2±0.84ab<br />

1.6±0.54ab<br />

2.8±0.84ab<br />

1.6±0.89a<br />

1.4±0.55b<br />

1.2±0.44a<br />

Values followed by the same letter within each column are not significantly different<br />

Discussion<br />

The fresh smaller size <strong>of</strong> explants provide less<br />

chance <strong>of</strong> contamination, longer leaves showed a<br />

total loss <strong>of</strong> morphogenic potential as well. A<br />

similar report has been published in Rauvolfia<br />

serpentine by Singh et al. (2009) who reported that<br />

shoot regeneration from small leaf explants <strong>of</strong><br />

Rauvolfia serpentine L. The surface sterilization <strong>of</strong><br />

explants is very essential for establishment, as well<br />

as for optimum induction <strong>of</strong> callus <strong>and</strong> plantlet<br />

regeneration in vitro condition (Yeoman <strong>and</strong><br />

Macleod, 1977). In the present study 3% hydrogen<br />

peroxide, 0.1% mercuric chloride <strong>and</strong> 70% ethanol<br />

was used to sterilize the leaves, resulted the<br />

maximum growth without contamination.<br />

Similarly, Sairkar et al. (2009) reported that the<br />

cultured explants showed more than 80%<br />

contamination free cultures when treated with 0.1%<br />

HgCl2 for surface sterilization.<br />

The MS medium was the most effective for<br />

callusing <strong>of</strong> leaf explants. The explants cultured on<br />

MS medium supplemented with different auxins <strong>of</strong><br />

IBA, NAA <strong>and</strong> IAA showed varied response for<br />

callusing. Among three types <strong>of</strong> auxins, IBA <strong>and</strong><br />

IAA were previously found to be very effective<br />

(Singh et al., 2009). However, in the present<br />

Shoot length<br />

(cm)<br />

3.00±0.25abc<br />

2.50±0.28a<br />

2.45±0.23b<br />

2.30±0.23c<br />

2.10±0.23ac<br />

1.85±0.41b<br />

1.80±0.19a<br />

1.53±0.18bc<br />

2.00±0.18ac<br />

1.85±0.12b<br />

1.65±0.16a<br />

1.50±0.20bc<br />

investigation calli were initiated from leaf explants<br />

<strong>of</strong> Cleome after two weeks <strong>of</strong> culture on MS<br />

medium fortified with different auxins IBA (0.5-4<br />

mg/l), NAA (0.5-4 mg/l) <strong>and</strong> IAA (0.5-4 mg/l).<br />

About 81% callusing response with maximum <strong>of</strong><br />

178mg fresh mass was observed in leaf explants<br />

cultured on MS medium supplemented with IAA<br />

(2mg/l).<br />

In this present research that the callus cultured<br />

on MS medium, hormones such as BAP, KN <strong>and</strong><br />

BAP+KN produced microshoots. High frequency<br />

(95%) multiple shoot induction with 7.6±0.54<br />

number <strong>of</strong> shoots <strong>and</strong> an average length <strong>of</strong><br />

4.10±0.18 shoots in MS medium supplemented<br />

with 2.0mg/l BAP, was observed. Similarly, the<br />

two cytokinins used BAP induced significantly<br />

higher percentage <strong>of</strong> shoot initiation <strong>and</strong> mean<br />

number <strong>of</strong> shoot, whereas higher mean shoot length<br />

was obtained in the shoots obtained on media<br />

supplement with KN (Gokhale <strong>and</strong> Bansal 2009).<br />

The healthy shoots were isolated from shoot<br />

clumps <strong>and</strong> cultured on root induction medium to<br />

induce adventitious rooting. MS medium was<br />

fortified with different concentrations <strong>of</strong> auxins<br />

IBA (0.1-1.0mg/l), NAA (0.1-1.0mg/l) <strong>and</strong> IAA


(0.1-1.0mg/l). The individual plantlets cultured on<br />

MS medium supplemented with NAA (0.1mg/l)<br />

fortified medium induced high frequency (91%)<br />

rooting with 3.4±0.89 number <strong>of</strong> microroots <strong>and</strong> an<br />

average length <strong>of</strong> 3.00±0.25 roots. When cultured<br />

on the MS medium containing other hormones such<br />

as IBA (0.1mg/l) <strong>and</strong> IAA (0.1mg/l), both explants<br />

showed lower response than that <strong>of</strong> 0.1mg/l <strong>of</strong><br />

NAA. A similar report has been published by Amin<br />

et al, (2003), who reported the root formation was<br />

induced in in vitro regenerated shoots by culturing<br />

them on half strength <strong>of</strong> MS medium with 0.1-<br />

1.0mg/l either <strong>of</strong> NAA, IBA <strong>and</strong> IAA. Among three<br />

types <strong>of</strong> auxins, NAA was found to be most<br />

effective at different concentrations tested for root<br />

production. The findings are in agreement with<br />

those observed in other plant species. Although<br />

Gokhale <strong>and</strong> Bansal (2009) reported that the three<br />

auxins (IAA, IBA, NAA) induced roots in in vitro<br />

raised shoots <strong>of</strong> O. indicum, yet NAA responded<br />

best for all parameters <strong>of</strong> rooting. For shoots with<br />

highest percentage <strong>of</strong> root induction, maximum<br />

number <strong>of</strong> elongated roots was developed on MS<br />

medium containing NAA. Long, branched healthy<br />

roots were produced in this rooting media.<br />

The in vitro derived plants acclimated better<br />

under ex vitro conditions when they were<br />

transferred on specially made plastic trays<br />

containing coco-peat as potting mix <strong>and</strong> moistened<br />

uniformly at periodic intervals taking special care<br />

not to damage the roots. The rest <strong>of</strong> the procedure,<br />

followed from this stage up to their establishment<br />

in soil was as usual (Amin et al., 2003). In the<br />

present investigation the healthy rooted plants were<br />

carefully removed from the culture tubes <strong>and</strong><br />

washed in running tap water to remove agar gels<br />

<strong>and</strong> transferred to plastic pots containing soil<br />

mixture. Finally, the regenerated plants were<br />

successfully transferred to earthen pot containing<br />

soils. Almost all (90%) the in vitro regenerated<br />

plants successfully survived at green house<br />

conditions. Similarly, the success <strong>of</strong> transplantation<br />

was 85% when plantlets were sufficiently healthy<br />

with new growth.They were subsequently<br />

transferred to larger pots <strong>and</strong> gradually acclimated<br />

to outdoor conditions. The protocol reported here is<br />

reproducible, it has a potential for being utilized to<br />

conserve the germplasm <strong>and</strong> allowing at the same<br />

time, a large scale micropropagation <strong>of</strong> this<br />

important medicinal plants (Jeyakumar <strong>and</strong><br />

Jayabalan, 2002).<br />

In conclusion, a significant progress has been<br />

made in the in vitro regeneration system <strong>of</strong> this<br />

Regeneration <strong>of</strong> Cleome viscosa 43<br />

medicinally important Cleome viscosa. Using this<br />

technique, it is possible to produce healthy <strong>and</strong><br />

disease free clones which could be released to their<br />

natural habitat in large scale. It may also be useful<br />

for gene manipulation for this important medicinal<br />

species.<br />

Acknowledgements<br />

I am extremely grateful to Dr. M. Vimala Devi, the<br />

head at Department <strong>of</strong> Biotechnology, Ayya Nadar<br />

Janaki Ammal College, Sivakasi, India for his<br />

stimulating guidance, invaluable suggestions <strong>and</strong><br />

critical <strong>and</strong> persistent encouragement. I wish to<br />

thank Mr. Ga. Bakavathiappan <strong>and</strong> Mr. M. Pavaraj,<br />

for helping me to carry out my project work in<br />

Ayya Nadar Janaki Ammal College, Sivakasi,<br />

India.<br />

References<br />

Amin MN, Rahman MM, Manik MS. In vitro<br />

clonal propagation <strong>of</strong> Paederia foetida L.- A<br />

medicinal plant <strong>of</strong> Bangaladesh. Plant tissue<br />

Cult. 13:117-123, 2003.<br />

Brummit RK. Vascular plants families <strong>and</strong> genera.<br />

Kew: Royal Botanic Gardens; 1992.<br />

Chatterjee A, Pakrashi SC. The Treatise on Indian<br />

Medicinal Plants. <strong>Vol</strong>.1, PID, CSIR, New<br />

Delhi, P.215, 1991.<br />

Chopra RN, Nayar SL, Chopra IC. Glossary <strong>of</strong><br />

Indian Medicinal Plants. Council <strong>of</strong> Scientific<br />

<strong>and</strong> Industrial Research, New Delhi, 1986.<br />

CSIR, The wealth <strong>of</strong> India: A dictionary <strong>of</strong> Indian<br />

raw materials <strong>and</strong> industrial products raw<br />

materials. Council <strong>of</strong> Scientific <strong>and</strong> Industrial<br />

Research, New Delhi, India, <strong>Vol</strong>. 2, pp 427,<br />

1950.<br />

Devi BP, Boominathan R, M<strong>and</strong>al SC. Evaluation<br />

<strong>of</strong> anti-diarrheal activity <strong>of</strong> Cleome viscosa L.<br />

extract in rats. Phytomedicine. 9: 739–742,<br />

2002.<br />

Devi BP, Boominathan R, M<strong>and</strong>al SC. Evaluation<br />

<strong>of</strong> antipyretic potential <strong>of</strong> Cleome viscosa<br />

Linn. (Capparidaceae) extract in rats. <strong>Journal</strong><br />

<strong>of</strong> Ethnopharmacology. 87: 11–13, 2003.<br />

Facciola S. Cornucopia- A source Book <strong>of</strong> Edible<br />

Plants. Kampong Publications, ISBN 0-<br />

9628087-0-9, 1990.


44 Jeyaraj ANBURAJ et al.<br />

Gokhale M, Bansal YK. Direct In vitro<br />

regeneration <strong>of</strong> a medicinal tree Oroxylum<br />

indicum (L.) Vent. through tissue culture.<br />

African <strong>Journal</strong> <strong>of</strong> Biotechnology. 8: 3777-<br />

3781, 2009.<br />

Gupta NK, Dixit VK. Evaluation <strong>of</strong><br />

hepatoprotective activity <strong>of</strong> Cleome viscose<br />

Linn. extract. Indian J Pharmacol. 41: 36-40,<br />

2009<br />

Jeyakumar M, Jeyabalan N. In vitro plant<br />

regeneration from cotyledonary node <strong>of</strong><br />

Psoralea corylifolia L. Plant Tissue Cult.<br />

12:125-129, 2002.<br />

Kirtikar KR, Basu BD. Indian medicinal plants. 2nd<br />

ed. <strong>Vol</strong>. 1. Periodical Experts, New Delhi: p.<br />

183-5, 1975.<br />

Man<strong>and</strong>har NP. Plants <strong>and</strong> people <strong>of</strong> Nepal.<br />

Timber Press. Oregon. ISBN 0-88192-527-6,<br />

2002.<br />

Mishra A, Mishra AK, Jain SK. Anticonvulsant<br />

activity <strong>of</strong> cleome viscosa seed extracts in<br />

Swiss albino mice. International <strong>Journal</strong> <strong>of</strong><br />

Pharmacy <strong>and</strong> Pharmaceutical Sciences. 2:<br />

177-181, 2010.<br />

Murashige T, Skoog F. A revised medium for rapid<br />

growth <strong>and</strong> bioassays with tobacco tissue<br />

cultures. Plant Physiol. 15:473-497, 1962.<br />

Parimala DB, Boominathan R, M<strong>and</strong>al SC. Studies<br />

on psychopharmacological effects <strong>of</strong> Cleome<br />

viscosa Linn. Extracts in rats <strong>and</strong> mice.<br />

Phytotherapy Research. 18:169-172, 2004.<br />

Parimaladevi B, Boominathan R, M<strong>and</strong>al SC.<br />

Studies on analgesic activity <strong>of</strong> Cleome<br />

viscosa in mice. Fitoterapia. 74: 262–266,<br />

2003.<br />

Rukmini C. Chemical, nutritional <strong>and</strong> toxicological<br />

evaluation <strong>of</strong> the seed oil <strong>of</strong> Cleome viscose.<br />

Indian <strong>Journal</strong> <strong>of</strong> Medical Research. 67: 604–<br />

607, 1978.<br />

Sairkar P, Ch<strong>and</strong>ravanshi MK, Shukla NP,<br />

Mehrotra NN. Mass production <strong>of</strong> an<br />

economically important medicinal plant<br />

Stevia rebaudiana using in vitro propagation<br />

techniques. <strong>Journal</strong> <strong>of</strong> Medicinal Plant<br />

Research. 3:266-270, 2009.<br />

Saxena BR, Koli MC, Saxena RC. Preliminary<br />

ethnomedical <strong>and</strong> phytochemical study <strong>of</strong><br />

Cleome viscosa L. Ethnobotany. 12: 47–50,<br />

2000.<br />

Singh P, Singh A, Shukla AK, Singh L, P<strong>and</strong>e V,<br />

Nailwal TK. Somatic embryogenesis <strong>and</strong> in<br />

vitro regeneration <strong>of</strong> an endangered medicinal<br />

plant Sarpag<strong>and</strong>ha(Rauvolfia serpentiana L.).<br />

Life Science <strong>Journal</strong>. 6:57-62, 2009.<br />

Singh PDA, West ME. Pharmacological<br />

investigations <strong>of</strong> sticky viscome extract<br />

(Cleome viscosa L.) in rats, mice <strong>and</strong> guineapigs.<br />

Phytotherapy Research. 5: 82–84, 1991.<br />

Tripathi L, Tripathi JN. Role <strong>of</strong> biotechnology in<br />

medicinal plants. Tropical <strong>Journal</strong> <strong>of</strong><br />

Pharmaceutical Research. 2:243-253, 2003.<br />

Yeoman MM, Macleod AJ. Tissue (callus) culture<br />

technique. Plant tissue <strong>and</strong> cell culture. 1:31-<br />

59, 1977.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 45-52, 2011 Research Article 45<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Bio-database compression using enhanced suffix array for pairwise<br />

sequence alignment<br />

Arumugam KUNTHAVAI *1 <strong>and</strong> Somasundaram VASANTHA RATHNA 2<br />

1 Department <strong>of</strong> CSE/IT, Coimbatore Institute <strong>of</strong> Technology, Coimbatore, Tamilnadu, India<br />

2 Department <strong>of</strong> EEE, Coimbatore Institute <strong>of</strong> Technology, Coimbatore, Tamilnadu, India<br />

(* author for correspondence; kunthavai@cit.edu.in)<br />

Received: 19 February 2011; Accepted: 10 June 2011<br />

Abstract<br />

Sequence alignment is a bioinformatics application that determines the degree <strong>of</strong> similarity between<br />

nucleotide or amino acid sequences which is assumed to have same ancestral relationships. This sequence<br />

alignment method reads query sequence from the user <strong>and</strong> makes an alignment against large <strong>and</strong> genomic<br />

sequence data sets <strong>and</strong> locate targets that are similar to an input query sequence. Traditional accurate<br />

algorithm, such as Smith-Waterman <strong>and</strong> FASTA are computationally very expensive, which limits their use<br />

in practice. The current set <strong>of</strong> popular search tools, such as BLAST <strong>and</strong> WU-BLAST, employ heuristics to<br />

improve the speed <strong>of</strong> such searches. However, such heuristics can sometimes miss targets, in which many<br />

cases are undesirable. This paper provides BioDB Compression Tool using enhanced suffix array, to perform<br />

accurate <strong>and</strong> faster biological sequence analysis as an improvement on the computation time <strong>of</strong> existing tools<br />

in this area using data base compression. The main idea is to pick matched patterns <strong>of</strong> the query sequence <strong>and</strong><br />

identify sequences in the database which share a large number <strong>of</strong> these matched patterns, thereby<br />

compressing the size <strong>of</strong> the database to very few sequences. Experiment results are cross validated using data<br />

mining technique. This shows that a new BioDB Compression developed effectively compresses the database<br />

<strong>and</strong> obtains very similar results compared to that traditional algorithm in approximately half the time taken<br />

by them.<br />

Keywords: Sequence alignment, enhanced suffix array, compression, local alignment, data mining<br />

Çiftli dizi sıralaması için kuvvetlendirilmiş sonek dizilişi kullanarak biyo-veritabanı<br />

sıkıştırması<br />

Özet<br />

Dizi sıralaması aynı atasal ilişkiye sahip olduğu tahmin edilen nükleotid ve amino asit dizisi arasında<br />

benzerlik derecesini tayin eden bir biyoenformatik uygulamadır. Dizi sıralama metodu kullanıcıdan sorgu<br />

dizisini okur, büyük ve genomik dizi veri setlerine karşı sıralama yapar ve giriş sorgu dizisine benzer olan<br />

hedefleri yerleştirir. Smith-Waterman ve FASTA gibi geleneksel güvenilir algoritmaların çok pahalı olması<br />

pratik olarak kullanımlarını kısıtlar. BLAST ve WU-BLAST gibi güncel popüler araştırma araç setleri bu tür<br />

araştırmaların hızını geliştirmek için buluşsal yöntemler kullanırlar. Ancak, bu tür buluşsal yöntemlerin çoğu<br />

istenmeyen durumlarda bazen hedefleri kaçırabilir. Bu yayın bu al<strong>and</strong>a var olan araçların hesaplama<br />

zamanını geliştirmek amaçlı kesin ve daha hızlı biyolojik dizi analizi yapmak üzere kuvvetlendirilmiş sonek<br />

dizilişi kullanarak BioDB Sıkıştırma Aracını sunar. Ana fikir sorgu dizisinin eşleşen paternlerini seçmek ve<br />

veri tabanında büyük sayıda eşleşen paterni paylaşan dizileri tayin ederek veri tabanı büyüklüğünü çok az<br />

sayıda diziye sıkıştırmaktır. Deneysel sonuçlar veri madenciliği tekniği kullanılarak çapraz onaylanmıştır. Bu<br />

da yeni geliştirilen BioDB Sıkıştırmanın veritabanını efektif olarak sıkıştırdığını ve klasik algoritmalarla<br />

karşılaştırıldığında yarı zam<strong>and</strong>a çok benzer sonuçlar elde edildiğini gösterir.<br />

Anahtar Sözcükler: Dizi sıralaması, kuvvetlendirilmiş sonek dizilişi, sıkıştırma, veri madenciliği


46 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />

Introduction<br />

Bioinformatics is the field <strong>of</strong> analyzing the<br />

biological information using computers <strong>and</strong><br />

statistical techniques; the science <strong>of</strong> developing <strong>and</strong><br />

utilizing computer databases <strong>and</strong> algorithms to<br />

accelerate <strong>and</strong> enhance biological research. The<br />

primary goal <strong>of</strong> bioinformatics is to increase the<br />

underst<strong>and</strong>ing <strong>of</strong> biological processes. Common<br />

activities <strong>of</strong> bioinformatics include mapping <strong>and</strong><br />

analyzing DNA <strong>and</strong> protein sequences, aligning<br />

different DNA <strong>and</strong> protein sequences to compare<br />

them <strong>and</strong> creating <strong>and</strong> viewing 3-D models <strong>of</strong><br />

protein structures. It has been successfully applied to<br />

predict the function, structure <strong>and</strong> evolution <strong>of</strong><br />

biological sequences. It can reveal biological<br />

relationship among organisms, for example, finding<br />

evolutionary information, determining causes <strong>and</strong><br />

cures <strong>of</strong> diseases.<br />

Sequence comparison is a basic operation <strong>of</strong> the<br />

sequencing problem. Sequences can be aligned<br />

across their entire length (global alignment) or only<br />

in certain regions (local alignment). Local sequence<br />

alignment plays a major role in the analysis <strong>of</strong> DNA<br />

<strong>and</strong> protein sequences (GusFeild, 1997). This paper<br />

describes the pair wise local alignment, which is the<br />

basic step for many other applications like detecting<br />

homology, finding protein structure <strong>and</strong> function,<br />

deciphering evolutionary relationships, etc. Smith<br />

Waterman developed a dynamic programming<br />

approach to sequence alignment problem that is<br />

widely used (Smith <strong>and</strong> Waterman, 1999). BLAST<br />

(Altschul et al., 1990), FASTA (Pearson, 2000), WU-<br />

BLAST (blast.wustl.edu) <strong>and</strong> (Matthew et al., 2003)<br />

is two commonly used programs for similarity<br />

searching on biological sequences. The methods<br />

widely used are based on heuristic paradigms <strong>and</strong><br />

have relatively a fast execution time, they do not<br />

produce optimal alignments sought by entirely<br />

sequenced. This reality presents the need for<br />

comparing long DNA or protein sequences, which is<br />

a challenging task due to its high dem<strong>and</strong>s for<br />

computational requirements (power <strong>and</strong> memory).<br />

One important feature <strong>of</strong> BLAST is its ability to<br />

compare a query with a database <strong>of</strong> sequences.<br />

Considering the rapid growth <strong>of</strong> database sizes, this<br />

problem dem<strong>and</strong>s ever-growing computation<br />

resources, <strong>and</strong> remains as a computational challenge.<br />

Divya in Sequence Comparison Tool - SCT (Divya<br />

et al., 2006) developed sequence similarity in a<br />

database instead <strong>of</strong> pair wise sequence alignment.<br />

This tool preprocesses the database to create a<br />

special generalized suffix tree from the sequences in<br />

the database. The suffix tree (Divya et al., 2006) is<br />

one <strong>of</strong> the most important data structures in string<br />

processing <strong>and</strong> comparative genomic. The space<br />

consumption <strong>of</strong> the suffix tree is a bottleneck in<br />

large-scale applications such as genome analysis. To<br />

overcome this bottleneck, in this paper suffix tree is<br />

replaced with suffix arrays enhanced with the Lcptable.<br />

Every algorithm that uses a suffix tree as data<br />

structure can systematically be replaced with an<br />

algorithm that uses an enhanced suffix array<br />

(Abouelhoda et al., 2004) <strong>and</strong> solves the same<br />

problem in the same time complexity but with<br />

improved space complexity. The generic name<br />

enhanced suffix array (Manber <strong>and</strong> Myers, 1993)<br />

st<strong>and</strong>s for data structures consisting <strong>of</strong> the basic<br />

suffix array enhanced with additional tables.<br />

Generalized suffix array (GSArray) is formed for<br />

the query sequence <strong>and</strong> longest common<br />

subsequence (LCS) is obtained <strong>and</strong> is compared<br />

against the database; sequences, which consist <strong>of</strong><br />

LCS, are identified from the database. Sequences are<br />

ranked with respect to the number <strong>of</strong> significant<br />

patterns they share with the query sequence. Finally<br />

database is compressed by selecting only a given<br />

number <strong>of</strong> sequences with topmost ranks.<br />

Materials <strong>and</strong> methods<br />

Let S be a string <strong>of</strong> length ‘n’ over an ordered<br />

alphabet ∑. It is assumed that the size <strong>of</strong> the alphabet<br />

is a constant, <strong>and</strong> i.e. n < 232.The latter implies that<br />

an integer in the range [0: n] can be stored in 4 bytes<br />

<strong>and</strong> also assumed that the special symbol $ is an<br />

element <strong>of</strong> ∑ (which is larger than all other<br />

elements) but does not occur in S. S[i] denotes the<br />

character at position i in S, for 0 ≤ i < n. For i ≤ j, S<br />

[i...j] denotes the substring <strong>of</strong> S starting with the<br />

character at position i <strong>and</strong> ending with the character<br />

at position j. The substring S [i...j] is also denoted by<br />

the pair <strong>of</strong> positions (i, j).<br />

Suffix Tree: A suffix tree for the string S is a<br />

rooted directed tree with exactly n+1 leaves<br />

numbered 0 to n. Each internal node, other than the<br />

root, has at least two children <strong>and</strong> each edge is<br />

labeled with a nonempty sub string <strong>of</strong> S$. No two<br />

edges out <strong>of</strong> a node can have edge-labels beginning<br />

with the same character. The key feature <strong>of</strong> the suffix<br />

tree is that for any leaf i, the concatenation <strong>of</strong> the<br />

edge-labels on the path from the root to leaf i exactly<br />

spells out the string Si, where Si = S [i...n – 1]


denotes the ith nonempty suffix <strong>of</strong> the string S$, 0 ≤ i<br />

< n. The space <strong>and</strong> time complexity <strong>of</strong> this suffix<br />

tree is O (n). Consider the suffix tree as an example<br />

shown in Figure 1 for the string S = acaaacatat.<br />

Using the suffix tree <strong>of</strong> S1 # S2, MUMs(Maximum<br />

Unique Match) (Delcher et al., 1999) can be<br />

computed in O (n) time <strong>and</strong> space, where n = [S1 #<br />

S2] <strong>and</strong> # is a symbol neither occurring in S1 nor in<br />

S2.<br />

However, the space consumption <strong>of</strong> the suffix tree<br />

is a major problem when comparing large genomes.<br />

Figure 1. The suffix tree for S = acaaacatat.<br />

Suffix array<br />

Suffix array is designed for efficient searching <strong>of</strong> a<br />

large text. It requires only 4n bytes (4 bytes per<br />

input character) in its basic form. Searching a text<br />

can be performed by binary search using the suffix<br />

array. Suffix trees can be constructed in O (n) time<br />

in the worst case, versus O (nlogn) time for suffix<br />

arrays. Suffix arrays will prove to be better than<br />

suffix trees for many applications. The suffix array<br />

(denoted by suftab) <strong>of</strong> the string S is an array <strong>of</strong><br />

integers in the range 0 to n, specifying the<br />

lexicographic ordering <strong>of</strong> the n + 1 suffixes <strong>of</strong> the<br />

string S$. That is, S (suftab [0]), S (suftab [1] … S<br />

(suftab[n]) is the sequence <strong>of</strong> suffixes <strong>of</strong> S$ in<br />

ascending lexicographic order as shown in Table 1.<br />

Suffix array generation<br />

Creating suffix array requires time O (nlogn) <strong>and</strong><br />

searching for a pattern in it requires time O<br />

(nlogm), where n is the length <strong>of</strong> the pattern <strong>and</strong> m<br />

is the length <strong>of</strong> the string. In (Abouelhoda et al.,<br />

2002), the authors provides a systematic way <strong>of</strong><br />

replacing string processing algorithm based on a<br />

bottom-up traversal <strong>of</strong> a suffix tree by a<br />

corresponding algorithm that is based on an<br />

enhanced suffix array. The advantages <strong>of</strong> this<br />

approach are better search, more space efficient<br />

Bio-database compression using enhanced suffix array 47<br />

than suffix tree since the implementation <strong>of</strong> the<br />

enhanced suffix array requires only 5n bytes <strong>and</strong><br />

the running times <strong>of</strong> the algorithms are much better<br />

than those based on the suffix tree <strong>and</strong> the<br />

algorithm is easier to implement on enhanced suffix<br />

arrays than on suffix trees.<br />

Table 1. The Lcp-interval table <strong>of</strong> S = acaaacatat$<br />

s.no Suftab Lcptab S(suftab[i])<br />

0 2 0 aaacatat$<br />

1 3 2 aacatat$<br />

2 0 1 acaaacatat$<br />

3 4 3 acatat$<br />

4 6 1 atat$<br />

5 8 2 at$<br />

6 1 0 caaacatat$<br />

7 5 2 catat$<br />

8 7 0 tat$<br />

9 9 1 t$<br />

10 10 0 $<br />

A pair <strong>of</strong> substrings R = ((i1, j1); (i2, j2)) is a<br />

repeated pair if <strong>and</strong> only if = ((i1, j1) ≠ (i2, j2)) <strong>and</strong><br />

S [(i1… j1)] = S [(i2 …j2)]. The length <strong>of</strong> R is j1 -<br />

i1+1. A repeated ((i1, j1); (i2, j2)) is called left<br />

maximal if S[i1 ─ 1] ≠ S[i2 ─ 1] <strong>and</strong> right maximal<br />

if S[j1 ─ 1] ≠ S[j2 ─ 1]. A repeated pair is called<br />

maximal if it is left <strong>and</strong> right maximal. A substring<br />

ω <strong>of</strong> S is a (maximal) repeat if there is a (maximal)<br />

repeated pair ((i1, j1); (i2, j2)) such that ω = S<br />

[i1...j1]. A super maximal repeat is a maximal<br />

repeat that never occurs as a substring <strong>of</strong> any other<br />

maximal<br />

repeat.<br />

The suffix array suftab is an array <strong>of</strong> integers in<br />

the range 0 to n, specifying the lexicographic<br />

ordering <strong>of</strong> the n+1 suffixes <strong>of</strong> the string S$. That<br />

is, Ssuftab [0]; Ssuftab [1] … Ssuftab[n] is the sequence<br />

<strong>of</strong> suffixes <strong>of</strong> S$ in ascending lexicographic order,<br />

where Si = S [i ... n -1 $ denotes the ith nonempty<br />

suffix <strong>of</strong> the string S$ , 0 ≤ i ≤ n. The suffix array<br />

requires<br />

4n bytes.<br />

The Lcp-interval table Lcptab is an array <strong>of</strong><br />

integers in the range 0 to n <strong>and</strong> Lcptab [0] = 0<br />

shown table 1. Lcptab[i] is the length <strong>of</strong> the longest<br />

common prefix <strong>of</strong> Ssuftab [i−1] <strong>and</strong> Ssuftab[i], for 1 ≤<br />

i ≤ n. Since Ssuftab[n] = $, it is always have<br />

Lcptab[n] = 0. The Lcp-table can be computed as a<br />

by-product during the construction <strong>of</strong> the suffix


48 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />

array. The lcp-interval tree <strong>of</strong> S = acaaacatat$ is<br />

shown in Figure 2.<br />

Figure 2. The Lcp-interval tree <strong>of</strong> S = acaaacatat$<br />

An interval [i...j], where 0 ≤ i ≤ j ─ n, in an Lcparray<br />

is called an Lcp-interval<br />

<strong>of</strong> Lcp-value ℓ<br />

(denoted by ℓ-[i...j]) if<br />

Lcptab[i] < ℓ<br />

Lcptab[k] ≤ ℓ for all k with i+1 ≤ k ≤ j<br />

Lcptab[k] = ℓ for at least one k with<br />

i+1 ≤ k ≤ j<br />

Lcptab [j + 1] < ℓ<br />

Every index k, i+1 ≤ k ≤ j, with Lcptab[k] = Ssuftab<br />

is called ℓ index. The set <strong>of</strong> all ℓ indices <strong>of</strong> an ℓ<br />

interval [i...j] will be denoted by ℓ Indices (i...j). If<br />

[i...j] is an ℓ-interval such that ω =<br />

S[suftab[i]..Suftab[i]+ ℓ -1] is the longest common<br />

prefix <strong>of</strong> the suffixes Ssuftab[i]; Ssuftab[i+1]; … ;<br />

Suftab[j], then [i...j] is also called ω-interval. Based<br />

on the analogy between the suffix array <strong>and</strong> the<br />

suffix tree, it is desirable to enhance the suffix array<br />

with additional information to determine, for any ℓ-<br />

interval [i..j], all its child intervals in constant time<br />

using enhancing the suffix array with two tables.<br />

Enhanced Suffix array<br />

The new data structure consists <strong>of</strong> the suffix array,<br />

the Lcp-interval table, <strong>and</strong> an additional<br />

table: the<br />

child-table cldtab shown in Table 2.<br />

The child-table is a table <strong>of</strong> size n+1 indexed<br />

from 0 to n <strong>and</strong> each entry contains three values:<br />

up, down, <strong>and</strong> nextℓIndex. Each <strong>of</strong> these three<br />

values requires 4 bytes in the worst case. The<br />

values <strong>of</strong> each cldtab-entry are defined as follows<br />

(it is assumed that min Φ = max Φ = 1):<br />

1. cldtab[i].up =<br />

Min {q Є [0..i - 1] | Lcptab[q] > Lcptab[i]<br />

<strong>and</strong> for all k Є [q + 1..i - 1] :<br />

Lcptab[k] ≥ Lcptab[q]}<br />

2. cldtab[i].down<br />

=<br />

Max {q Є [i + 1.. n] | Lcptab[q] > Lcptab[i]<br />

<strong>and</strong> for all k Є [i + 1..q - 1] : Lcptab[k] ≥<br />

Lcptab[q]}<br />

3. cldtab[i].next ℓ Index =<br />

Min {q Є [i + 1.. n] | Lcptab[q] = Lcptab[ i]<br />

<strong>and</strong> for all k Є [i + 1..q - 1] : Lcptab[k] ><br />

Lcptab[i]}<br />

The child-table stores the parent-child<br />

relationship <strong>of</strong> Lcp-intervals. For an ℓ -interval<br />

[i...j] whose ℓ -indices are i1 < i2


with a highly conserved region. It is calculated<br />

based on the length <strong>of</strong> the pattern <strong>and</strong> frequency<br />

i.e., number <strong>of</strong> occurrences in the database. The<br />

given pattern p is classified as significant if it<br />

satisfies the following constraints:<br />

The length <strong>of</strong> p ≥ a given length-threshold: a<br />

significant pattern must be sufficiently long<br />

to carry important biological information.<br />

The score <strong>of</strong> p ≥ a given score-threshold: a<br />

significant pattern<br />

must have a sufficiently<br />

high score.<br />

GSArray is constructed for the entire sequences<br />

in the database. While constructing GSArray, at<br />

each node i, the length <strong>and</strong> the<br />

frequency ) (i.e. the number <strong>of</strong> occurrences <strong>of</strong><br />

pi in the database) is stored for the corresponding<br />

pattern pi this frequency is incremented for every<br />

new node. Then the score function<br />

is<br />

calculated using the equation (1)<br />

(1)<br />

Where = Function value <strong>of</strong> the pattern,<br />

= frequency <strong>of</strong> the node,<br />

= length <strong>of</strong> the label <strong>of</strong> prefix,<br />

i = node number,<br />

|DB| = Database size.<br />

The score function is used as a measure<br />

to determine whether a particular pattern is<br />

significant to be included in the post-processing for<br />

evaluation <strong>of</strong> sequences, to determine the closest<br />

set <strong>of</strong> sequences. Then the query sequence Q <strong>and</strong><br />

number <strong>of</strong> sequences to be selected from the<br />

database is read from the user, temporarily added<br />

onto GSArray. This enables to determine which<br />

suffixes <strong>of</strong> the query are shared by the sequence in<br />

the database. The query sequence is only<br />

temporarily added to the tree so that GSAlign is not<br />

affected for future sequence searches. Initially all<br />

the nodes in the GSArray are 0. When the query<br />

sequence Q is added as a suffix, the nodes visited is<br />

set to 1. This expedites the search for common<br />

patterns within the GSArray because only those<br />

paths in the tree for patterns that contain substrings<br />

<strong>of</strong> the query sequence are examined. In depth-first<br />

manner, starting at the root all the nodes are visited<br />

to check the value 1. If the current node has no<br />

child whose value is 1, then the search backtrack to<br />

its parent node. During this traversal all the<br />

significant patterns are collected. The sequence<br />

may have other common patterns that are not<br />

significant. An optimal alignment between these<br />

two sequences in an ideal case contains all<br />

significant patterns. After this process the query<br />

Bio-database compression using enhanced suffix array 49<br />

sequence from GSArray is deleted. Top ten<br />

significant patterns are selected <strong>and</strong> stored. The<br />

sequence that contains significant patterns is<br />

extracted <strong>and</strong> stored. Reverse check is made to<br />

obtain the accuracy <strong>of</strong> the results; it computes how<br />

many chosen patterns are being shared by each <strong>of</strong><br />

the sequences extracted already. Higher the number<br />

(weight), greater will be the similarity <strong>of</strong> the<br />

corresponding sequence to the query. Based on this<br />

weight<br />

the sequences are ranked.<br />

A top n sequences are transferred to new<br />

database. Algorithm for<br />

BioDB Compression Tool<br />

is shown in Figure 3.<br />

//Input: Set <strong>of</strong> DNA <strong>and</strong> Protein Sequences<br />

// Output: Compressed set <strong>of</strong> DNA <strong>and</strong> Protein sequences<br />

S1: Read DNA or Protein database;<br />

S2: Construct GSArray for the input sequences, Set node visit<br />

=0;<br />

S3: While constructing the suffix array, store the information <strong>of</strong><br />

label length, frequency at nodes <strong>and</strong> sequences traversing<br />

through the branches;<br />

S4: Use the equation (1) to calculate the degree <strong>of</strong> similarity <strong>of</strong><br />

patterns in the form <strong>of</strong> prefixes;<br />

S5: Read query sequence Q <strong>and</strong> the number <strong>of</strong> sequences n to<br />

select from the user;<br />

S6: Temporarily add the suffixes <strong>of</strong> query to the generalized<br />

GSArray;<br />

S7: While adding the suffixes highlight nodes <strong>of</strong> the paths which<br />

are traversed by the query sequence;<br />

S8: Post process the GSArray to extract patterns shared by the<br />

query Sequence, which lies above a defined threshold on<br />

the<br />

function-value;<br />

S9: Pick the top ten <strong>of</strong> these patterns <strong>and</strong> store;<br />

S8: Do a reverse check to compute the weight <strong>of</strong> each sequence<br />

in the subset;<br />

S9: Rank the sequences according to these weights;<br />

S11: Pick top n sequences from the subset <strong>and</strong> write to a new<br />

database;<br />

Figure 3. Algorithm for BioDB Compression Tool<br />

Cross validation<br />

The real world DNA (GSS, EST) <strong>and</strong> Protein<br />

sequence (Protein C, S) databases from Oryza<br />

sativa group is extracted from NCBI website <strong>and</strong><br />

enhanced suffix array is formed for all the<br />

sequences in the database. Based on the user given<br />

query sequence, the significant patterns are<br />

generated. The sequences in the DNA or Protein<br />

database are given weights according to the number<br />

<strong>of</strong> patterns they contain. The compressed database<br />

is formed by selecting top ‘n’ sequences with<br />

highest<br />

ranks <strong>and</strong> written into a new database.<br />

The latest data mining technique, 7-fold cross<br />

validation is used to validate the results obtained<br />

from BioDB Compression Tool <strong>and</strong> WU-BLAST.


50 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />

The main idea <strong>of</strong> 7-fold cross validation approach<br />

is ‘train on 6 folds, test on 1 fold. The data set is<br />

divided into 7 parts. Among the 7 parts 6/7 <strong>of</strong> the<br />

data are used for training data set <strong>and</strong> the remaining<br />

1/7 is used for testing data set. BioDB Compression<br />

Tool is applied on training data set <strong>and</strong> then on<br />

WU_BLAST for single user given query sequence.<br />

For the same query sequence WU-BLAST alone is<br />

applied on the testing data set. The average <strong>of</strong> this<br />

seven runs is computed for analysis. In this paper<br />

such seven queries are taken <strong>and</strong> analyzed. 49<br />

sequences from Oryza sativa GSS gi: 288881557 to<br />

gi: 288881606 are taken as a database set, 42<br />

sequences are used for training data set <strong>and</strong> 7<br />

sequences are used for test data set. Single query<br />

sequence is applied first on BioDB Compression<br />

Tool, data base is compressed. WU-BLAST is<br />

performed on the new data base <strong>and</strong> the same query<br />

sequence. Then for same sequence WU-BLAST<br />

alone is applied. The sequences in the training <strong>and</strong><br />

test data set are interchanged <strong>and</strong> the above steps<br />

are repeated until every fold is used for training.<br />

Average <strong>of</strong> the result from 7 runs are calculated <strong>and</strong><br />

stored. This is experimented for 7 different queries.<br />

The objective is to test whether the results are<br />

consistent for all the queries on a particular<br />

database in terms <strong>of</strong> computational time.<br />

Results<br />

Compressed database from BioDB Compression<br />

Tool is cross validated using 7-fold cross validation<br />

approach. The cross validation results <strong>of</strong> seven<br />

different queries for DNA database set GSS gi:<br />

288881557 to gi: 288881606 are shown in Figure 4<br />

<strong>and</strong> EST gi: 288886142 to gi: 288886191 are<br />

shown in Figure 5 <strong>and</strong> the results <strong>of</strong> seven different<br />

queries Protein C &S are shown in Figures 6 <strong>and</strong> 7.<br />

Figure 4.<br />

Results <strong>of</strong> cross validation for GSS DNA<br />

dataset<br />

Figure 5. Results <strong>of</strong> cross validation for EST DNA<br />

dataset<br />

The idea is to test whether the results are<br />

consistent for all queries on a particular database in<br />

terms <strong>of</strong> computation time. From the figures 4-6 it<br />

is inferred that the developed BioDB Compression<br />

Tool performs much better than WU-BLAST.<br />

Computational complexity <strong>of</strong> using developed<br />

BioDB Compression Tool is reduced compared to<br />

WU-BLAST because; compression takes place<br />

along sequence alignment. The Enhanced suffix<br />

array algorithm used in BioDB Compression Tool<br />

requires 5n bytes character where SCT requires 20n<br />

bytes which uses suffix tree.<br />

Figure 6. Results <strong>of</strong> cross validation for Protein C<br />

Hence it is proved that space complexity is<br />

approximately five times less than SCT.<br />

Implementation results show that the running time<br />

<strong>of</strong> developed algorithm BioDB Compression Tool<br />

using enhanced suffix array is much better than<br />

SCT which uses suffix tree.


Figure 7. Results <strong>of</strong> cross validation for Protein S<br />

Discussion<br />

In this paper the BioDB Compression Tool using<br />

enhanced suffix array has been developed. BioDB<br />

Compression Tool pre-processes the database to<br />

create a generalized enhanced suffix array <strong>and</strong><br />

extended by adding frequency <strong>and</strong> length<br />

information for the patterns. BioDB Compression<br />

Tool distinguishes patterns by computing<br />

significance-scores. A pattern is regarded as<br />

significant if it is long enough, <strong>and</strong> it appears<br />

frequently enough in the database. The scoring<br />

function takes into account a pattern's length <strong>and</strong><br />

frequency, the given threshold values, <strong>and</strong><br />

determines if a pattern is significant. Using these,<br />

for a given query sequence BioDB Compression<br />

Tool compresses the database to only a few<br />

sequences that share the most significant patterns<br />

with the query. This compression in database size<br />

speeds-up the local alignment <strong>of</strong> the query<br />

sequence against the database. Experimental results<br />

have shown that BioDB Compression Tool<br />

provides a speed-up over WU-BLAST. It is able to<br />

reduce the time <strong>of</strong> a database search to nearly five<br />

times originally taken by WU-BLAST. Results<br />

from WU-BLAST have shown that this method is<br />

experimentally effective, as the results obtained by<br />

BioDB Compression Tool produces accurate<br />

alignment. Combined with the extended suffix<br />

array, BioDB Compression Tool has the advantage<br />

<strong>of</strong> using WU-BLAST to do the local sequence<br />

alignment. Latest Data Mining technique, 7-fold<br />

cross validation is applied to attain a greater<br />

accuracy in the results <strong>and</strong> the results are<br />

satisfactory. The Enhanced suffix array algorithm<br />

used in BioDB Compression Tool requires 5n bytes<br />

/character where SCT requires 20n bytes which<br />

uses suffix tree. So, space complexity is<br />

approximately five times more than SCT.<br />

Experimental results show that the running time <strong>of</strong><br />

Bio-database compression using enhanced suffix array 51<br />

BioDB Compression Tool is much better than SCT<br />

which uses suffix tree.<br />

In this paper, a small domain <strong>of</strong> sequences have<br />

been selected from the DNA <strong>and</strong> Protein database<br />

<strong>and</strong> experimentally proved that, enhanced suffix<br />

array reduces space complexity by five times.<br />

BioDB Compression Tool can also be applied to<br />

Global Sequence Alignment <strong>and</strong> Multiple Sequence<br />

Alignment. This work can also be applied on<br />

databases <strong>of</strong> protein sequences for alignment.<br />

References<br />

Abouelhoda MI, Kurtz S <strong>and</strong> Ohlebusch E. The<br />

enhanced suffix array <strong>and</strong> its applications to<br />

genome analysis. Proc. Workshop on<br />

Algorithms in Bioinformatics. Springer- Verlag,<br />

Berlin. 2452: 449- 463, 2002.<br />

Abouelhoda MI, Stefan Kurtz <strong>and</strong> Enno Ohlebusch.<br />

Replacing suffix trees with enhanced suffix<br />

arrays. <strong>Journal</strong> <strong>of</strong> Discrete Algorithms. 2:53-86,<br />

2004.<br />

Altschul SF, Gish W, Miller W, Myers E <strong>and</strong><br />

Lipmann D. Basic Local Alignment Search<br />

Tool. <strong>Journal</strong> <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong>. 215:403 -<br />

410, 1990.<br />

Delcher AL, Kasif S, Fleischmann RD, Peterson J,<br />

White O <strong>and</strong> Salzberg SL. Alignment <strong>of</strong> Whole<br />

Genomes. Nucleic Acids Res. 27:2369-2376,<br />

1999.<br />

Divya RS, Abdullah NA <strong>and</strong> Xindong Wu. Using<br />

an extended suffix Treeto speed-up sequence<br />

alignment. IADIS International Conference<br />

Applied Computing. 655-660, 2006.<br />

Gus Field D. Algorithms on Strings, Trees <strong>and</strong><br />

Sequences. Cambridge University Press. 1997.<br />

Basic Local Sequence Alignment Tool. Retrieved<br />

May 4, 2009, from http://blast.wustl.edu/<br />

Manber U <strong>and</strong> Myers EW. Suffix Arrays: A New<br />

Method for On-Line String Searches. SIAM<br />

<strong>Journal</strong> on Computing. 22(5):935-948, 1993.<br />

Matthew Bellgard, Thomas Gamble, Mark<br />

Reynolds, Adam Hunter, Ed Trifonov, <strong>and</strong> Ross<br />

Taplin. Gap apping: a paradigm for aligning two<br />

sequences. Applied Bioinformatics. 2(3 Suppl):<br />

31-35, 2003.<br />

Pearson WR. Flexible sequence similarity<br />

searching with the FASTA3 program package.<br />

Methods in <strong>Molecular</strong> <strong>Biology</strong>.132: 185-219,


52 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />

2000.<br />

Smith TF <strong>and</strong> Waterman MS. Identification <strong>of</strong><br />

common molecular subsequences. <strong>Journal</strong> <strong>of</strong><br />

<strong>Molecular</strong> <strong>Biology</strong>. 147:195-197, 1981


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 53-61, 2011 Research Article 53<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Cloning <strong>and</strong> expression <strong>of</strong> Lentinula edodes cellobiohydrolase gene<br />

in E. coli <strong>and</strong> characterization <strong>of</strong> the recombinant enzyme<br />

Sabira TAIPAKOVA 1 , Bauyrzhan SMAILOV 1 , Gulshan STANBEKOVA 2 <strong>and</strong><br />

Amangeldy BISSENBAEV 1, *<br />

1<br />

Department <strong>of</strong> Genetics <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong>, Faculty <strong>of</strong> <strong>Biology</strong>, al-Farabi Kazakh National University,<br />

050038, Almaty,al-Farabi 71, Kazakhstan<br />

2<br />

Institute <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong> Biochemistry, Dosmukhamedov 86, 480012, Almaty, Kazakhstan<br />

(* author for correspondence; Amangeldy.Bisenbaev@kaznu.kz)<br />

Received: 11 March 2011; Accepted: 10 June 2011<br />

Abstract<br />

A gene encoding cellobiohydrolase CEL7A was successfully isolated from the L. edodes mushroom strain<br />

N127 using RT-PCR. The deduced amino acid sequence encoded by cel7A showed high homology with the<br />

sequence <strong>of</strong> glycoside hydrolase family 7. To confirm the gene sequence encoding the CEL7A the cloned<br />

gene was expressed in E. coli. For the first time the cel7A gene from the L. edodes was expressed in E. coli<br />

<strong>and</strong> characterized. The recombinant CEL7A has the ability to hydrolyze Avicel, Filter paper, p-Nitrophenyl<br />

β-D-lactopyranoside (pNP-Lac) <strong>and</strong> p-Nitrophenyl β-D-cellobioside (pNP-Cel). The activity <strong>of</strong> the cloned<br />

enzyme towards carboxymethylcellulose (CMC) is much lower. It showed an optimal working condition at<br />

50 0 C <strong>and</strong> pH 7.<br />

Keywords: <strong>Cell</strong>ulose, cellobiohydrolase, Lentinula edodes, gene expression, enzyme activity<br />

Lentinula edodes selobiyohidrolaz geninin E. coli’de klonlanması, ekspresyonu ve<br />

recombinant enzimin karakterizasyonu<br />

Özet<br />

L. edodes mantarı N127 suşundan selobiyohidrolaz CEL7A’yı kodlayan bir gen RT-PCR kullanarak<br />

başarıyla izole edilmişti. Cel7A tarafından kodlanan tahmini aminoasit dizisi gilikosid hidrolaz ailesi 7 dizisi<br />

ile yüksek homoloji göstermiştir. CEL7A’yı kodlayan gen dizisini doğrulamak için klonlanan gen E. coli’de<br />

eksprese edilmiştir. L. edodes’den izole edilen cel7A ilk kez E. coli’de ifade edilip karakterize edilmiştir.<br />

Rekombinant CEL7A, Avisel’i, Filtre kağıdını, p-Nitr<strong>of</strong>enil β-D-laktopiranosidi (pNP-Lac) ve p-Nitr<strong>of</strong>enil β-<br />

D-selobiosidi (pNP-Cel) hidrolize etme yeteneğine sahiptir. Klonlanan enzimin karboksimetilselüloza (CMC)<br />

aktivitesi daha azdır. 50 0 C ve pH 7’nin optimal çalışma şartları olduğu gösterilmiştir.<br />

Anahtar Sözcükler: Selüloz, selobiyohidrolaz, Lentinula edodes, gen ifadesi, enzim aktivitesi<br />

Introduction<br />

<strong>Cell</strong>ulose, consisting <strong>of</strong> glucose units linked<br />

together by β-1,4-glycosidic bonds, is the most<br />

abundant carbohydrate in the biosphere. An<br />

estimated rate <strong>of</strong> cellulose synthesis is<br />

approximately 4 x 10 7 tons per year. For a longrange<br />

solution for problems <strong>of</strong> energy, chemicals,<br />

<strong>and</strong> food, cellulose is the most promising renewable<br />

carbon source that is available in large quantities<br />

(Murai et al., 1998).<br />

Full hydrolysis <strong>of</strong> cellulose requires synergistic<br />

action <strong>of</strong> three major types <strong>of</strong> enzymatic activity:<br />

1,4-β-D-endoglucanases (EC 3.1.2.4), 1,4-β-Dcellobiohydrolases<br />

(CBH; EC 3.1.2.91) <strong>and</strong> βglucosidases<br />

(EC 3.2.1.21). CBHs hydrolyze


54 Sabira TAIPAKOVA et al.<br />

crystalline cellulose by initiating their action from<br />

the ends <strong>of</strong> the cellulose chains <strong>and</strong> producing<br />

primarily cellobiose. Endoglucanases catalyze<br />

hydrolysis internally in the cellulose chain <strong>and</strong><br />

attack the amorphous regions in cellulose,<br />

providing new chain ends for CBHs. β-<br />

glucosidases hydrolyze cellobiose to glucose. These<br />

enzymes are collectively known as cellulases <strong>and</strong><br />

act in a synergistic manner to facilitate complete<br />

cleavage <strong>of</strong> the cellulose β -1,4-glycosidic bonds<br />

(Teeri, 1997)<br />

CBHs are key components in the multi-enzyme<br />

cellulose complexes. Most <strong>of</strong> them belong to<br />

glycosyl hydrolase families 6 or 7. <strong>Cell</strong>ulolytic<br />

fungus generally produces two different CBHs,<br />

CBHI <strong>and</strong> CBHII. These two types <strong>of</strong> enzymes<br />

which are classified based on sequence identity <strong>and</strong><br />

can achieve complete, although slow, solubilization<br />

<strong>of</strong> cellulose crystals even without help <strong>of</strong><br />

endoglucanases (Teeri, 1997).<br />

Lentinula edodes, commonly referred to as the<br />

Shiitake mushroom, is the most popular <strong>and</strong><br />

economically important edible mushroom in the<br />

world because <strong>of</strong> its taste, nutritional <strong>and</strong> medicinal<br />

properties (Mizuno, 1995). L. edodes has<br />

traditionally been grown on freshly cut logs<br />

(Leatham, 1985). It is a white rot fungus that<br />

decays for nutrients all the major polymers<br />

(cellulose, hemicelluloses, <strong>and</strong> lignin) found in<br />

wood lignocelluloses (Lee et al., 2001). Thus, L.<br />

edodes produces a wide variety <strong>of</strong> enzymes that<br />

may have high activities against cellulosic biomass.<br />

Several papers reported that L. edodes has a<br />

strong ability to produce thermostable cellulases,<br />

including CBH (Leatham, 1985; Lee et al., 2001;<br />

Pereira Júnior et al., 2003). L. edodes produces at<br />

least two forms <strong>of</strong> cellobiohydrolase (CEL7A <strong>and</strong><br />

CEL6B). Genes encoding each <strong>of</strong> these enzymes<br />

were cloned from L. edodes grown on a wood<br />

substrate using a PCR based strategy with<br />

degenerate primers directed at the cellulose-binding<br />

domain (Lee et al., 2001). On the basis <strong>of</strong><br />

nucleotide sequence analysis it was shown that<br />

cel7A encodes a 516-amino acid (aa) protein that<br />

belongs to glycosyl hydrolase family 7 <strong>and</strong> has<br />

sequence similarities to CBHI genes from other<br />

fungi. Whereas cel6B gene encodes a 444 aa<br />

protein that belongs to glycosyl hydrolase family 6<br />

<strong>and</strong> has sequence similarities to CBHII genes from<br />

other fungi. However, both fungal CBHs genes<br />

have not been previously expressed <strong>and</strong><br />

characterized.<br />

In this paper we report the cloning <strong>of</strong> a L.<br />

edodes cel7A gene <strong>and</strong> its successful expression in<br />

a heterologous host, E. coli.<br />

Materials <strong>and</strong> methods<br />

Materials<br />

Restriction enzymes, T4 DNA ligase <strong>and</strong> Taq DNA<br />

polymerase were purchased from Fermentas Life<br />

Sciences (St. Leon-Rot, Germany). Plasmid DNA<br />

was isolated using High Pure Plasmid Isolation Kit<br />

<strong>and</strong> DNA fragments were purified using Agarose<br />

Gel DNA Extraction Kit (Roche Diagnostics<br />

GmbH. Mannheim, Germany). All other chemicals<br />

<strong>and</strong> reagents were analytical grade <strong>and</strong> were<br />

supplied by Sigma-Aldrich Corp (St. Louis, MO<br />

USA). The expression vector pET11d was from<br />

Invitrogen, USA.<br />

Strains <strong>and</strong> culture conditions<br />

L. edodes strain N127 was obtained from collection<br />

<strong>of</strong> Kazakh National Agrarian University (Almaty,<br />

Kazakhstan). L. edodes strain N127 was cultured at<br />

room temperature on poplar sawdust blocks. From<br />

sawdust blocks the mycelium was harvested with a<br />

scalpel. The mycelium samples were pooled <strong>and</strong><br />

frozen in liquid nitrogen <strong>and</strong> stored at -80 0 C until<br />

further processing. Escherichia coli DH5a were<br />

used as a host for plasmid propagation. E.coli<br />

Rosetta (DE3) (Invitrogen, USA) was used as a<br />

host for expression <strong>of</strong> the recombinant CEL7A.<br />

Total RNA extraction <strong>and</strong> RT-PCR<br />

Total RNA extraction <strong>of</strong> L.edodes <strong>and</strong> RT-PCR<br />

was performed as described (Sambrook et al.,<br />

1989). Total RNA isolated as described above was<br />

used as a template for RT reactions. Using the<br />

sequence <strong>of</strong> the L. edodes cel7A cDNA available in<br />

the GenBank database (GenBank accession number<br />

AF411250), the forward primer, сel7A Dir: 5’-<br />

GATCACCATGGTCCGAACAGCAGCTCTCCT<br />

CT-<strong>and</strong> the reverse primer, сel7А Rev: 5’-<br />

CTAGGATCCCTACAAACATTGACTGTAGTA<br />

AGG-3’ were designed <strong>and</strong> used for RT-PCR. The<br />

underlined bases in primers are the sites <strong>of</strong><br />

restriction enzymes NcoI <strong>and</strong> BamHI, respectively.


Construction <strong>of</strong> expression vector <strong>and</strong> protein<br />

expression<br />

The PCR product <strong>and</strong> pET11d vector were doubledigested<br />

by NcoI <strong>and</strong> BamHI at 37 0 C according to<br />

the protocol. The digested products were ligated by<br />

T4 ligase at 4 0 C for overnight. The recombinant<br />

vector pET-11d/cel7A was transformed into E.coli<br />

Rosetta (DE3) competent cells <strong>and</strong> the<br />

transformants were selected on LB plates with<br />

ampicillin. The different resistant transformants<br />

were picked <strong>and</strong> inoculated into 20 mL LB medium<br />

with 200 μg/ml ampicillin <strong>and</strong> grown at 37°C in a<br />

shaking incubator (150 rpm) for 12 to 16 h. Then,<br />

the incubation was continued in 1L LB medium.<br />

When the culture grown at 30°C reached an<br />

OD600=0.4–0.6, isopropyl-D-thiogalactopyranoside<br />

(IPTG) was added to a final concentration <strong>of</strong> 0.2<br />

mM to induce expression. After incubation cells<br />

were harvested by centrifugation at 6000 rpm for 5<br />

min at 4°C. <strong>Cell</strong>s were resuspended in storage<br />

buffer containing 20 mM HEPES-KOH pH 7.6, 40<br />

mM NaCl. The cells were lysed by successive<br />

cycles <strong>of</strong> freezing (liquid nitrogen) <strong>and</strong> thawing by<br />

sonication for 20 s at half power (14 mA) until a<br />

clear cell lysate was obtained. This mix was used as<br />

crude protein extracts or alternatively the sonicated<br />

mixture was centrifuged at 14 000 g for 10 min to<br />

remove cell debris, <strong>and</strong> this cleared supernatant<br />

fluid was used as crude proteins extracts. The crude<br />

protein extracts <strong>and</strong> cellular fractions regarded as<br />

crude enzyme extracts were used for identifying<br />

CEL7A expression by SDS-PAGE, Western<br />

blotting <strong>and</strong> enzyme analysis.<br />

Preparation <strong>of</strong> anti-CEL7A antibodies <strong>and</strong> Western<br />

blotting<br />

The enzyme sample (preincubated with Complete<br />

EDTA-free Protease Inhibitor Cocktail) was<br />

electrophoresed on a 10% (w/v) polyacrylamide gel<br />

contaning 0.1% (w/v) SDS. The gel was stained<br />

with Coomassie Brillant Blue R-250 <strong>and</strong> the major<br />

protein b<strong>and</strong> was excised from the gel <strong>and</strong> used as<br />

antigen. The gel piece was homogenized with<br />

liquid nitrogen <strong>and</strong> emulsified in Freund’s complete<br />

adjuvant (Sigma) <strong>and</strong> injected subcutaneously into<br />

a rabbit. The same amount <strong>of</strong> booster injections<br />

was given every two weeks using incomplete<br />

Freund’s adjuvant. The rabbit was bled before the<br />

first injection (preimmune serum) <strong>and</strong> then one<br />

week after the last booster to obtain immune serum<br />

(anti-CEL7A antibodies). Western blots were<br />

Expression <strong>of</strong> L. edodes cel7A gene in E.coli 55<br />

performed by st<strong>and</strong>ard protocols using 1:400 anti-<br />

CEL7A polyclonal antibody diluted in blocking<br />

buffer <strong>and</strong> 1:10000 horseradish peroxidaseconjugated<br />

secondary antibody.<br />

Mass spectrometry<br />

The target b<strong>and</strong>s on SDS-PAGE gels were excised<br />

<strong>and</strong> subjected to in-gel digestion with trypsin<br />

followed by peptide mass fingerprinting by matrix<br />

assisted laser desorption ionization time-<strong>of</strong>-flight<br />

mass spectrometry (MALDI-TOF) using a<br />

MALDI-TOF-TOF spectrometer, Ultraflex II<br />

(Bruker). Spectra from all experiments were<br />

converted to DTA files <strong>and</strong> merged to facilitate<br />

database searching using the Mascot search<br />

algorithm v2.1 (Matrix Science, Boston, MA)<br />

against the non-redundant protein sequences <strong>of</strong><br />

GenBank (National Center for Biotechnology<br />

Information).<br />

Protein <strong>and</strong> enzyme assays<br />

The protein content was determined by Bradford<br />

method (Bradford, 1976) Enzyme activity was<br />

assayed with Avicel, filter paper,<br />

carboxymethylcellulose (CMC) as a substrate by<br />

measuring the amount <strong>of</strong> reducing sugar according<br />

to the Nelson-Somogyi method (Somogyi, 1952;<br />

Nelson, 1944). The reaction mixture consisted <strong>of</strong><br />

50 mM sodium phosphate buffer (pH 7.0), 1%<br />

(w/v) <strong>of</strong> CMC or Avicel or 50 mg <strong>of</strong> filter paper<br />

(1x 6 cm) <strong>and</strong> an appropriate amount <strong>of</strong> enzyme.<br />

The generated reducing sugar was quantified at 540<br />

nm <strong>and</strong> using D-glucose as a st<strong>and</strong>ard for<br />

spectrophotometric estimation. One unit <strong>of</strong><br />

cellobiohydrolase activity was defined as the<br />

amount <strong>of</strong> enzyme that releases 1 μM <strong>of</strong> reducing<br />

sugar per minute per mg <strong>of</strong> total protein under the<br />

assay conditions.<br />

When p-Nitrophenyl β-D-lactopyranoside<br />

(pNP-Lac) <strong>and</strong> p-Nitrophenyl β-D-cellobioside<br />

(pNP-Cel) were used as a substrate, assays were<br />

performed in 500 μl reaction volume in 50 mM<br />

sodium phosphate buffer (pH 7.0) containing 8 mM<br />

<strong>of</strong> pNP-Cel or pNP-Lac with appropriate amounts<br />

<strong>of</strong> enzyme. The reaction was terminated by the<br />

addition <strong>of</strong> 2 ml <strong>of</strong> 1 M Na2CO3 after 1 h<br />

incubation. One unit <strong>of</strong> enzyme activity was<br />

defined as the amount <strong>of</strong> the enzyme that produced<br />

the equivalence <strong>of</strong> 1 μM pNP at the optimal<br />

conditions in 1 min per 1 mg <strong>of</strong> total protein.


56 Sabira TAIPAKOVA et al.<br />

Results<br />

To isolate a gene coding CEL7A, we designed two<br />

oligonucleotide primers based on the previously<br />

published sequence (Lee et al., 2001). First, PCR<br />

was done using genomic DNA <strong>of</strong> L. edodes N127<br />

as a template. PCR product showed a clear b<strong>and</strong><br />

about 2000 bp (Figure 1B).<br />

In the following experiments we amplified<br />

cel7A cDNA by reverse transcriptase (RT) PCR<br />

starting from total RNA. High quality RNA was<br />

isolated from mycelium <strong>of</strong> L. edodes grown on the<br />

poplar sawdust using the CTAB-based extraction<br />

method. RNA examined by electrophoresis on<br />

0.8% agarose gel showed two b<strong>and</strong>s corresponding<br />

to 18S <strong>and</strong> 25S rRNA (Figure 1A), that little or no<br />

RNA degradation occurred during the isolation.<br />

The A260/A280 <strong>and</strong> A260/A230 absorbance ratios<br />

were 1.9 <strong>and</strong> 2.0, respectively. This indicates low<br />

contamination by protein substances <strong>and</strong> secondary<br />

metabolites in the isolated RNA samples. In<br />

general, the RNA obtained was <strong>of</strong> high quality <strong>and</strong><br />

integrity. Total RNA prepared as above was<br />

subjected to RT-PCR with the same primers. A<br />

single DNA b<strong>and</strong> about 1551 bp in size was<br />

amplified (Figure 1B). The 1551 bp DNA fragment<br />

was ligated into pET11d vector <strong>and</strong> propagated in<br />

E.coli. The clones were sequenced from both<br />

directions.<br />

Figure 1. A) Extraction <strong>of</strong> total RNA from L. edodes N127, B) PCR amplification <strong>of</strong> cel7A gene. M: marker<br />

(bp), Lane1: Genomic DNA as template, Lane2: total RNA as template.<br />

Determination <strong>of</strong> the nucleotide sequence<br />

revealed complete coincidence with the nucleotide<br />

sequence <strong>of</strong> the cel7A gene L. edodes strain<br />

Stamets CS-2, that was published earlier (Lee et al.,<br />

2001).<br />

The blastp results in Table 1 showed that the<br />

deduced amino acid sequence <strong>of</strong> 516 amino acids is<br />

identical with L. edodes cellobiohydrolase I amino<br />

acid sequence <strong>and</strong> showed high homology to other<br />

fungal CBHI enzymes belonging to glycosyl<br />

hydrolases family 7: 99% identity to cellulase <strong>of</strong><br />

Irpex lacteus, 96% to cellobiohydrolase I <strong>of</strong><br />

Schizophyllum commune <strong>and</strong> 95% to<br />

cellobiohydrolase I–II <strong>of</strong> <strong>Vol</strong>variella volvacea.<br />

Results in this study show that amino acid<br />

sequence deduced from the nucleotide sequence <strong>of</strong><br />

cel7A is homologous to other CBHs. However,<br />

until now the cel7A gene <strong>of</strong> L. edodes<br />

cellobiohydrolase has not been expressed in<br />

bacterial <strong>and</strong> yeast systems. Therefore, it was<br />

needed to be determined if it really codes a CBH.<br />

In order to confirm that the cel7A gene encodes<br />

a cellobiohydrolase we used E. coli Rosetta (DE3)<br />

expression system. The synthesized by RT-PCR<br />

1551bp fragment was digested with restriction<br />

endonucleases NcoI <strong>and</strong> BamHI <strong>and</strong> cloned in the<br />

pET11d plasmid with retention <strong>of</strong> the reading<br />

frame. The inserted fragment was tested for the<br />

absence <strong>of</strong> mutations by sequencing. The resulting


plasmid pET11d/cel7A was then used to transform<br />

E. coli Rosetta (DE3).<br />

Table 1. The significant matches <strong>of</strong> blastp analysis for cDNA <strong>of</strong> L.edodes N127<br />

Expression <strong>of</strong> L. edodes cel7A gene in E.coli 57<br />

Genbank accession Organism <strong>and</strong> gene Score E value Identity<br />

AAK95563.1<br />

Lentinula edodes cellulase CEL7A<br />

mRNA<br />

1043 1043 100%<br />

BAA76365.1 Irpex lacteus cellulase mRNA 639 639 99%<br />

AAX55505.1<br />

Schizophyllum commune H4-8<br />

glycoside hydrolase family 7 protein<br />

586 625 96%<br />

AAT64007.1<br />

<strong>Vol</strong>variella volvacea<br />

cellobiohydrolase I-II mRNA<br />

The transformation <strong>of</strong> competent E.coli cells<br />

with the ligation products <strong>of</strong> the pET11d vector <strong>and</strong><br />

the L. edodes cel7A gene amplicon yielded over 47<br />

colonies, among which 4 individual clones were<br />

selected. All the selected colonies were assayed by<br />

PCR <strong>and</strong> restriction analysis for the presence <strong>of</strong> the<br />

recombinant plasmids carrying the cel7A gene.<br />

Plasmid DNAs were isolated <strong>and</strong> purified<br />

according to the protocol <strong>of</strong> High Pure Plasmid<br />

Isolation Kit. Plasmid DNAs were digested by NcoI<br />

<strong>and</strong> BamHI, followed by agarose gel<br />

electrophoresis. From Figure 2 we can see that<br />

plasmid DNAs was cut into two fragments, one<br />

Figure 2. Verification <strong>of</strong> the recombinant plasmid<br />

pET11d/cel7A digested by Nco I <strong>and</strong> BamHI M -<br />

Marker (bp); 1-4 Clones<br />

647 681 95%<br />

about 1551 bp corresponding to cel7A gene, <strong>and</strong> the<br />

other about 5674 bp corresponding to the vector.<br />

We amplified the cel7A gene by PCR, using<br />

transformant plasmid DNA as a template <strong>and</strong> gene<br />

specific primers. The fragment detected by agarose<br />

gel electrophoresis corresponded in length to the<br />

cloned cel7A gene (Figure 3). Detection <strong>of</strong> the PCR<br />

product corresponding in length to the cloned cel7A<br />

gene sequence indicated that the analyzed colonies<br />

contained plasmids carrying the relevant gene. As a<br />

result <strong>of</strong> screening, we identified four colonies<br />

carrying the recombinant plasmids.<br />

Figure 3. Verification <strong>of</strong> the recombinant plasmid<br />

pET11d/cel7A M - Marker (bp); 1- 4 Clones


58 Sabira TAIPAKOVA et al.<br />

Synthesis <strong>of</strong> CEL7A protein was assessed in<br />

recombinant E. coli. <strong>Cell</strong> lysate <strong>of</strong> an E. coli<br />

expressing the cel7A gene was analyzed by SDS-<br />

PAGE <strong>and</strong> Western blotting using polyclonal anti-<br />

CEL7A antibodies.<br />

After induction with IPTG for 4-12 hours the<br />

cells were lysed <strong>and</strong> the protein samples were<br />

prepared for SDS-PAGE by boiling in 2x sample<br />

buffer. 53,5kDa <strong>and</strong> 49 kDa protein b<strong>and</strong>s from<br />

crude extracts <strong>of</strong> cells harboring the plasmid<br />

pET11b/cel7A were shown on SDS-PAGE (Figure<br />

4A), whereas no similar protein b<strong>and</strong>s from crude<br />

extracts <strong>of</strong> cells harboring the plasmid pET11d<br />

were detected (Figure 4A). In Figure 4B, the SDS-<br />

PAGE gel was transferred to a PVDF membrane<br />

<strong>and</strong> probed with anti-CEL7A polyclonal antibody.<br />

Western blot analysis revealed a major protein<br />

b<strong>and</strong> <strong>of</strong> 53,5-kDa specific to CEL7A in the crude<br />

extracts <strong>of</strong> the cells harboring the plasmid<br />

pET11d/cel7A, but not pET11d (Figure 4B). To<br />

validate the identity <strong>of</strong> these proteins to CEL7A,<br />

the polypeptides were excised from the gel,<br />

subjected to trypsin digestion <strong>and</strong> MALDI-TOF-<br />

MS analysis. MASCOT search results revealed a<br />

top score <strong>of</strong> 659 for CBHI, where probability based<br />

mowse score > 44 are significant <strong>and</strong> indicate<br />

identity or extensive homology (p


Expression <strong>of</strong> L. edodes cel7A gene in E.coli 59<br />

Figure 5. Effects <strong>of</strong> pH <strong>and</strong> temperature on the activities <strong>of</strong> recombinant CEL7A. A) pH pr<strong>of</strong>ile was<br />

determined by incubating the enzyme at 50 0 C for 1 h at varying pHs (sodium acetate buffer pH 4-6, sodium<br />

phosphate buffer pH 6-7 <strong>and</strong> glycine buffer pH 9). B) Temperature pr<strong>of</strong>ile was determined by incubating the<br />

enzyme in 0.05M sodium phosphate buffer pH 7 for 1 h at different temperatures.<br />

Crude extract <strong>of</strong> an E. coli expressing the cel7A<br />

gene was examined for its ability to hydrolyze<br />

various cellulosic substrates at pH 7 <strong>and</strong> 50 0 C<br />

(Table 2). It could hydrolyze Avicel, Filter paper,<br />

pNP-Lac <strong>and</strong> pNP-<strong>Cell</strong>, but activity towards<br />

carboxymethylcellulose (CMC) was much lower<br />

compared to Avicel <strong>and</strong> Filter paper. These results<br />

strongly indicate that CEL7A has cellobiohydrolase<br />

activity.<br />

Table 2. Activities <strong>of</strong> the recombinant enzyme toward different cellulosic substrates at pH 7.0 <strong>and</strong> 50 0 C<br />

Substrate<br />

Activity<br />

(U/mg total protein)<br />

Avicel 21.4 ± 1.4<br />

Filter paper 23.2 ± 0.3<br />

CMC 2.9 ± 0.5<br />

pNP-Lac 4.1 ± 0.08<br />

pNP-<strong>Cell</strong> 3.8 ± 0.1


60 Sabira TAIPAKOVA et al.<br />

Discussion<br />

CBH enzymes are key components in fungal<br />

cellulase systems, <strong>and</strong> their functional activity is<br />

critical for consolidated bioprocessing for<br />

bioethanol production. For example, CBHs make<br />

up to 80% <strong>of</strong> the total mass for the T. reesei system,<br />

<strong>and</strong> CBH plays a particularly important role,<br />

making up 60% <strong>of</strong> the total mass (van Zyl et al.,<br />

2007). A number <strong>of</strong> cellulase genes from bacteria<br />

<strong>and</strong> fungus have been cloned <strong>and</strong> expressed in yeast<br />

or E. coli (Qiao et al., 2004; Hong et al., 2001,<br />

Hong et al., 2003). However fungal <strong>and</strong> bacterial<br />

endoglucanase (EG) production in recombinant<br />

strains was more successful than CBH production<br />

(van Zyl et al., 2007). This is not surprising<br />

considering that EG enzymes usually have specific<br />

activities <strong>of</strong> 2 to 3 orders higher in magnitude on<br />

synthetic <strong>and</strong> amorphous cellulose substrates, such<br />

as carboxymethylcellulose (CMC), in comparison<br />

to CBHs. Thus it is easier to measure the presence<br />

<strong>of</strong> even small amounts <strong>of</strong> heterologous EG<br />

compared to CBHs.<br />

Expression <strong>of</strong> fungal cellulases in E. coli as<br />

non-glycosylated forms has been attempted with<br />

limited success. Only a few cellulose genes, such as<br />

cbhI <strong>and</strong> egl3 <strong>of</strong> the well-studied fungus T. reesei,<br />

were expressed in E. coli, but the productivity <strong>of</strong><br />

cellulases was very low (Ekino et al., 1999).<br />

In this study, we have successfully expressed the<br />

cel7A gene <strong>of</strong> L. edodes in E. coli under the control<br />

<strong>of</strong> the T7 promoter. SDS–PAGE <strong>and</strong> Western<br />

blotting analysis showed that CEL7A constitutes a<br />

major protein produced in E. coli with a molecular<br />

weight <strong>of</strong> 53,5 kDa, which agrees with the<br />

predicted size from the deduced amino acid<br />

sequence. Amino acid sequencing <strong>of</strong> the putative<br />

recombinant protein by MALDI-TOF <strong>and</strong> its<br />

analysis using NCBI BLAST indicated that the<br />

enzyme contained putative conserved domains <strong>of</strong><br />

glycosyl hydrolase family 7.<br />

As shown in Figure 4A plasmid vector<br />

pET11d/cel7A expresses two additional b<strong>and</strong>s<br />

which in SDS-PAGE migrate as 53 kDa <strong>and</strong> 49<br />

kDa proteins. Since the difference in molecular<br />

weight between these two proteins is approximately<br />

5 kDa we may suggest that the CEL7A protein was<br />

partially degraded possibly during cell lysis. The<br />

cel7A enzyme contains 430 aa catalytic domain <strong>and</strong><br />

57 aa C-terminal cellulose-binding domain (CBD)<br />

<strong>and</strong> serine/threonine-rich linker sequence (Lee et<br />

al., 2001). We may speculate that the proteolytic<br />

degradation <strong>of</strong> 57 aa C-terminal CBD <strong>and</strong> linker<br />

sequence results in truncated 49 kDa protein.<br />

Indeed, western blot analysis confirms the presence<br />

<strong>of</strong> low molecular weight CEL7A proteins which<br />

migrate below the full-length recombinant protein<br />

in SDS-PAGE suggesting proteolytic degradation<br />

<strong>of</strong> CEL7A during expression <strong>and</strong>/or cell lysis.<br />

Furthermore we hypothesize that the linker region<br />

<strong>of</strong> E. coli-expressed CEL7A might be more<br />

susceptible to proteolysis as compared to<br />

glycosylated form <strong>of</strong> this protein expressed in yeast<br />

cells (unpublished observation). It seems likely that<br />

glycosylated linker region in native CEL7A <strong>of</strong> L.<br />

edodes protects the enzyme from proteolytic<br />

degradation nevertheless further investigations are<br />

required.<br />

The substrate specificities indicated that CEL7A<br />

contains cellobiohydrolase activity since it could<br />

hydrolyze crystalline cellulose (Avicel, Filter<br />

paper). Activity <strong>of</strong> cloned enzyme toward CMC<br />

was much lower than to Avicel <strong>and</strong> filter paper.<br />

These data are consistent with the established<br />

results that fungal CBH proteins have very limited<br />

action on substituted cellulose such as CMC or<br />

hydroxyethylcellulose (Basiria <strong>and</strong> Mishra, 1989;<br />

Kanokratana et al., 2002). Since most <strong>of</strong> the fungal<br />

cellulases are glycoproteins, the modification <strong>of</strong> the<br />

native protein by glycosylation has been reported to<br />

play an important role in synthesis, secretion, <strong>and</strong><br />

stability <strong>of</strong> extracellular cellulases (Basiria <strong>and</strong><br />

Mishra, 1989). Here we have demonstrated that<br />

CEL7A synthesized in E. coli without<br />

glycosylation has an enzymatical activity. This<br />

indicates that glycosylation is not necessary for<br />

enzymatic activity <strong>of</strong> CEL7A.<br />

In summary, a gene encoding CEL7A was<br />

successfully isolated from L. edodes strain N127<br />

using RT-PCR technique. The determined<br />

nucleotide sequence is completely corresponded to<br />

the nucleotide sequence <strong>of</strong> the cel7A gene <strong>of</strong> L.<br />

edodes strain Stamets CS-2 which was described<br />

previously (Lee et al., 2001). The enzyme was<br />

successfully expressed in E. coli in an active form.<br />

Enzymatic properties <strong>of</strong> CEL7A were also<br />

determined. The optimal temperature for enzyme<br />

activity was 50 0 C <strong>and</strong> the optimal pH was 7.0.<br />

Acknowledgement<br />

This work was supported by grant from National<br />

Centre for Biotechnology <strong>of</strong> the Republic <strong>of</strong><br />

Kazakhstan.


References<br />

Basiria VS <strong>and</strong> Mishra S. Regulation aspects <strong>of</strong><br />

cellulose biosynthesis <strong>and</strong> secretion. CRC Crit<br />

Rev Biotechnol. 9: 61-162, 1989.<br />

Bradford MM. A rapid <strong>and</strong> sensitive method for the<br />

quantitation <strong>of</strong> microgram quantities <strong>of</strong> protein<br />

using the principle <strong>of</strong> protein–dye binding.<br />

Anal Biochem. 72: 248-252, 1976.<br />

Ekino KK, Goto M <strong>and</strong> Furukawa K. Heterologous<br />

expression <strong>and</strong> characterization <strong>of</strong><br />

endoglucanase I (EGI) from Trichoderma<br />

viride HK-75. Biosci Biotechnol Biochem. 63<br />

(10): 1714-1720, 1999.<br />

Hong J, Tamaki H, Akiba S, Yamamoto K <strong>and</strong><br />

Kumagai H. Cloning <strong>of</strong> a gene encoding a<br />

highly stable endo-b-1,4-β-glucanase from<br />

Aspergillus niger <strong>and</strong> its expression in yeast. J<br />

Biosci Bioeng. 92: 434-441, 2001.<br />

Hong J, Tamaki H, Yamamoto K <strong>and</strong> Kumagai H.<br />

Cloning <strong>of</strong> a gene encoding thermo-stable<br />

endo-b-1,4-glucanase from Thermoascus<br />

aurantiacus <strong>and</strong> its expression in yeast.<br />

Biotechnol Lett 25: 657–661, 2003.<br />

Kanokratana P, Chantasingh D, Champreda V,<br />

Tanapongpipat S, Pootanakit K <strong>and</strong><br />

Eurwilaichitr L. Identification <strong>and</strong> expression<br />

<strong>of</strong> cellobiohydrolase (CBHI) gene from an<br />

endophytic fungus, Fusicoccum sp.<br />

(BCC4124) in Pichia pastoris. Protein Expr<br />

Purif. 58: 148-153, 2008.<br />

Leatham GF. Extracellular enzymes produced by<br />

the cultivated mushroom Lentinus edodes<br />

during degradation <strong>of</strong> a lignocellulosic<br />

medium. Appl Environ Microbiol. 50: 859-867,<br />

1985.<br />

Lee CC, Wong DWS <strong>and</strong> Robertson GH. Cloning<br />

<strong>and</strong> characterization <strong>of</strong> two cellulase genes<br />

from Lentinula edodes. FEMS Microbiology<br />

Letters. 205: 355-360, 2001.<br />

Expression <strong>of</strong> L. edodes cel7A gene in E.coli 61<br />

Mizuno T. Shiitake, Lentinus edodes: functional<br />

properties for medicinal <strong>and</strong> food purposes.<br />

Food Rev Int. 11: 111-128, 1995.<br />

Murai T, Ueda M, Kawaguchi T, Arai M <strong>and</strong><br />

Tanaka A. Assimilation <strong>of</strong><br />

cellooligosaccharides by a cell surfaceengineered<br />

yeast expressing beta -glucosidase<br />

<strong>and</strong> carboxymethylcellulase from Aspergillus<br />

aculeatus. Appl Environ Microbiol. 64: 4857-<br />

4861, 1998.<br />

Nelson NJ. A photometric adaptation <strong>of</strong> the<br />

Somogyi method for the determination <strong>of</strong><br />

glucose. J Biol Chem. 153: 375-380, 1944.<br />

Pereira Júnior JA, Correia MJ <strong>and</strong> Oliveira NT.<br />

<strong>Cell</strong>ulase activity <strong>of</strong> a Lentinula edodes (Berk.)<br />

Pegl. strain grown in media containing<br />

carboximethylcellulose or microcrystalline<br />

cellulose. Brazilian Archives <strong>of</strong> <strong>Biology</strong> <strong>and</strong><br />

Technology. 46: 333-337, 2003<br />

Qiao Y, Mao AJ, He YZ, Liu WF <strong>and</strong> Dong ZY.<br />

Secreted expression <strong>of</strong> Trichoderma reesei<br />

endo-glucanase II gene in Pichia pastoris <strong>and</strong><br />

analysis <strong>of</strong> enzymatic properties. Mycosystema.<br />

23(3): 388–396, 2004.<br />

Sambrook et al. <strong>Molecular</strong> Cloning: a Laboratory<br />

Manual (2 nd ed.). Cold Spring Harbor<br />

Laboratory Press. 1989.<br />

Somogyi M. Notes on sugar determination. J Biol<br />

Chem. 195: 19-23, 1952.<br />

Teeri TT. Crystalline cellulose degradation: new<br />

insight into the function <strong>of</strong> cellobiohydrolases.<br />

Trends in Biotechnology. 15: 160-167, 1997.<br />

van Zyl WH, Lynd LR, den Haan R <strong>and</strong> McBride<br />

JE. Consolidated bioprocessing for bioethanol<br />

production using Saccharomyces cerevisiae in<br />

bi<strong>of</strong>uels. Adv Biochem Eng Biotechnol. 108:<br />

205-235, 2007.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 63-68, 2011 Research Article 63<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Investigation <strong>of</strong> the MMP1 <strong>and</strong> MMP3 promoter polymorphisms in<br />

temporom<strong>and</strong>ibular joint disorder<br />

Necati TASKIN 1 , Korkut ULUCAN 2,* , Guhan DEGIN 3 , Arzu AKCAY 4 , Berfin<br />

KARATAS 3 <strong>and</strong> Teoman AKCAY 5<br />

1<br />

Istanbul Education <strong>and</strong> Research Hospital, Department <strong>of</strong> Pediatrics, Istanbul, Turkey.<br />

2<br />

Marmara University, Faculty <strong>of</strong> Dentistry, Department <strong>of</strong> Medical <strong>Biology</strong> <strong>and</strong> Genetics, Istanbul, Turkey.<br />

3<br />

Marmara University, Faculty <strong>of</strong> Dentistry, Department Of Oral And Maxill<strong>of</strong>acial Surgery, Istanbul,<br />

Turkey.<br />

4<br />

Bakirkoy Maternity <strong>and</strong> Child Education <strong>and</strong> Research Hospital, Pediatric Hematology, Istanbul, Turkey.<br />

5<br />

Sisli Etfal, Education <strong>and</strong> Research Hospital, Istanbul, Turkey.<br />

(* author for correspondence; korkutulucan@hotmail.com)<br />

Received: 24 May 2011; Accepted: 16 June 2011<br />

Abstract<br />

Matrix metalloproteinases 1 <strong>and</strong> 3 (MMP1 <strong>and</strong> MMP3) are metal dependent endopeptidases responsible for<br />

hydrolyzing extracellular matrix molecules, <strong>and</strong> also have important roles during the matrix destruction in<br />

temporom<strong>and</strong>ibular joint (TMJ) degeneration. In the present study, we aimed to investigate the relation<br />

between characterized promotor polymorphisms <strong>of</strong> MMP1 <strong>and</strong> MMP3 genes <strong>and</strong> TMJ in a Turkish<br />

population. 35 TMJ patients <strong>and</strong> 50 healthy controls were recruited to the study. MMP1 <strong>and</strong> MMP3 promotor<br />

polymorphisms were examined by PCR-RFLP methodology. For MMP1 polymorphism; 8, 14 <strong>and</strong> 13 <strong>of</strong> 35<br />

patients were 1G/1G, 1G/2G <strong>and</strong> 2G/2G, respectively. For the same polymorphism; 11, 28, 11 <strong>of</strong> 50 controls<br />

were 1G/1G, 1G/2G <strong>and</strong> 2G/2G, respectively. 6, 14, 15 <strong>of</strong> 35 patients were 5A/5A, 5A/6A <strong>and</strong> 6A/6A,<br />

respectively, for MMP3 genotype. Of the 50 controls, 8, 23, 19 were 5A/5A, 5A/6A <strong>and</strong> 6A/6A, respectively.<br />

Comparison <strong>of</strong> the polymorphism between healthy subjects <strong>and</strong> patients yielded no statistically significant<br />

difference (p0,05). The examined polymorphisms didn’t have major effects on the TMJ formation. With the<br />

increasing number <strong>of</strong> the both groups <strong>and</strong> classification <strong>of</strong> the patients with their pain level <strong>and</strong> disease<br />

severity will give us more informative data about the polymorphism <strong>of</strong> the genes <strong>and</strong> TMJ formation.<br />

Keywords: Temporom<strong>and</strong>ibular joint disorder, matrix metalloproteinase, MMP1 promotor polymorphism,<br />

MMP3 promotor polymorphism, or<strong>of</strong>acial pain.<br />

Temporom<strong>and</strong>ibular bağlantı bozukluklarında MMP1 ve MMP3 promotor polimorfizmlerinin<br />

incelenmesi<br />

Özet<br />

Matriks metaloproteinaz 1 ve 3 (MMP1 ve MMP3) ektraselüler matriks moleküllerini parçalayan metal<br />

iyonlarına bağımlı endopeptidazlardır ve temporom<strong>and</strong>ibular bağlantı bozukluklarında (TBB) hücrelerarası<br />

matriks yıkımında önemli rolleri bulunmaktadır. Bu çalışmada 35 TBB hastasında, hastalığın oluşumunda rol<br />

oynayan MMP1 ve MMP3 genlerindeki promotor polimorfizmlerinin ilişkisini saptamayı amaçladık. Bu<br />

nedenle 35 hasta ve 50 sağlıklı kontrolü çalışmaya dahil ettik. Polimorfizm analizleri st<strong>and</strong>art PCR-RFLP<br />

metodu ile gerçekleştirildi. MMP1 polimorfizm sonuçlarına göre 35 hastanın 8’i 1G/1G, 14’ü 1G/2G ve 13’ü<br />

ise 2G/2G, 50 kontrolün ise 11’i 1G/1G ve 2G/2G, 28’i ise 1G/2G genotiplerinde bulunmuştur. MMP3<br />

polimorfizm sonuçları ise hasta grubunda 6’sı 5A/5A, 14’ü 5A/6A ve 15’I 6A/6A, kontrol grubunun ise 8’i<br />

5A/5A, 23’ü 5A/6A ve 19’u ise 6A/6A genotipinde bulunmuştur. Kontrol grubu ve hasta gruplarının<br />

istatistiksel olarak karşılaştırıldıklarında anlamlı bir fark bulunamamıştur. Bu sonuçlara dayanarak analiz<br />

edilen polimorfizmler ve TBB arasında çalışılan populasyonda bir ilişki saptanamamıştır. Hasta ve kontrol<br />

sayısının artırılması ve TBB’li hastaların ağrı ve hastalığın ilerleme durumlarına göre sınıfl<strong>and</strong>ırmalarının<br />

yapılması ile daha anlamlı sonuçların alınacağına inanmaktayız.


64 Necati TASKIN et al.<br />

Anahtar Sözcükler: Temporom<strong>and</strong>ibular bağlantı bozuklukları, matriks metaloproteinaz, MMP1 promotor<br />

polimorfizmi, MMP3 promotor polimorfizmi, or<strong>of</strong>asyal ağrı<br />

Introduction<br />

Temporom<strong>and</strong>ibular joint disorders (TMJD) are the<br />

or<strong>of</strong>acial problems involving masticatory<br />

musculature, the temporom<strong>and</strong>ibular joint (TMJ),<br />

<strong>and</strong> related structures. This disorder frequently<br />

causes chronic pain in the or<strong>of</strong>acial region<br />

(Dworkin et al., 2002). Degeneration <strong>of</strong> articular<br />

cartilage, capsule, ligaments <strong>and</strong> synovial<br />

membrane are the major clinical outcomes <strong>of</strong> TMJ.<br />

These degenerative changes in the tissues are slow<br />

at the beginning but with the progression <strong>of</strong> the<br />

disease, irreversible changes occur in the joint<br />

(Stegenga, 2001).<br />

The main characteristic change in TMJ is the<br />

alteration <strong>of</strong> the equilibrium between synthesis <strong>and</strong><br />

degradation <strong>of</strong> extracellular matrix (ECM)<br />

collagens, especially by proteolysis (Planello et al.,<br />

2011). Accumulation <strong>of</strong> the hydrolyzed proteins,<br />

catabolites formed by proteolytic activities,<br />

inflammatory modulators like cytokines <strong>and</strong> nitric<br />

oxide, matrix metalloproteinases (MMPs) found in<br />

the synovial fluid are the reason <strong>of</strong> inflammatory<br />

process <strong>of</strong> TMJ (Dijkgraaf et al,1995; Srinivas et<br />

al., 2001; Kubota et al., 1998). On the other h<strong>and</strong>,<br />

MMPs are considered to be the key proteolytic<br />

enzymes for the destruction <strong>of</strong> ECM in TMJ<br />

(Wadhwa <strong>and</strong> Kapila, 2008).<br />

MMPs are metal dependent endopeptidases that<br />

are capable <strong>of</strong> cleaving most, if not all <strong>of</strong> the<br />

constituents <strong>of</strong> the extracellular matrix including<br />

collagen, fibronectin, <strong>and</strong> proteoglycans (Astolfi et<br />

al., 2006; Plenello et al., 2011). They are secreted<br />

as pro-enzymes, inactive state <strong>of</strong> the enzyme, <strong>and</strong><br />

activated after the cleavage <strong>of</strong> N- terminal domain<br />

(Visse <strong>and</strong> Negasse, 2003) by other proteinases.<br />

Also several promotor polymorphisms were<br />

reported to regulate transcription activity <strong>and</strong> these<br />

have been associated with degenerative diseases<br />

like periodontitis <strong>and</strong> arthritis (Barlas et al., 2009;<br />

Astolfi et al., 2006). These promotor variations can<br />

influence the basal <strong>and</strong> inducible levels <strong>of</strong> MMP<br />

expression. An insertion/ deletion variation <strong>of</strong><br />

MMP1 promotor at position -1607 creates two<br />

alleles, 1G having one guanin <strong>and</strong> 2G, having two<br />

guanines at this position (Rutter et al., 1998).<br />

MMP3 also has a functional variation at -1612<br />

which give rise to 5A <strong>and</strong> 6A alleles, according to<br />

repeat number (de Maat, 1999). MMP3 degrades a<br />

wide range <strong>of</strong> extracellular matrix proteins <strong>and</strong><br />

should be regarded as a potential interest in DNA<br />

polymorphism- TMJ studies.<br />

Of the big family <strong>of</strong> MMPs, MMP1 <strong>and</strong> MMP3<br />

are synthesized <strong>and</strong> exocytosed in fibroblasts <strong>and</strong><br />

chondrocytes, increasing the possibility <strong>of</strong> their<br />

probable role in TMJ. In this study, we aimed to<br />

identify the effect <strong>of</strong> 1G/2G MMP1 <strong>and</strong> 5A/6A<br />

MMP3 polymorphisms in TMJ formation.<br />

Materials <strong>and</strong> methods<br />

Study Group<br />

35 TMJ patients <strong>and</strong> 50 healthy subjects with no<br />

history <strong>of</strong> any genetically based disease were<br />

enrolled to the study. All the participants were<br />

informed in detail about the study. The participants<br />

were unrelated Turkish people from the eastern<br />

region <strong>of</strong> Turkey. The TMJ degeneration group<br />

included 30 individuals <strong>of</strong> both genders <strong>and</strong><br />

undergone MRI scans in Marmara University,<br />

Faculty <strong>of</strong> Dentistry, Department <strong>of</strong> Oral <strong>and</strong><br />

Maxill<strong>of</strong>acial Surgery. The individuals who have<br />

shown at least one sign <strong>of</strong> degenerative process in<br />

any <strong>of</strong> the m<strong>and</strong>ibular condyles were included to<br />

the TMJ group, according to their MRI scans.<br />

Amplification <strong>and</strong> Genotyping <strong>of</strong> SNPs<br />

Genomic DNA isolated from peripheral blood by<br />

using a commercial kit (Roche, Germany) by<br />

following the instruction guide. For MMP1<br />

analysis, PCR reactions were carried out in a<br />

volume <strong>of</strong> 50 µl containing 50–100 ng DNA<br />

template in 10 mM Tris–HCl (pH 8.0), 50 mM<br />

KCl, 1.5 mM MgCl2, 1 mM each <strong>of</strong> dNTPs, 1.0 U<br />

Taq DNA polymerase (Fermentas, Germany) <strong>and</strong><br />

1.0 mM <strong>of</strong> each primer previously described<br />

(Rutter 98). The conditions <strong>of</strong> PCR amplification<br />

were as follows: a denaturation step at 95˚C for 5<br />

min followed by 38 cycles at 95˚C for 1 min, 55˚C<br />

for 1 min, 72˚C for 1 min, a final extension at 72˚C<br />

for 10 min <strong>and</strong> stop at 4˚C. For MMP3 analysis,<br />

PCR reactions were carried out in a volume <strong>of</strong> 50


µl containing 50–100 ng DNA template in 10 mM<br />

Tris–HCl (pH 8.0), 50 mM KCl, 1.5 mM MgCl2, 1<br />

mM each <strong>of</strong> dNTPs, 1.0 U Taq DNA polymerase<br />

(Fermentas, Germany) <strong>and</strong> 1.0 mM <strong>of</strong> each primer<br />

previously described (Ye et al., 1996) The<br />

conditions <strong>of</strong> PCR amplification were as follows:<br />

denaturation step at 94˚C for 5 min followed by 35<br />

cycles at 94˚C for 1 min, 65˚C for 45 s, 72˚C for 1<br />

min, a final extension at 72˚C for 7 min <strong>and</strong> stop at<br />

4˚C.<br />

In order to complete genotype analyses, amplicons<br />

MMP1 <strong>and</strong> MMP3 promotor polymorphisms in TMJ disorder 65<br />

<strong>of</strong> MMP1 <strong>and</strong> MMP3 were digested by XmnI (New<br />

Engl<strong>and</strong> Biolabs) <strong>and</strong> Tth111I (New Engl<strong>and</strong><br />

Biolabs) restriction enzymes, respectively, as<br />

previously described (Planello et al., 2011). 1G<br />

allele <strong>of</strong> MMP1 was digested to 89 <strong>and</strong> 29 bp<br />

whereas 2G allele was not digested <strong>and</strong> remained in<br />

its original amplicon length, 118 bp. 5A allele <strong>of</strong><br />

MMP3 yielded 97 <strong>and</strong> 33 bp products by digestion,<br />

6A allele was not digested <strong>and</strong> maintained the<br />

original length <strong>of</strong> 130 bp. All the visualization<br />

processes were carried out by 12% polyacrylamide<br />

gel stained with etidium bromide (Figure 1)<br />

Figure 1. RFLP analyses <strong>of</strong> MMP1 <strong>and</strong> MMP3 genes, M: <strong>Molecular</strong> marker (Fermentas, Germany), 2G/2G:<br />

Homozygous genotype <strong>of</strong> 2G allele for MMP1, 1G/2G: Heterozygous genotype for MMP1, 1G/1G:<br />

Homozygous <strong>of</strong> 1G allele for MMP1, 5A/5A: Homozygous genotype <strong>of</strong> 5A allele for MMP3, 5A/6A:<br />

Heterozygous genotype for MMP3, 6A/6A: Homozygous genotype <strong>of</strong> 6A allele for MMP3.<br />

Statistical analysis<br />

Statistical analysis for identifying the differences<br />

between TMJ <strong>and</strong> control groups was performed<br />

with Chi-square test by using SPSS 18.0. p0,05<br />

was accepted as statistically significant whereas<br />

values higher than 0,05 was not.<br />

Results<br />

For the MMP1 genotypes, 8 <strong>of</strong> the 35 patients <strong>and</strong><br />

11 <strong>of</strong> the 50 controls were 1G/1G, 14 patients <strong>and</strong><br />

28 were 1G/2G <strong>and</strong> 13 patients <strong>and</strong> 11 controls<br />

were 2G/2G, respectively. Genotypes <strong>of</strong> MMP1<br />

polymorphisms <strong>and</strong> p- values were summarized in<br />

Table 1. When we compare two groups for MMP1<br />

genotypes, we could not find any statistically<br />

significant association, all <strong>of</strong> the p- values are <br />

0,5%.<br />

For the MMP3 genotypes, <strong>of</strong> the 50 controls, 8<br />

were 5A/5A, 23 were 5A/6A <strong>and</strong> 19 were 6A/6A,<br />

respectively. 6 <strong>of</strong> the 35 patients were 5A/5A, 14<br />

were 5A/6A <strong>and</strong> 15 were 6A/6A. Genotypes <strong>of</strong><br />

MMP1 polymorphisms were summarized in Table<br />

2. Like in MMP1 genotypes, we could not find any<br />

statistically significant association in patient <strong>and</strong><br />

control group, the p- values are 0,5%.


66 Necati TASKIN et al.<br />

Discussion<br />

Table 1. Genotype distribution <strong>and</strong> OR <strong>of</strong> MMP1 polymorphism in control <strong>and</strong> TMJ groups<br />

Genotypes<br />

Control Group<br />

(n=50)<br />

TMJ Group<br />

(n=35)<br />

p- value<br />

OR (95% CI)<br />

Control/TMJ Group<br />

1G/1G 11 8 0,56 0,952 (0,338-2,678)<br />

1G/2G 28 14 0,14 1,909 (0,794-4,589)<br />

2G/2G 11 13 0,1 0,541 (0,206-1,422)<br />

Table 2. Genotype distribution <strong>and</strong> OR <strong>of</strong> MMP3 polymorphism in control <strong>and</strong> TMJ groups<br />

Genotypes<br />

Control Group<br />

(n=50)<br />

TMJ Group<br />

(n=35)<br />

p- value<br />

OR (95% CI)<br />

Control/TMJ Group<br />

5A/5A 8 6 0,889 0,921 (0,289-2,935)<br />

5A/6A 23 14 0,659 1,278 (0,532-3,067)<br />

6A/6A 19 15 0,653 0,817 (0,339-1,970)<br />

MMPs are secreted by pro- enzymes <strong>and</strong> activated<br />

after the removal <strong>of</strong> their N- terminal domain<br />

(Visse <strong>and</strong> Negase, 2003). For MMP1 <strong>and</strong> MMP3<br />

enzymes, there is an additional activation process,<br />

transcriptional regulation. Promoter 1G/2G<br />

polymorphism at the -1607 position <strong>of</strong> MMP1 gene<br />

<strong>and</strong> 5A/6A promoter polymorphism <strong>of</strong> MMP3 were<br />

reported to influence gene expression levels <strong>of</strong><br />

related MMPs, <strong>and</strong> associate these SNPs with<br />

degenerative diseases (Ye et al., 1996; Barlas et al.,<br />

2009; Astolfi et al., 2006).<br />

Rutter et al. reported that 2G allele <strong>of</strong><br />

MMP1gene increases the gene expression <strong>and</strong><br />

mRNA levels <strong>of</strong> MMP1 gene (Rutter et al., 1998).<br />

This allele creates a binding site for Ets<br />

transcription factor family, which promotes 37-<br />

fold in vitro increase <strong>of</strong> transcription activity. Also<br />

another study, in transgenic mice, showed the in<br />

vivo effect <strong>of</strong> 2G allele on transcription activity<br />

(Coon et al., 2009).<br />

We could not observe a significant difference in<br />

1G/2G SNP <strong>of</strong> MMP1 gene between TMJ patients<br />

<strong>and</strong> control group. Our findings are in accordance<br />

with the study reporting no association between<br />

MMP1 -1607 polymorphism <strong>and</strong> rheumatoid<br />

arthritis progression, degenerative disease including<br />

systemic joints. Although there are some reports<br />

indicating the molecular difference <strong>of</strong> systemic<br />

joints <strong>and</strong> TMJ, the exact mechanism <strong>of</strong><br />

degenerative effect, in which MMP1 is in charge, is<br />

still unclear (Wadhwa <strong>and</strong> Capila, 2008). There are<br />

also other studies that our findings are not in<br />

agreement. These studies reported the association<br />

<strong>of</strong> 2G allele <strong>and</strong> certain types <strong>of</strong> cancer (Peng et al.,<br />

2010), periodontitis (de Souza et al., 2003) <strong>and</strong><br />

TMJ (Planello et al., 2011). The latter associated<br />

the 2G allele <strong>and</strong> TMJ degeneration <strong>and</strong> showed<br />

that 2G/2G individuals have a 2,47 time higher<br />

probability <strong>of</strong> developing TMJ when compared to<br />

1G/1G <strong>and</strong> 1G/2G individuals. At the same study,<br />

authors couldn’t find any allelic association,<br />

claiming only 2G/2G individuals are in risk <strong>of</strong><br />

developing TMJ, individuals without 2G allele are<br />

protected from the disease. Small sample size,<br />

heterogenetic nature <strong>of</strong> genetic diseases <strong>and</strong><br />

probable multifactorial background <strong>of</strong> TMJ may be<br />

the reasons <strong>of</strong> our results that are not in agreement<br />

with previous mentioned studies.<br />

Like MMP1, MMP3 has an SNP at position -<br />

1612 which shows variation in enzyme activity. 5A<br />

allele in this position <strong>of</strong> the gene has a greater<br />

activity to 6A allele, in vitro (Ye at al., 1996).<br />

Allele 5A is associated to increase the risk <strong>of</strong> acute<br />

myocardial infarction (Terashima et al., 1999) <strong>and</strong><br />

in another study, 5A allele has been suspected to<br />

atherosclerosis (Ye, 2000). MMP3 has an<br />

accumulative activity during the initial phase <strong>of</strong><br />

TMJ, degrades various types <strong>of</strong> matrix proteins <strong>and</strong><br />

activates other MMPs like MMP1, MMP8 <strong>and</strong><br />

MMP13, leading to an increase in tissue<br />

degradation (Planello et al., 2011; Fujita et al.,<br />

2009). We couldn’t find any association with the<br />

polymorphism <strong>and</strong> TMJ, like Planello et al (2011).<br />

The exact activity <strong>of</strong> MMP3 in tissue degradation is<br />

not clear <strong>and</strong> may be the SNP examined has a<br />

limited influence on the enzyme activity.


There are number <strong>of</strong> factors which affect<br />

unexpected results on polymorphism- disease<br />

association studies. Ethnicities <strong>of</strong> the races,<br />

different allele frequencies between populations,<br />

classifications <strong>of</strong> patient groups are only some <strong>of</strong><br />

them. Also the metabolism or the activity processes<br />

<strong>of</strong> the examined molecules are important. In our<br />

study, MMP1 <strong>and</strong> MMP3, they are regulated not<br />

only by transcription, but also activation <strong>of</strong> the pro-<br />

enzyme <strong>and</strong> inhibitions <strong>of</strong> enzymes by their tissue<br />

inhibitors (TIMPs) (Astolfi et al., 2006). There are<br />

other factors that influence secretion, cell surface<br />

localization <strong>and</strong> clearance <strong>of</strong> the degraded MMPs.<br />

These regulation factors may help us to explain<br />

why our results didn’t support the information on<br />

the literature. Astolfi et al. (2006) also supported<br />

the idea that increase in mRNA levels may not<br />

necessarily lead to increased levels <strong>of</strong> MMPS.<br />

References<br />

Astolfi CM, Shinohara AL, da Silva RA, Santos<br />

MC, Line SR, de Souza AP. Genetic<br />

polymorphisms in the MMP-1 <strong>and</strong> MMP-3 gene<br />

may contribute to chronic periodontitis in a<br />

Brazilian population. J Clin Periodontol. 33:<br />

699–703, 2006.<br />

Barlas IO, Sezgin M, Erdal ME, Sahin G, Ankarali<br />

HC, Altintas ZM, Turkmen E. Association <strong>of</strong> (-<br />

1,607) 1G/2G polymorphism <strong>of</strong> matrix<br />

metalloproteinase-1 gene with knee<br />

osteoarthritis in the Turkish population (knee<br />

osteoarthritis <strong>and</strong> MMPs gene polymorphisms).<br />

Rheumatol Int. 29: 383– 388, 2009.<br />

Coon CI, Fiering S, Gaudet J, Wyatt CA,<br />

Brinckerh<strong>of</strong>f CE. Site controlled transgenic<br />

mice validating increased expression from<br />

human matrix metalloproteinase (MMP-1)<br />

promoter due to a naturally occurring SNP.<br />

Matrix Biol. 28: 425–431, 2009.<br />

De Maat MP, Jukema J, Ye S. Effect <strong>of</strong><br />

stromelysin-1 promotor on efficacy <strong>of</strong><br />

pravastatin in coronary atherosclerosis <strong>and</strong><br />

restenosis. Am. J. <strong>of</strong> Cardiology. 83:852-856,<br />

1999.<br />

de Souza AP, Trevilatto PC, Scarel-Caminaga RM,<br />

Brito RB, Line SR. MMP-1 promoter<br />

polymorphism: association with chronic<br />

periodontitis severity in a Brazilian population.<br />

J Clin Periodontol. 30: 154–158, 2003.<br />

MMP1 <strong>and</strong> MMP3 promotor polymorphisms in TMJ disorder 67<br />

Dijkgraaf LC, de Bont LG, Boering G, Liem RS.<br />

The structure, biochemistry, <strong>and</strong> metabolism <strong>of</strong><br />

osteoarthritic cartilage: a review <strong>of</strong> the<br />

literature. J Oral Maxill<strong>of</strong>ac Surg. 53: 1182–<br />

1192, 1995.<br />

Dworkin SF, Tuner JA, Mancl L, Wilson L,<br />

Massoth D, Huggins KH, Le Reshe L, Truelove<br />

E. A r<strong>and</strong>omized clinical trial <strong>of</strong> a tailored<br />

comprehensive care treatment program for<br />

temporom<strong>and</strong>ibular disorders. J Orafac<br />

Pain.16:259–276, 2002.<br />

Fujita H, Morisugi T, Tanaka Y, Kawakami T,<br />

Kirita T, Yoshimura Y. MMP-3 activation is a<br />

hallmark indicating an early change in TMJ<br />

disorders, <strong>and</strong> is related to nitration. Int J Oral<br />

Maxill<strong>of</strong>ac Surg. 38: 70–78, 2009.<br />

Kubota E, Kubota T, Matsumoto J, Shibata T,<br />

Murakami KI. Synovial fluid cytokines <strong>and</strong><br />

proteinases as markers <strong>of</strong> temporom<strong>and</strong>ibular<br />

joint disease. J Oral Maxill<strong>of</strong>ac Surg. 56: 192–<br />

198, 1998.<br />

Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J,<br />

Zhang Z, Wang X, Yu L. Polymorphisms in the<br />

promoter regions <strong>of</strong> matrix metalloproteinases 1<br />

<strong>and</strong> 3 <strong>and</strong> cancer risk: a meta- analysis <strong>of</strong> 50<br />

case-control studies. Mutagenesis. 25: 41–48,<br />

2010.<br />

Planello AC, Campos MIG, Meloto CB, Secolin R,<br />

Rizatti-Barbosa CM, Line SRP, de Souza AP.<br />

Association <strong>of</strong> matrix metalloproteinase gene<br />

polymorphism with temporom<strong>and</strong>ibular joint<br />

degeneration. Eur J Oral Sci. 119: 1–6, 2011.<br />

Rutter JL, Mitchell TI, Buttice G, Meyers J,<br />

Gusella JF, Ozelius LJ, Brinckerh<strong>of</strong>f CE. A<br />

single nucleotide polymorphism in the matrix<br />

metalloproteinase-1 promoter creates an Ets<br />

binding site <strong>and</strong> augments transcription. Cancer<br />

Res. 58: 5321–5325, 1998.<br />

Srinivas R, Sorsa T, Tjaderhane L, Niemi E,<br />

Raustia A, Pernu H, Teronen O, Salo T. Matrix<br />

metalloproteinases in mild <strong>and</strong> severe<br />

temporom<strong>and</strong>ibular joint internal derangement<br />

synovial fluid. Oral Surg Oral Med Oral Pathol<br />

Oral Radiol Endod. 91: 517–525, 2001.<br />

Stegenga B. Osteoarthritis <strong>of</strong> the<br />

temporom<strong>and</strong>ibular joint organ <strong>and</strong> its<br />

relationship to disc displacement. J Or<strong>of</strong>ac<br />

Pain. 15: 193–205, 2001.<br />

Terashima M, Akita H, Kanazawa K, Inoue N,


68 Necati TASKIN et al.<br />

Yamada S, Ito K, Matsuda Y, Takai E, Iwai C,<br />

Kurogane H, Yoshida Y, Yokoyama M.<br />

Stromelysin promoter 5A/6A polymorphism is<br />

associated with acute myocardial infarction.<br />

Circulation. 99: 2717–2719, 1999.<br />

Visse R, Nagase H. Matrix metalloproteinases <strong>and</strong><br />

tissue inhibitors <strong>of</strong> metalloproteinases:<br />

structure, function, <strong>and</strong> bio-chemistry. Circ Res.<br />

92: 827–839, 2003.<br />

Wadhwa S, Kapila S. TMJ disorders: future<br />

innovations in diagnostics <strong>and</strong> therapeutics. J<br />

Dent Educ. 72: 930–947, 2008.<br />

Ye S, Eriksson P, Hamsten A, Kurkinen M,<br />

Humphries SE, Henney AM. Progression <strong>of</strong><br />

coronary atherosclerosis is associated with a<br />

common genetic variant <strong>of</strong> the human<br />

stromelysin-1 promoter which results in reduced<br />

gene expression. J Biol Chem. 271: 13055–<br />

13060, 1996.<br />

Ye S. Polymorphism in matrix metalloproteinase<br />

gene promoters: implication in regulation <strong>of</strong><br />

gene expression <strong>and</strong> susceptibility <strong>of</strong> various<br />

diseases. Matrix Biol. 19: 623– 629, 2000.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1):69-74, 2011 Research Article 69<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Lead induced alterations in blood cell counts <strong>and</strong> hemoglobin<br />

during gestation <strong>and</strong> lactation in Swiss albino mice<br />

Isha BARBER, Ragini SHARMA*, Sheetal MOGRA, Khushbu PANWAR <strong>and</strong> Umesh<br />

GARU<br />

Environmental <strong>and</strong> Developmental Toxicology Research Lab, Department <strong>of</strong> Zoology, M. L. S. University,<br />

Udaipur- 313001 Rajasthan (INDIA)<br />

(* author for correspondence; taurasragini@yahoo.com)<br />

Received: 31 March 2011; Accepted: 20 June 2011<br />

Abstract<br />

Although a number <strong>of</strong> studies in animal models have shown changes in hemoglobin content <strong>and</strong> blood cell<br />

counts after lead administration during gestation <strong>and</strong> lactation, lead induced hematological changes are not<br />

well established. In the present study, hemoglobin content <strong>and</strong> blood cells <strong>of</strong> normal <strong>and</strong> lead exposed<br />

pregnant <strong>and</strong> lactating Swiss mice were compared in which selected pregnant females were treated with lead<br />

acetate by gavages (266.66, 533.33, 1066.66 mg/kg BW) during gestation <strong>and</strong> lactation. Animals were<br />

exposed to heavy metal lead orally from day 10 <strong>of</strong> gestation to 3 rd weeks <strong>of</strong> lactation. Hemoglobin content<br />

<strong>and</strong> blood cell counts were examined on 17 th day <strong>of</strong> gestation <strong>and</strong> on 1 st , 7 th , 14 th <strong>and</strong> 21 st day after birth. The<br />

results indicated that in lead intoxicated pregnant females, hemoglobin content <strong>and</strong> red blood cell (RBC)<br />

counts decreased <strong>and</strong> white blood cell (WBC) counts increased. From the results <strong>of</strong> above study it can be<br />

concluded that high levels <strong>of</strong> lead exposure during gestation <strong>and</strong> lactation can severely damage heme<br />

synthesis <strong>and</strong> alter the number <strong>of</strong> RBC <strong>and</strong> WBC.<br />

Keywords: Lead acetate, Swiss albino mice, hemoglobin, RBC, WBC.<br />

Swiss albino farelerde gebelik ve süt verme süresince kurşun ile tetiklenen<br />

hemoglobin ve kan hücreleri sayılarındaki değişimler<br />

Özet<br />

Pek çok hayvan modeli çalışmalarının gebelik ve süt verme boyunca kurşun yüklemesi sonrasında kan<br />

hücrelerinin sayıları ve hemoglobin miktarlarındaki değişiklikleri göstermesine rağmen, kurşun ile tetiklenen<br />

hematolojik değişiklikler iyi belirlenememiştir. Bu çalışmada normal ve kurşuna maruz kalan hamile ve süt<br />

veren Swiss farelerin hemoglobin miktarı ve kan hücreleri gebelik ve emzirme sırasında gavajla kurşun asetat<br />

(266.66, 533.33, 1066.66 mg/kg BW) uygulanan seçilmiş hamile dişilerinkiyle karşılaştırılmıştır. Hayvanlar<br />

gebeliğin 1. gününden süt vermenin 3. haftasına kadar oral olarak ağır metal kurşuna maruz bırakılmıştır.<br />

Hemoglobin miktarı ve kan hücresi sayıları gebeliğin 17. günü ve doğumdan sonraki 1., 7., 14., ve 21.<br />

günlerde incelenmiştir. Sonuçlar, kurşun ile zehirlenmiş gebe dişilerde hemoglobin miktarının ve kırmızı kan<br />

hücresi (RBC) sayılarının azaldığını ve beyaz kan hücrelerinin (WBC) arttığını göstermiştir. Yukarıda<br />

belirtilen sonuçlardan, gebelik ve süt verme sırasında yüksek miktarda kurşuna maruz kalmanın hem grubu<br />

sentezine ciddi zarar verebileceği ve RBC ve WBC sayılarını değiştireceği sonucuna varılabilir.<br />

Anahtar Sözcükler: Kurşun asetat, Swiss albino fare, hemoglobin, RBC, WBC.


70 Isha BARBER et al.<br />

Introduction<br />

In the modern society, thous<strong>and</strong>s <strong>of</strong> hazardous<br />

chemicals <strong>and</strong> heavy metals are being produced <strong>and</strong><br />

used in a wide variety <strong>of</strong> work places all over the<br />

world. Heavy metals are trace metals that are at<br />

least five times denser than water <strong>and</strong> are taken into<br />

body via inhalation, ingestion <strong>and</strong> skin absorption.<br />

It should be noted that most <strong>of</strong> the pathological<br />

conditions in body arise as a result <strong>of</strong> the exposure<br />

to these injurious substances.<br />

Lead <strong>and</strong> other heavy metals create reactive<br />

radicals which damage cell structure including<br />

DNA <strong>and</strong> cell membrane (Flora et al., 2008). Lead<br />

poisoning can cause a variety <strong>of</strong> symptoms <strong>and</strong><br />

signs which vary depending on the individual <strong>and</strong><br />

the duration <strong>of</strong> lead exposure (Karri et al., 2008;<br />

Kosnett, 2005). Gestational lead exposure has many<br />

adverse effects on development; a few <strong>of</strong> them may<br />

be most pronounced during the first trimester<br />

(Mogra et al., 2009)<br />

Many investigators studied the lower as well as<br />

higher exposure levels to lead. According to<br />

Escribano et al., (1997) 140 mg/ kg BW dose was<br />

an approximate environmental daily-exposure<br />

level. This dose was used as the minimum dose.<br />

Gurber et al. (1997) studied the higher<br />

concentration <strong>of</strong> lead that was 1000 mg/kg BW<br />

exposure in industrial areas.<br />

The amount <strong>of</strong> lead in blood <strong>and</strong> tissues, as well<br />

as the time course <strong>of</strong> exposure, determines the level<br />

<strong>of</strong> toxicity (Pearson <strong>and</strong> Schonfeld, 2003). Blood<br />

<strong>of</strong>ten shows pathological changes before the<br />

external signs <strong>of</strong> poisoning become apparent.<br />

The absorbed lead enters the blood stream<br />

where over 90 percent <strong>of</strong> it is bound to the red cells<br />

with a biological half life <strong>of</strong> 25-28 days (Azar et<br />

al., 1975). Toxicological effects <strong>of</strong> lead have their<br />

origin in perturbation in cell function <strong>of</strong> various<br />

organ systems. The major biochemical effect <strong>of</strong><br />

lead is its interference with heme synthesis which<br />

leads to hematological damage (Awad <strong>and</strong> William,<br />

1997). Despite several published accounts on<br />

pathophysiological alterations <strong>of</strong> lead toxicity <strong>and</strong><br />

the cure <strong>of</strong> lead poisoning by sequestering agents<br />

(Royce <strong>and</strong> Rosenberg, 1993), the approaches are<br />

limited in scope. Therefore the present<br />

investigation was focused to evaluate the changes<br />

in the number <strong>of</strong> blood cells <strong>and</strong> Hb content during<br />

pregnancy <strong>and</strong> lactation followed by comparison <strong>of</strong><br />

this data with the high levels <strong>of</strong> lead intoxication<br />

during gestation <strong>and</strong> lactation.<br />

Materials <strong>and</strong> methods<br />

R<strong>and</strong>om breed Swiss albino mice were used for the<br />

present study. Sexually mature male <strong>and</strong> females<br />

weighing 28-30 gm were put in breeding cages in<br />

the ratio <strong>of</strong> 1:4 <strong>and</strong> provided st<strong>and</strong>ard diet <strong>and</strong><br />

water ad libitum. The cages were checked every<br />

day in the morning <strong>and</strong> females showing vaginal<br />

plug were isolated. The selected pregnant females<br />

were divided into 4 groups <strong>and</strong> exposed orally by<br />

lead acetate (266.66, 533.33 <strong>and</strong> 1066.66 mg/kg<br />

BW) with the help <strong>of</strong> canula. All the experimental<br />

work was approved by the institutional animal<br />

ethics committee (No.CS/Res/07/759).<br />

(1) Group 1- Control (distilled water only)<br />

(2) Group 2- Exposure <strong>of</strong> lead acetate (266.66<br />

mg/kg BW) from 10 th day <strong>of</strong> gestation up to 21 st<br />

day <strong>of</strong> lactation.<br />

(3) Group 3- Exposure <strong>of</strong> lead acetate (533.33<br />

mg/kg BW) from 10 th day <strong>of</strong> gestation up to 21 st<br />

day <strong>of</strong> lactation.<br />

(4) Group 4- Exposure <strong>of</strong> lead acetate (1066.66<br />

mg/kg BW) from 10 th day <strong>of</strong> gestation up to 21 st<br />

day <strong>of</strong> lactation.<br />

During the respective tenure <strong>of</strong> experiment,<br />

hemoglobin, RBC <strong>and</strong> WBC counts <strong>of</strong> female<br />

Swiss mice were recorded on 17 th day <strong>of</strong> gestation<br />

<strong>and</strong> on 1 st , 7 th , 14 th <strong>and</strong> 21 st days <strong>of</strong> lactation. Blood<br />

samples for hemoglobin <strong>and</strong> blood cell counts were<br />

obtained from the tail <strong>of</strong> each mouse. The tip <strong>of</strong> the<br />

tail was cleaned with spirit before being cut with a<br />

sharp blade <strong>and</strong> was not squeezed to avoid dilution<br />

<strong>of</strong> blood by tissue fluid. The first few drops <strong>of</strong><br />

blood were discarded <strong>and</strong> the blood was diluted, for<br />

cell counting with the help <strong>of</strong> haemocytometer. The<br />

hemoglobin was estimated by hemoglobinometer.<br />

Number <strong>of</strong> (RBCs) <strong>and</strong> (WBCs) were estimated<br />

with haemocytometer adopting the method<br />

described by Dacie <strong>and</strong> Lewis (1975). The<br />

statistical analysis was performed by using analysis<br />

<strong>of</strong> variance (ANOVA) for the comparison <strong>of</strong> data<br />

between different experimental groups.<br />

Results<br />

Introducing lead acetate to female Swiss mice<br />

during gestation <strong>and</strong> lactation period produced a<br />

significant decrease in the hemoglobin content <strong>and</strong><br />

number <strong>of</strong> RBC. Exposure during the gestation<br />

period produced a significant decrease in WBC<br />

counts at the time <strong>of</strong> birth whereas number <strong>of</strong> cells<br />

increase during lactation period.


Data regarding changes in hemoglobin, RBC<br />

<strong>and</strong> WBC counts among different experimental<br />

groups <strong>and</strong> the results obtained for hemoglobin,<br />

RBC <strong>and</strong> WBC are summarized in Tables 1-3. It is<br />

evident from the tables that control animals have<br />

12.5 g/dL Hb, 9.21×10 6 RBC/mm 3 <strong>and</strong> 8.22×10 3<br />

WBC/mm 3 in their blood on 17 th day <strong>of</strong> gestation.<br />

As compared to controls, hemoglobin content, RBC<br />

<strong>and</strong> WBC counts <strong>of</strong> lead- treated female mice were<br />

significantly decreased at the time <strong>of</strong> birth, after<br />

introduction <strong>of</strong> 266.66, 533.33 <strong>and</strong> 1066.66 mg/kg<br />

BW <strong>of</strong> lead acetate.<br />

Lead induced hematological changes 71<br />

The results collected for the hemoglobin is<br />

summarized in Table 1.<br />

It is evident that control animals have 11.5,<br />

12.0, 13.1 <strong>and</strong> 14.0 g/dL Hb in their blood on 1 st ,<br />

7 th , 14 th <strong>and</strong> 21 st day <strong>of</strong> lactation, respectively.<br />

Introduction <strong>of</strong> 266.66, 533.33 <strong>and</strong> 1066.66mg/kg<br />

BW doses <strong>of</strong> lead acetate produced a significant<br />

decrease (p


72 Isha BARBER et al.<br />

Table 3. WBC count (×10 3 cells/mm 3 ) in pregnant <strong>and</strong> lactating female mice treated with lead acetate.<br />

Treatment group<br />

Prenatal<br />

Days<br />

Postnatal<br />

17 1 7 14 21<br />

Control 8.22±3.92 8.07±3.30 8.33±4.30 8.56±3.56 8.86±3.47<br />

Lead acetate (266.66 mg/kg BW) 8.62±5.00* 8.48±1.79* 8.70±5.77 8.71±7.50 9.18±1.25<br />

Lead acetate (533.33 mg/kg BW) 8.98±9.46* 8.62±2.95* 9.10±1.47* 9.20±2.04* 9.31±2.09*<br />

Lead acetate (1066.66 mg/kg BW) 9.26±1.70* 9.00±1.73* 9.17±8.66* 9.35±1.68* 9.46±1.43*<br />

Values were expressed as means ± S.D., values are significantly different (p


elated to major structural <strong>and</strong> functional changes<br />

<strong>of</strong> the intimate relation between fetus <strong>and</strong> mother.<br />

These structural changes are related to implantation<br />

<strong>and</strong> placentation; <strong>and</strong> the functional changes to<br />

increasing hypoxia in the crowded condition <strong>of</strong> the<br />

gravid uterus (Robert <strong>and</strong> Rosenberg, 1993).<br />

In conclusion, the present study indicates that<br />

lead adversely affects hemoglobin <strong>and</strong> blood cell<br />

counts. Dose dependent significant decrease in<br />

hemoglobin <strong>and</strong> RBC counts were observed after<br />

administration <strong>of</strong> 266.66, 533.33 <strong>and</strong> 1066.66<br />

mg/kg/body weight doses <strong>of</strong> lead acetate. However,<br />

WBC counts showed increase in their number.<br />

The results observed in this paper can be used<br />

as a background information for the evaluation <strong>of</strong><br />

reproductive toxicity induced by lead during<br />

gestation <strong>and</strong> lactation in Swiss mice. Moreover,<br />

the mice seem to be a useful animal model for<br />

investigating the mechanisms <strong>of</strong> alterations in the<br />

blood cells <strong>and</strong> hemoglobin content which is<br />

reported to occur during pregnancy <strong>and</strong> lactation in<br />

mice.<br />

References<br />

Angle CR, McIntire MS <strong>and</strong> Swanson MS.<br />

Erythrocyte nucleotides in children increased<br />

blood lead <strong>and</strong> cytidine triphosphate. Pediatr<br />

Res 16:331-334, 1982.<br />

Awad M <strong>and</strong> William Jr. Textbook <strong>of</strong> biochemistry<br />

with clinical correlation. John Wiley <strong>and</strong><br />

Sons, INC, Newyork. 1997.<br />

Azar A, Snee RD, Habibi K. Lead toxicity in<br />

mammalian blood. In: Griffin TB, Knelson<br />

JH (Ed) Lead. Academic, Newyork. 254,<br />

1975.<br />

Banu R, Sharma R <strong>and</strong> Qureshi N. Amelioration <strong>of</strong><br />

lead induced alterations in body weight <strong>and</strong><br />

blood cell counts by antioxidant vitamins.<br />

<strong>Journal</strong> <strong>of</strong> Herbal Medicine <strong>and</strong> Toxicology<br />

1(2): 59-66, 2007.<br />

Dacie JV <strong>and</strong> Lewis SM. In: Practical Hematology,<br />

5th Edn. J. <strong>and</strong> A. Churchill Ltd. London,<br />

1975.<br />

De Rijk EP, van Esch E <strong>and</strong> Flik G. Pregnancy<br />

dating in the rat: placental morphology <strong>and</strong><br />

maternal blood parameters. Toxicol Pathol<br />

30:271–282, 2002.<br />

Lead induced hematological changes 73<br />

EPA, U.S. Air Quality Criteria for Lead. EPA<br />

600/8-83-028F. Washington, DC: U.S.<br />

Environmental Protection Agency, 1986.<br />

Escribano,A.,Revilla, M., Herna’ndez, E.R., Seco,<br />

C., Gonza’lez-Riola, J., Villa, L.F. <strong>and</strong> Rico,<br />

H. Effect <strong>of</strong> lead on bone development <strong>and</strong><br />

bone mass: a morphometric, densitometric,<br />

<strong>and</strong> histomorphometric study in growing<br />

rats. Calcif Tissue Int. 60: 200-203, 1997.<br />

Flora Sj, Mittal M <strong>and</strong> Mehta A. Heavy metal<br />

induced oxidative stress & its possible<br />

reversal by chelation therapy. The Indian<br />

<strong>Journal</strong> <strong>of</strong> Medical Research 128 (4): 501–<br />

23, 2008.<br />

Fruhman GJ. Blood formation in the pregnant<br />

mouse. Blood J. Hematol. 31: 242-248,<br />

1968.<br />

Gruber, H.E., Gonic, H.C., Khalil-Manesh, F.,<br />

Sanchez, T.V., Matsinger, S., Meyer, M. <strong>and</strong><br />

Sharp, C.F. Osteopenia induced by longterm,<br />

low <strong>and</strong> high-level exposure <strong>of</strong> the<br />

adult rat <strong>of</strong> lead. Miner. Electrolyte Metab.,<br />

23, 65-33,1997.<br />

Harkness JE <strong>and</strong> Wagner JE. Biologia e clínica de<br />

coelhos e roedores. 3ª ed. São Paulo: Roca,<br />

1993.<br />

Howells MR, Jones SE, Napier JA, Saunders K <strong>and</strong><br />

Cavill I. Erythropoiesis in pregnancy. Br J<br />

Haematol 64:595–599, 1986.<br />

Karri Sk, Saper Rb <strong>and</strong> Kales Sn. Lead<br />

encephalopathy due to traditional medicines.<br />

Current Drug Safety 3 (1): 54–9, 2008.<br />

Kosnett MJ. Lead. In Brent, J. Critical Care<br />

Toxicology: Diagnosis <strong>and</strong> Management <strong>of</strong><br />

the Critically Poisoned Patient. Gulf<br />

Pr<strong>of</strong>essional Publishing. 2005.<br />

Mercelina-Roumans PE, Ubachs JM <strong>and</strong> van<br />

Wersch JW. Leukocyte count <strong>and</strong> leukocyte<br />

differential in smoking <strong>and</strong> non-smoking<br />

females during pregnancy. Eur J Obstet<br />

Gynecol Reprod Biol 55:169–173,1994.<br />

Mogra S, Sharma R <strong>and</strong> Qureshi N. Effects <strong>of</strong><br />

maternal lead acetate exposure on prenatal<br />

development <strong>of</strong> Swiss albino mice. Asian J<br />

Environ. Sci. 4(2):216-220, 2009.<br />

Paglia DE, Valentine WN <strong>and</strong> Dahigren JG. Effects<br />

<strong>of</strong> low-level lead exposure on pyrimidine 5'nucleotidase<br />

<strong>and</strong> other erythrocyte enzymes.


74 Isha BARBER et al.<br />

Possible role <strong>of</strong> pyrimidine 5'-nucleotidase<br />

in the pathogenesis <strong>of</strong> lead-induced anemia.<br />

J Clin Invest 56:1164-1169, 1975.<br />

Paglia DE, Valentine WN <strong>and</strong> Fink K. Lead<br />

poisoning. Further observations on<br />

erythrocyte pyrimidine-nucleotidase<br />

deficiency <strong>and</strong> intracellular accumulation <strong>of</strong><br />

pyrimidine nucleotides. J Clin Invest.<br />

60:1362-1366, 1977.<br />

Paprika MV <strong>and</strong> Sharma BB. <strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />

Tissue Research 3(1):12-17, 2003.<br />

Pearson HA, <strong>and</strong> Schonfeld DJ.. Lead. In Rudolph,<br />

C.D.. Rudolph'sPediatrics, 21st edition.<br />

McGraw-Hill Pr<strong>of</strong>essional. 2003<br />

Robbins SL <strong>and</strong> Angell M. In: Basic pathology,<br />

2nd Edn. W.B. Saunders Co. Philadelphia,<br />

3-30, 1976.<br />

Robert R <strong>and</strong> Csilla S. The effect <strong>of</strong> pregnancy on<br />

peripheral blood in the mouse. Biol. Bull.,<br />

136: 454-460, 1969.<br />

Royce S <strong>and</strong> Rosenberg J. Chelation therapy in<br />

workers with lead exposure. Western J Med<br />

158: 371-375, 1993.<br />

Rugh R <strong>and</strong> Somogyi C. Pre-<strong>and</strong> postnatal normal<br />

mouse blood cell counts. Proc Soc Exp Biol<br />

Med 127, 1267-1271, 1968.<br />

Yu MH. Soil <strong>and</strong> water pollution: Environmental<br />

metals <strong>and</strong> metalloids. Environmental<br />

Toxicology: Biological <strong>and</strong> Health Effects <strong>of</strong><br />

Pollutants. CRC Press. 2005.<br />

Zarrow MX. Gestation, In: Edgar Allen, Ed., Sex<br />

<strong>and</strong> Internal Secretion, <strong>Vol</strong>ume II. Williams<br />

<strong>and</strong> Wilkins Co., Baltimore. 958-1031, 1961.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 75-82, 2011 Research Article 75<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

The effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> Vernonia<br />

amygdalina on some vital organs in adult Wistar rats<br />

Spencer NWANGWU 1 , David Adesanya OFUSORI 2,* , Sunday JOSIAH 1 , Osasere Frank<br />

AMEGOR 3 , Helen NJOYA 1 <strong>and</strong> Abiodun Oladele AYOKA 4<br />

1 Department <strong>of</strong> Biochemistry, School <strong>of</strong> Basic Medical Sciences, Igbinedion University, Okada, Edo-State,<br />

Nigeria<br />

2 Department <strong>of</strong> Anatomy <strong>and</strong> <strong>Cell</strong> <strong>Biology</strong>, Faculty <strong>of</strong> Basic Medical Sciences, Obafemi Awolowo University,<br />

Ile-Ife, Osun-State, Nigeria<br />

3 Department <strong>of</strong> Medical Laboratory Science, College <strong>of</strong> Health Sciences, Igbinedion University, Okada, Edo<br />

State, Nigeria<br />

4 Department <strong>of</strong> Physiological Sciences, Faculty <strong>of</strong> Basic Medical Sciences, Obafemi Awolowo University,<br />

Ile-Ife, Osun-State, Nigeria<br />

(* author for correspondence; david<strong>of</strong>us234@yahoo.com<br />

Received: 15 February 2011; Accepted: 20 June 2011<br />

Abstract<br />

The aim <strong>of</strong> this study was to comparatively determine the effects <strong>of</strong> aqueous <strong>and</strong> ethanolic extracts <strong>of</strong><br />

Vernonia amygdalina (Asteraceae) leaves, adopting histological procedures on the liver, stomach <strong>and</strong> kidney<br />

in adult wistar rats.There were four groups <strong>of</strong> animals: A, B, C <strong>and</strong> D. Groups A, B <strong>and</strong> C served as the<br />

treated animals while group D served as the control animals. Each <strong>of</strong> the groups was further subdivided into<br />

two i.e A1 & A2; B1 & B2; C1 & C2 <strong>and</strong> D1 & D2. Animals in groups A1, B1 <strong>and</strong> C1 were administered<br />

orally with aqueous extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong> 300 mg/kg respectively while animals in groups<br />

A2, B2 <strong>and</strong> C2 were administered orally with ethanolic extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong> 300 mg/kg<br />

respectively. The control groups, D1 <strong>and</strong> D2, received equal volume <strong>of</strong> normal saline. There were no<br />

significant derangement in the cytoarchitecture <strong>of</strong> the stomach, liver <strong>and</strong> kidney. Rather, the cytoarchitecture<br />

<strong>of</strong> the animals treated with both the ethanolic <strong>and</strong> aqueous extracts (300mg/kg) <strong>of</strong> V. amygdalina were better<br />

organized when compared with the control. It was therefore concluded that both ethanolic <strong>and</strong> aqueous leaf<br />

extracts <strong>of</strong> V. amygdalina are non-toxic <strong>and</strong> may possess cytoprotective potential.<br />

Keywords: Vernonia amygdalina, histological procedures, liver, stomach, kidney<br />

Vernonia amygdalina yaprağının sulu ve etanolik özütlerinin erişkin Wistar<br />

sıçanlarının bazı hayati organlarına etkileri<br />

Özet<br />

Çalışmanın amacı, erişkin Wistar sıçanlarda Vernonia amygdalina (Asteraceae) yapraklarının sulu ve<br />

etanolik özütlerinin karaciğer, mide ve böbrek üzerindeki etkilerini histolojik yöntemlerle karşılaştırmalı<br />

olarak belirlemektir. Çalışmada dört grup hayvan bulunmaktadır: A, B, C ve D. D grubu kontrol hayvanları<br />

olarak belirlenirken; A, B ve C grupları muamele edilmiş hayvanları göstermektedir. Her bir grup ayrıca iki<br />

alt gruba bölünmüştür; A1 & A2; B1 & B2; C1 & C2, D1 & D2. A1, B1 ve C1 gruplarındaki hayvanlara<br />

sırasıyla 100, 200 ve 300 mg/kg V.amygdalina sulu özütü oral olarak uygulanırken A2, B2 ve C2’ye ise<br />

sırasıyla 100, 200 ve 300 mg/kg V.amygdalina etanolik özütü oral olarak uygulanmıştır. Kontrol grupları<br />

olan D1 ve D2 eşit hacimde normal tuz almışlardır. Mide, karaciğer ve böbreğin hücresel yapısında belirgin<br />

bir bozulma bulunmamıştır. Bilakis hem sulu, hem de etanolik V. amygdalina (300mg/kg) özütü uygulanan


76 Spencer NWANGWU et al.<br />

hayvanların hücresel yapıları kontrollerle karşılaştırıldığında daha iyi organizedir. Bu nedenle sulu ve<br />

etanolik V. amygdalina yaprak özütlerinin her ikisinin de toksik olmadığı ve hücre koruyucu potansiyele<br />

sahip olabileceği sonucuna varılmıştır.<br />

Anahtar Sözcükler: Vernonia amygdalina, histolojik süreçler, karaciğer, mide, böbrek.<br />

Introduction<br />

Vernonia amygdalina (Del. Asteraceae)<br />

commonly known as “bitter leaf” is a valuable<br />

shrub that is widespread in East <strong>and</strong> West Africa.<br />

It is 2-5 m tall with petiolate green leaves <strong>of</strong> about<br />

6 mm diameter (Ojiako <strong>and</strong> Nwanjo, 2006). In<br />

Nigeria the stem is used as chew-sticks, while the<br />

leaves are being used as a popular vegetable for<br />

soups particularly among the Igbos <strong>of</strong> Southern<br />

Nigeria, Africa (Ojiako <strong>and</strong> Nwanjo, 2006). Its<br />

medicinal values for fever, laxative, pile<br />

(haemorrhoids) <strong>and</strong> gastro-intestinal troubles have<br />

been investigated <strong>and</strong> reported by the following<br />

authors: (Oliver, 1960; Ainslie, 1973; Kupcham,<br />

1971; Akah <strong>and</strong> Okafor, 1992; Abosi <strong>and</strong><br />

Raseroka, 2003; Huffman, 2003; Izevbigie et al.,<br />

2004). In fact all parts <strong>of</strong> the plant have been<br />

known to be pharmacologically useful. Oral<br />

administration <strong>of</strong> the aqueous leaf extract <strong>of</strong> the<br />

plant was found to relieve pain (Tekobo et al.,<br />

2002) <strong>and</strong> to lower body temperature (Tekobo et<br />

al., 2002). Atangwho et al. (2010) reported<br />

instantaneous reduction <strong>of</strong> blood glucose <strong>and</strong> a<br />

variation in blood glucose similar to that <strong>of</strong><br />

insulin-treated rats in animals administered with<br />

ethanol extract <strong>of</strong> V. amygdalina.<br />

Nutritionally, V. amygdalina is used mainly in<br />

soup making in the tropics <strong>and</strong> also as an<br />

appetizer <strong>and</strong> febrifuge (Ijeh et al., 1996; Iwu,<br />

1996, Ojiako <strong>and</strong> Nwanjo, 2006) <strong>and</strong> has proven<br />

to be a successful supplement in weaning foods<br />

(Ojiako <strong>and</strong> Nwanjo, 2006). In Nigeria, as in<br />

other tropical countries <strong>of</strong> Africa where the daily<br />

diet is dominated by starchy staple foods,<br />

vegetables are the cheapest <strong>and</strong> most readily<br />

available sources <strong>of</strong> important proteins, vitamins,<br />

minerals <strong>and</strong> essential amino acids (Okafor, 1983,<br />

Ojiako <strong>and</strong> Nwanjo, 2006). The importance <strong>of</strong> V.<br />

amygdalina in animal nutrition in Nigeria has also<br />

been well documented (Onwuka et al., 1989;<br />

Aregheore et al., 1998; Ojiako <strong>and</strong> Nwanjo 2006).<br />

Despite these beneficial uses <strong>of</strong> the plant, there<br />

has been conflicting reports on its exact<br />

toxicological potentials on some visceral organs.<br />

For instance Aregheore et al., (1998) reported the<br />

presence <strong>of</strong> toxic phytochemicals. There are also<br />

reports <strong>of</strong> actual hepatotoxicity in mice (Igile et<br />

al., 1995), also, there was a report on<br />

hepatoprotective effects in rats (Babalola et al.,<br />

2001). Ojiako <strong>and</strong> Nwanjo (2006) reported that V.<br />

amygdalina leaves may be toxic (just like several<br />

other vegetables) if consumed in very large<br />

quantities but the potential danger is not higher<br />

than has been observed for other common<br />

vegetables that are routinely consumed in Africa<br />

in even larger quantities.<br />

In view <strong>of</strong> these conflicting reports, we<br />

therefore set to comparatively determine the<br />

effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> V.<br />

amygdalina, adopting histological procedures on<br />

the stomach, liver <strong>and</strong> kidney in adult wistar rats.<br />

Materials <strong>and</strong> methods<br />

Experimental Site<br />

This research was conducted in the Department <strong>of</strong><br />

Biochemistry, School <strong>of</strong> Basic Medical Sciences,<br />

Igbinedion University, Nigeria.<br />

Experimental Animals<br />

A total <strong>of</strong> forty healthy wistar rats obtained from a<br />

private farm in Benin City were used for the<br />

experiment. These animals were acclimatized for<br />

two weeks before the commencement <strong>of</strong> the<br />

study. The animals were treated in accordance<br />

with the “Guide for the Care <strong>and</strong> Use <strong>of</strong><br />

Laboratory Animals” prepared by the National<br />

Academy <strong>of</strong> Sciences <strong>and</strong> published by the<br />

National Institutes <strong>of</strong> Health (NIH, 1985) .<br />

Experimental Design<br />

There were four groups <strong>of</strong> animals: A, B, C <strong>and</strong><br />

D. Groups A, B <strong>and</strong> C served as the treated<br />

animals while group D served as the control<br />

animals. Each <strong>of</strong> the groups (n=10) was further<br />

subdivided into two i.e A: A1 & A2; B: B1 & B2;


C: C1 & C2 <strong>and</strong> D: D1 & D2. Animals in groups<br />

A1, B1 <strong>and</strong> C1 were administered orally with<br />

aqueous extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong><br />

300 mg/kg respectively while animals in groups<br />

A2, B2 <strong>and</strong> C2 were administered orally with<br />

ethanolic extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong><br />

300 mg/kg respectively. The control groups D1<br />

<strong>and</strong> D2 received equal volume <strong>of</strong> normal saline.<br />

Collection <strong>of</strong> plant materials<br />

Fresh but matured leaves <strong>of</strong> Vernonia amygdalina<br />

was procured from a local market in Okada, Edostate.<br />

They were authenticated in the Botany<br />

Department, Igbinedion University, Nigeria. The<br />

leaves were rinsed severally with clean tap water<br />

to remove dust particles <strong>and</strong> debris <strong>and</strong> thereafter<br />

allowed to completely drain.<br />

Preparation <strong>of</strong> plant extracts<br />

Plant materials were separately chopped into bits<br />

with a knife on a chopping board. The leaves<br />

were then air dried <strong>and</strong> one kilogram (1kg) V.<br />

amygdalina was reduced to powder with an<br />

electric blender. The powder was divided into two<br />

portions. One <strong>of</strong> the portions was percolated with<br />

80% ethanol while the other was percolated with<br />

distilled water. The mixtures were allowed for 48<br />

h in the refrigerator at 4 0 C for thorough extraction<br />

<strong>of</strong> the plants active components. These were then<br />

filtered with cheesecloth <strong>and</strong> later with Whatman<br />

No. 1 filter paper to obtain a homogenous filtrate.<br />

These filtrates were then concentrated in vacuo at<br />

low temperature (37- 40 0 C) to about one tenth the<br />

original volume using a rotary evaporator. The<br />

concentrates were allowed open in a water bath<br />

(40 0 C) for complete dryness for both ethanol <strong>and</strong><br />

aqueous extracts <strong>of</strong> V. amygdalina. The extracts<br />

(26.7% yield) were then refrigerated at 2- 8 0 C<br />

until use.<br />

Histological Procedure<br />

Histological study was carried out using the<br />

method <strong>of</strong> Carleton (1967). These procedures<br />

Effects <strong>of</strong> Vernonia amygdalina extracts on vital organs 77<br />

involved dehydration <strong>of</strong> the liver, kidney <strong>and</strong><br />

spleen tissues with graded ethanol concentrations<br />

(50%, 70%, 90% <strong>and</strong> 100%, respectively),<br />

clearing in xylene, followed by infiltration in<br />

paraffin wax for 2 h at 56 o C <strong>and</strong> embedding in<br />

paraffin wax for 48 h. Sections (5 μm thick) were<br />

then obtained, using a rotary microtome,<br />

subjected to haematoxylin <strong>and</strong> eosin (H & E)<br />

staining procedure <strong>and</strong> examined under a light<br />

microscope. Permanent photomicrographs <strong>of</strong> the<br />

observations were taken, using an Olympus<br />

Research Microscope (model BX51).<br />

Results<br />

There were no significant derangement in the<br />

cytoarchitecture <strong>of</strong> the stomach, liver <strong>and</strong> kidney.<br />

Rather, the cytoarchitecture <strong>of</strong> the animals treated<br />

with both the ethanolic <strong>and</strong> aqueous extract<br />

(300mg/kg) <strong>of</strong> V. amygdalina were better<br />

organized when compared with the control<br />

(Figures 1-3). In the stomachs <strong>of</strong> treated animals,<br />

there were no disruptions <strong>of</strong> surface epithelium<br />

<strong>and</strong> no presence <strong>of</strong> submucosal edema as well as<br />

leucocytes infiltration as compared with control<br />

groups (Figure 1). There were no hypertrophy <strong>of</strong><br />

the liver <strong>and</strong> no necrosis <strong>of</strong> the hepatocytes in the<br />

treated animals as compared with control groups<br />

(Figure 2). Also, the kidneys <strong>of</strong> animals in the<br />

treated groups presented well preserved renal<br />

corpuscles <strong>and</strong> Bowman’s spaces as compared<br />

with control groups (Figure 3). Animals in both<br />

the treated <strong>and</strong> control groups showed no physical<br />

changes in their appearances. The present study<br />

demonstrated that oral administration <strong>of</strong> both<br />

ethanolic <strong>and</strong> aqueous extracts (300 mg kg -1 )<br />

preserved the hepatic, renal <strong>and</strong> gastric integrity<br />

as compared to animals administered with lesser<br />

dose (200 <strong>and</strong> 100 mg kg -1 ) <strong>and</strong> only distilled<br />

water (Figures 1-3). There were no significant<br />

differences between the cytoprotective abilities <strong>of</strong><br />

the animals treated with ethanolic or aqueous<br />

extracts compared to the animals treated with<br />

control.


78 Spencer NWANGWU et al.<br />

A1 A2<br />

C1<br />

B1 B2<br />

Figure 1. Histological section <strong>of</strong> gastric mucosa treated with A: aqueous extract V. amygdalina (A1-100, B1-<br />

200, C1-300mg/kg); B: ethanolic extract <strong>of</strong> V. amygdalina (A2-100, B2-200, C2-300mg/kg). Note that there<br />

were no disruptions <strong>of</strong> surface epithelium. No presence <strong>of</strong> submucosal edema <strong>and</strong> leucocytes infiltration as<br />

compared with control groups D1 <strong>and</strong> D2 (H <strong>and</strong> E stain, 100x).<br />

C2<br />

D1 D2


Effects <strong>of</strong> Vernonia amygdalina extracts on vital organs 79<br />

Figure 2. Histological section <strong>of</strong> hepatic parenchyma treated with A: aqueous extract V. amygdalina (A1-<br />

100, B1-200, C1-300mg/kg); B: ethanolic extract <strong>of</strong> V. amygdalina (A2-100, B2-200, C2-300mg/kg). Note<br />

that there were no hypertrophy <strong>of</strong> the liver <strong>and</strong> no necrosis <strong>of</strong> the hepatocytes as compared with control<br />

groups D1 <strong>and</strong> D2 (H <strong>and</strong> E stain, 100x).


80 Spencer NWANGWU et al.<br />

Figure 3. Histological section <strong>of</strong> renal parenchyma treated with A: aqueous extract V. amygdalina (A1-100,<br />

B1-200, C1-300mg/kg); B: ethanolic extract <strong>of</strong> V. amygdalina (A2-100, B2-200, C2-300mg/kg). Note that<br />

the renal corpuscles <strong>and</strong> Bowman’s spaces were well preserved. Also, there were no evidence <strong>of</strong> cellular<br />

necrosis as compared with control groups D1 <strong>and</strong> D2 (H <strong>and</strong> E stain, 100x).<br />

Discussion<br />

The histopathological changes observed in the<br />

liver, kidney, stomach <strong>of</strong> aqueous <strong>and</strong> ethanolic<br />

extracts <strong>of</strong> V. amygdalina on rats showed no<br />

evidence <strong>of</strong> lesions in the treated animals when<br />

compared with control. Our histological findings<br />

further revealed that the cyto-architecture <strong>of</strong> the<br />

liver parenchyma was better organized in the<br />

groups treated with 300mg/kg <strong>of</strong> both ethanolic <strong>and</strong><br />

aqueous extracts <strong>of</strong> V. amygdalina. The functions<br />

<strong>of</strong> the liver which includes detoxification,<br />

metabolic activities, synthesis <strong>of</strong> plasma protein<br />

<strong>and</strong> destruction <strong>of</strong> spent red blood cells among<br />

other functions will be better enhanced based on


histological evidences from our study. This shows<br />

that administration <strong>of</strong> ethanolic <strong>and</strong> aqueous<br />

extracts <strong>of</strong> V. amygdalina provides a protective role<br />

for the liver which is the first organ susceptible to<br />

any injurious substances in case <strong>of</strong> toxicity. This is<br />

in line with previous work (Ofusori et al. 2008)<br />

who investigated the effect <strong>of</strong> Croton zambesicus<br />

(euphorbiaceae) on the liver. The renal parenchyma<br />

showed no evidence <strong>of</strong> vacuolations or distortion <strong>of</strong><br />

any kind rather, renal corpuscles <strong>and</strong> Bowman’s<br />

spaces were well preserved as compared with<br />

control groups in all the experimental groups. It<br />

was evident on the photomicrograph that the<br />

tubules constitute the bulk <strong>of</strong> the renal parenchyma<br />

with different shapes, diameters <strong>and</strong> staining<br />

intensities. This points to the fact that V.<br />

amygdalina may have a vital role to play in<br />

osmoregulation <strong>and</strong> excretion. Also, the gastric<br />

mucosa <strong>of</strong> the treated groups were better organized<br />

when compared with the control (Figure 1). There<br />

was no evidence <strong>of</strong> ulceration in the surface<br />

epithelium, no presence <strong>of</strong> submucosal edema <strong>and</strong><br />

leucocytes infiltration. Studies have shown that<br />

anti-oxidants significantly strengthen the gastric<br />

walls <strong>and</strong> protect tissue from oxidative damage<br />

(Marins, 1996).<br />

All these evidences revealed that V. amygdalina<br />

is a very important plant that can be exploited for<br />

cyto-protective purposes. The cyto-protective<br />

mechanism may be by moping up free radical there<br />

by protecting the cells <strong>of</strong> the organs from any type<br />

<strong>of</strong> assaults. Several other studies have shown that<br />

the aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> V.<br />

amygdalina is non-hazardous, even when taken for<br />

some time. The potency <strong>of</strong> these extracts may have<br />

been amplified on account <strong>of</strong> increased<br />

concentration or build up <strong>of</strong> specific<br />

phytochemicals, although the chemistry is yet<br />

unknown. Several findings showed that V.<br />

amygdalina has strong antioxidant activity<br />

corresponding to mitigation <strong>of</strong> the generation <strong>of</strong><br />

hydroxyl radicals. Yeh et al., (2003) <strong>and</strong> Battell et<br />

al., (1999) postulated that this antioxidant activity<br />

may provide possible rationale for the observed<br />

therapeutic effects <strong>of</strong> V. amygdalina.<br />

Based on the results obtained, it can be<br />

concluded that ethanolic <strong>and</strong> aqueous leaf extracts<br />

<strong>of</strong> V. amygdalina are non toxic <strong>and</strong> may possess<br />

cytoprotective potential.<br />

Effects <strong>of</strong> Vernonia amygdalina extracts on vital organs 81<br />

References<br />

Abosi AO <strong>and</strong> Raseroka BH. In vivo antimalarial<br />

activity <strong>of</strong> Vernonia amygdalina. Br. J.<br />

Biomedical Sci. 60(2): 89-91, 2003.<br />

Ainslie JR. List <strong>of</strong> plants used in native medicine in<br />

Nigeria. Imperial Forestry Institute, Oxford<br />

Publishing. 42, 1973.<br />

Akah PA <strong>and</strong> Okafor CI. Hypoglycaemic effect <strong>of</strong><br />

Vernonia amygdalina Del, in experimental<br />

rabbits. Plant Med. Res. 1: 6-10, 1992.<br />

Aregheore EMK, Makkar HPS <strong>and</strong> Becker K. Feed<br />

value <strong>of</strong> some browse plants from the central<br />

zone <strong>of</strong> Delta State, Nig. Trop. Sci. 38(2): 97-<br />

104, 1998.<br />

Babalola OO, Anetor JI <strong>and</strong> Adeniyi FA.<br />

Amelioration <strong>of</strong> carbon tetrachloride-induced<br />

hepatotoxicity by terpenoid extract from leaves<br />

<strong>of</strong> Vernonia amydgalina. Afr. J. Med. Sci. 30 (1-<br />

2): 91-93, 2001.<br />

Battell ML, Rodrigues B, Yuen VG <strong>and</strong> McNeill<br />

JH. Treatment <strong>and</strong> pharmacological<br />

interventions in streptozotocin diabetes. In:<br />

Experimental Models <strong>of</strong> Diabetes. (McNeill, J.<br />

H., Ed.), pp.195-216. CRC Press LLC, U.S.A,<br />

1999.<br />

Huffman MA. Animal self-medication <strong>and</strong> ethnomedicine:<br />

exploration <strong>and</strong> exploitation <strong>of</strong> the<br />

medicinal properties <strong>of</strong> plants. Proceedings <strong>of</strong><br />

the Nutr. Society. 62(2):371-81, 2003.<br />

Igile GO, Oleszek W, Jurzysta M, Burda S, Fafunso<br />

M <strong>and</strong> Fasanmade AA. Nutritional assesment <strong>of</strong><br />

Vernonia amygdalina leaves in growing mice.<br />

J. Agric. Food Chem. 43, 2162-2166, 1995.<br />

Ijeh I, Nwugo VO <strong>and</strong> Obidoa O. Comparative<br />

studies on the nutritive Phyto-chemical <strong>and</strong><br />

antimicrobial properties <strong>of</strong> two varieties <strong>of</strong><br />

Vernomia amygdalina. Plant Pros. Res. Comm.<br />

1: 71-75, 1996.<br />

Izevbigie EB, Bryant JL <strong>and</strong> Walker A. A novel<br />

natural inhibitor <strong>of</strong> extracellular signalregulated<br />

kinases <strong>and</strong> human breast cancer cell<br />

growth. Experimental Biol. Med. (Maywood)<br />

229(2): 163-169, 2004.<br />

Iwu MM, Okunji E, Akah PA, Tempesta MS, <strong>and</strong><br />

Carley DG. Dioscoretine: The hypoglycaemic


82 Spencer NWANGWU et al.<br />

principles <strong>of</strong> Dioscorea dumentorium. Plant<br />

Med. 56: 119-126, 1996.<br />

Kupcham SM. Drugs from Natural products. Plant<br />

source in drugs discovery, science <strong>and</strong><br />

development. Am. Chem. Soc. 6: 311-318, 1971.<br />

Martin A. The use <strong>of</strong> antioxidants in healing.<br />

Dermatol. Surg., 22: 156-160, 1996.<br />

Ofusori DA, Adelakun AE <strong>and</strong> Ayoka AO.<br />

Histological Investigation <strong>of</strong> the Effects <strong>of</strong><br />

Croton zambesicus on the Liver <strong>of</strong> Swiss albino<br />

mice. The Int. J. Gastroenterology. (7)1: 2008.<br />

Ojiako OA <strong>and</strong> Nwanjo H. Is Vernonia amygdalina<br />

hepatotoxic or hepatoprotective? Response from<br />

biochemical <strong>and</strong> toxicity studies in rats. Afr J.<br />

Biotech. 5 (18): 1648-1651, 2006.<br />

Okafor JC. Horticulturally promising indigenous<br />

wild plant species <strong>of</strong> the Nigerian forest zone.<br />

Acta Hort. 123: 165-176, 1983.<br />

Oliver B. Medicinal plants in Nigeria. Nig. Coll. Sci<br />

Techn. 50-51, 1960.<br />

Onwuka CFI, Akinsoyinu AO <strong>and</strong> Tewe OO. Feed<br />

value <strong>of</strong> some Nigerian browse plants: chemical<br />

composition <strong>and</strong> in vitro digestibility. East<br />

African Agri. Forestry J. 54: 157 – 163, 1989.<br />

Tekobo AM, Onabanjo AO, Amole OO <strong>and</strong> Emeka<br />

PM . Analgesic <strong>and</strong> antipyretic effects <strong>of</strong> the<br />

aqueous extract <strong>of</strong> Vernonia amygdalina. West<br />

Afri. J. Pharm. 16: 68-74, 2002.<br />

Yeh GY, Eisenberg DM, Kaptcuk TJ <strong>and</strong> Philips<br />

RS. System review <strong>of</strong> herbs <strong>and</strong> dietary<br />

supplements for glycemic control in diabetes.<br />

Diab. Care 26 (4), 1277 – 1294, 2003.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 83-86, 2011 Short communication 83<br />

<strong>Haliç</strong> University, Printed in Turkey.<br />

http://jcmb.halic.edu.tr<br />

Investigation <strong>of</strong> the EGFR gene variations in bladder cancer<br />

patients using INFINITI TM Analyzer<br />

Necip Ozan TİRYAKİOĞLU 1 , Özlem KURNAZ 1 , Ömer Onur ÇAKIR 2 , Nagehan ERSOY<br />

TUNALI 1,*<br />

1<br />

<strong>Haliç</strong> University, Faculty <strong>of</strong> Arts <strong>and</strong> Sciences, Department <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong> Genetics, Istanbul,<br />

Turkey<br />

2<br />

T.R. Ministry <strong>of</strong> Health, Bağcılar Training <strong>and</strong> Research Hospital, Istanbul, Turkey<br />

(* author for correspondence; nagehanersoy@halic.edu.tr)<br />

Received: 26 May 2011; Accepted: 22 June 2011<br />

Abstract<br />

Dysregulation <strong>of</strong> epidermal growth factor receptor (EGFR), which leads to increased proliferation, is a<br />

common event in most cancers. Since its recognition as a keyplayer in carcinogenesis, several anti-EGFR<br />

agents have been developed as chemotherapeutic agents. Studies investigating the effect <strong>of</strong> EGFR mutations<br />

on the activity <strong>of</strong> anti-EGFR agents resulted in the discovery <strong>of</strong> a number <strong>of</strong> cancer tissue-specific mutations<br />

which either increase or decrease sensitivity to tyrosine kinase inhibitors (TKI). Determination <strong>of</strong> these<br />

mutations is essential to prognostic processes, but is limited to tissue availability. Being able to determine<br />

tumour specific EGFR mutations by using blood sample as the genotyping material will eliminate the need<br />

for invasive techniques. This study is the first step <strong>of</strong> a wider research with the final goal <strong>of</strong> matching<br />

mutations in tumour tissues with that <strong>of</strong> normal somatic cells from the same individuals. All the known exon<br />

18-21 mutations were screened in 48 bladder cancer patients with INFINITI TM analyzer using leukocytes as<br />

the DNA source. However, none <strong>of</strong> the investigated mutations have been detected in the genomic DNA<br />

samples <strong>of</strong> bladder cancer patients.<br />

Keywords: INFINITI TM , epidermal growth factor receptor, tyrosine kinase inhibitor, drug sensitivity, bladder<br />

cancer.<br />

Mesane kanseri hastalarında EGFR geni varyantlarının INFINITI TM ile incelenmesi<br />

Özet<br />

Artmış çoğalmaya sebep olan epidermal büyüme faktörü reseptörünün (EGFR) düzenlenmesindeki<br />

bozukluklara çoğu kanser türünde rastlanır. Karsinogenezde oynadığı kilit rol farkedildiğinden beri anti-<br />

EGFR etkili bir çok kemoterapötik ajan geliştirilmiştir. EGFR mutasyonlarının anti-EGFR ajanlarının<br />

aktivitesine etkisinin incelendiği araştırmalarda tirozin kinaz inhibitörüne hassasiyetini artıran veya azaltan<br />

bir çok kanser dokusuna özgün mutasyon belirlenmiştir. Bu mutasyonların belirlenmesi tedavi aşamasının<br />

temelini oluşturur, fakat mutasyonların belirlenmesi kanser dokusuna erişebilirlik ile sınırlıdır. Tümör<br />

spesifik EGFR mutasyonlarının genotipleme aracı olarak kan örnekleri kullanılarak belirlenebilmesi invaziv<br />

tekniklere olan gerekliliği ortadan kaldıracaktır. Bu çalışma nihai olarak olarak tümör dokusu<br />

mutasyonlarının normal somatik hücre mutasyonları ile eşlenmesinin amaçl<strong>and</strong>ığı daha geniş bir araştırmanın<br />

ilk aşaması olarak gerçekleştirilmiştir. Bilinen tüm exon 18-21 mutasyonları 48 mesane kanseri hastasında<br />

INFINITI TM cihazı ile DNA kaynağı olarak lökositler kullanılarak taranmıştır. Ancak, araştırılan hiçbir<br />

mutasyon mesane kanseri hastalarının genomik DNA’larında belirlenememiştir.<br />

Anahtar Sözcükler: INFINITI TM , epidermal büyüme faktörü reseptörü, tirozin kinaz inhibitörü, ilaç<br />

hassasiyeti, mesane kanseri.


84 Necip Ozan TİRYAKİOĞLU et al.<br />

Introduction<br />

Epidermal growth factor receptor (EGFR) is a cell<br />

surface receptor that activates signalling cascades<br />

which mainly induce proliferation <strong>and</strong> cell survival.<br />

Human genome codes for four members <strong>of</strong> the<br />

EGFR family, EGFR/ErbB1, HER2/ErbB2/neu-2,<br />

HER3/ErbB3 <strong>and</strong> HER4/ErbB4. All the family<br />

members consists <strong>of</strong> a lig<strong>and</strong>-binding, a<br />

transmembrane <strong>and</strong> a cytoplasmic domain with<br />

tyrosine kinase activity (Gschwind et al., 2004).<br />

EGFR members reside on the cell membrane as<br />

monomers which dimerize upon phosphorylation<br />

by lig<strong>and</strong> binding. Eight different molecules have<br />

been identified as EGFR/ErbB1 lig<strong>and</strong>s. All the<br />

EGFR lig<strong>and</strong>s, except Crypto, are synthesized as<br />

precursor molecules <strong>and</strong> become functional only<br />

after proteolytic clevage. In addition, EGFR family<br />

members have been shown to be activated<br />

indirectly by chemokines, cell adhesion molecules<br />

<strong>and</strong> G-protein coupled receptors (Yarden <strong>and</strong><br />

Sliwkowski, 2001). The dimerisation <strong>of</strong> EGFR<br />

members can occur as homodimerisation or as<br />

heterodimerisation with another member <strong>of</strong> the<br />

family. Following dimerisation,<br />

autophosphorylation in homodimers <strong>and</strong><br />

transphosphorylation in heterodimers occurs.<br />

During this process five tyrosine residues, Y992,<br />

Y1045, Y1068,Y1148 <strong>and</strong> Y1173, located on Cterminal<br />

are phosphorylated. Consequently, EGFRs<br />

activate a multitude <strong>of</strong> transducer <strong>and</strong> adapter<br />

proteins including HP-2, GRB2, PI3K <strong>and</strong> Akt.<br />

Activation <strong>of</strong> these proteins induce a variety <strong>of</strong><br />

cytoplasmic pathways, mainly MAPK <strong>and</strong> JNK,<br />

which trigger cellular events like DNA synthesis<br />

<strong>and</strong> proliferation (Oda et al., 2005).<br />

Dysregulation <strong>of</strong> EGFRs are mainly caused by<br />

overexpression <strong>of</strong> the receptor itself, their lig<strong>and</strong>s<br />

or both. In addition to overexpression, mutations in<br />

the tyrosine kinase domain causing consistent<br />

activation <strong>of</strong> the receptor account for another major<br />

mechanism affecting EGFR signalisation. Such<br />

mutations have been identified in lung, stomach<br />

<strong>and</strong> breast cancer tissues, but not in normal tissues.<br />

Dysregulation <strong>of</strong> EGFR can also be the result <strong>of</strong><br />

HER2/ErB2 heterodimerisation. HER2 does not<br />

have lig<strong>and</strong> binding activity, instead it increases<br />

the lig<strong>and</strong> binding affinity <strong>of</strong> the protein it<br />

dimerises with. Thus, EGFR/HER2 dimerisation<br />

leads to a more active receptor <strong>and</strong> increased<br />

activity <strong>of</strong> the EGFR pathways (Herbst, 2004).<br />

Upon discovery <strong>of</strong> disturbed EGFR functions in<br />

multiple cancers, abundant number <strong>of</strong> studies have<br />

been conducted in order to develop drugs targeting<br />

EGFR. Inhibitory molecules targeting EGFR can be<br />

classified in three main categories; monoclonal<br />

antibodies, chemical inhibitors <strong>and</strong> antisense<br />

oligonucleotides.<br />

Monoclonal antibodies exert their inhibitory<br />

effect by binding to the lig<strong>and</strong> binding domain <strong>and</strong><br />

disrupt activation upon lig<strong>and</strong> binding. Monoclonal<br />

antibodies against EGFR have been showed to<br />

inhibit cell growth <strong>and</strong> induce apoptosis. However,<br />

since they exert their effect only on lig<strong>and</strong> binding<br />

domain, EGFRs with tyrosine domain mutations<br />

are prone to be irresponsive to the inhibitory effects<br />

<strong>of</strong> monoclonal antibodies. In contrast to<br />

monoclonal antibodies, chemical inhibitors target<br />

tyrosine kinase domain <strong>and</strong> inhibit EGFR by<br />

blocking ATP from interacting with the tyrosine<br />

kinase domain. Antisense nucleotides, on the other<br />

h<strong>and</strong>, prevent translation <strong>of</strong> the EGFRs <strong>and</strong> their<br />

lig<strong>and</strong>s <strong>and</strong> carry out their inhibitory effect at a<br />

much essential level.<br />

90% <strong>of</strong> the somatic EGFR mutations are located<br />

in the tyrosine kinase domain, namely exons 18-21<br />

(Table 1). Since tumor cells depend on the<br />

activating mutations on tyrosine kinase domain <strong>of</strong><br />

EGFR for proliferative signals, it has been shown<br />

that tumor cells harboring such mutations are more<br />

sensitive to thymidine kinase inhibitors (TKI).<br />

Thus, determination <strong>of</strong> the EGFR mutations has<br />

both prognostic value as an indicator <strong>of</strong> drug<br />

response <strong>and</strong> diagnostic value as a biomarker<br />

(Lynch et al. , 2004).<br />

Since the determination <strong>of</strong> EGFR mutations<br />

requires tumour samples <strong>and</strong> collecting a tumour<br />

sample is only possible through invasive<br />

techniques, EGFR mutation surveys are limited to<br />

tissue availability. Being able to scan for the EGFR<br />

mutations by using whole blood as an alternative<br />

DNA source may provide information about the<br />

genotype <strong>of</strong> the original tumour tissue without the<br />

need for invasive techniques. Therefore, the study<br />

presented here is initiated as the first step <strong>of</strong> a wider<br />

research with the final goal <strong>of</strong> matching mutations<br />

in tumour tissues with that <strong>of</strong> normal somatic cells<br />

from the same individuals.<br />

Table 1. Common EGFR Mutations<br />

Mutations Frequency Effect<br />

G719A/C/S 3% Increased sensitivity<br />

Ex 19 Deletion 48% Increased sensitivity<br />

Ex20 Deletion 4% Decreased sensitivity<br />

T790M 5% Decreased sensitivity<br />

L858R 43% Increased sensitivity<br />

L861Q 2% Increased sensitivity


EGFR variations in bladder cancer 85<br />

Materials <strong>and</strong> methods<br />

Ethical Committee for Clinical Research. DNA was<br />

As the first step, genomic DNA extracted from the<br />

leukocytes <strong>of</strong> 48 bladder cancer patients have been<br />

surveyed for the total <strong>of</strong> 50 mutations identified to<br />

date in exons 18-21 <strong>of</strong> the EGFR gene. The<br />

selected study population consisted <strong>of</strong> 40 males <strong>and</strong><br />

8 females with bladder cancer. Tumour tissue <strong>and</strong><br />

blood samples were obtained from each induvidial<br />

<strong>and</strong> categorised according to their tumour stage <strong>and</strong><br />

grade. Tumour samples were collected in tubes<br />

containing RNase Later (Invitrogen) solution, while<br />

blood samples were collected in tubes containing<br />

K2EDTA. Ethical approval for his study was<br />

obtained from Istanbul University Medical Faculty,<br />

extracted from blood samples by using QiaAmp<br />

DNA Blood Mini kit (Qiagen) as described in the<br />

package insert.<br />

Extracted DNA samples were surveyed for a<br />

total <strong>of</strong> 50 mutations in exons 18-21 by<br />

INFINITI Analyzer (Table 2). INFINITI<br />

Analyzer has different protocols for different<br />

assays, but the five essential steps are common to<br />

all; 1) multiplex PCR amplification <strong>of</strong> DNA, 2)<br />

fluorescent label incorporation using analyte<br />

specific primer extension (ASPE), 3) hybridization<br />

<strong>of</strong> the ASPE primers to a microarray followed by<br />

washing, 4) scanning <strong>of</strong> the microarray <strong>and</strong> 5)<br />

signal detection <strong>and</strong> analysis.<br />

Table 2. Scanned EGFR Mutations<br />

Exon 18 Exon 19 Exon 20 Exon 21<br />

Glu709 Lys Lys739_Ile744dup Glu762insEAFQ Asn826Ser<br />

Glu709 Gln Lys745_Glu746del Glu762ins His835Leu<br />

Glu709 Ala Glu746_Ala750del Val769Met Leu858Arg<br />

Glu709 Gly Glu746_Thr751delins Val769Leu Leu858Met<br />

Glu709 Val Glu746_Thr751delins Asp770ins Leu858Arg<br />

Gly719 Ser Glu746_Ala750delins Ala767_Val769dup Leu861Gln<br />

Gly719 Arg Glu746_Ala750del Asp770fs Leu861Arg<br />

Gly719 Cys Glu746 Lys Pro772Arg<br />

Gly719 Ala Glu746_Ala750delins Ser768_Asp770dup<br />

Ser720 Phe Glu746_Pro753delins His773Arg<br />

Glu746_Ser752del His773Leu<br />

Glu746_Ser752delins Asn771_His773dup<br />

Glu746_Thr751delins Val774Met<br />

Glu746_Thr751delins Arg776Cys<br />

Glu746_Ser752delins Gly779Phe<br />

Glu746_Thr751delins Thr790Met<br />

Glu746_Ser752delins<br />

Leu747_Glu749del<br />

Leu747_ Thr751delins<br />

Leu747_Ser752del<br />

Leu747_Ser752delins<br />

Leu747_Pro753delins<br />

Glu746_Glu749del<br />

Leu747_Glu749del<br />

Glu746_Thr751del<br />

Leu747_ Thr751del<br />

Leu747_ Thr751delins<br />

Leu747_ Lys754delins<br />

Leu747_Pro753delins<br />

Leu747_Ala750del<br />

Leu747_ Thr751del<br />

Arg748_Thr751delins<br />

Glu749_Thr751del<br />

Thr751_Ile759delins<br />

Ser752_Ile759del


86 Ozan TİRYAKİOĞLU et al.<br />

Results<br />

INFINITI Analyzer detects EGFR mutations<br />

according to the ratio <strong>of</strong> the specific fluorescence<br />

signal emitted from the analyte, represented in<br />

Relative Fluorescence Unit (RFU), to the<br />

fluorescence signal <strong>of</strong> the non-specific<br />

oligonucleotide background control spots. A ratio<br />

<strong>of</strong> 2 <strong>and</strong> higher indicates the existence <strong>of</strong> the<br />

particular EGFR mutation <strong>and</strong> a ratio lower than 2<br />

indicates the absence <strong>of</strong> the particular EGFR<br />

mutation.<br />

According to specific RFUs for each mutation,<br />

none <strong>of</strong> the 48 DNA samples extracted from blood<br />

carry inherited EGFR mutations within the tyrosine<br />

kinase domain (exons 18-21) <strong>of</strong> EGFR.<br />

Discussion<br />

The absence <strong>of</strong> any mutations in the surveyed<br />

specimens might be attributed to the rarity <strong>of</strong> EGFR<br />

mutations in bladder cancer cases as shown by<br />

other studies before (Blehm et al., 2006; Villares et<br />

al., 2007). However, it might also arise from the<br />

fact that using whole blood as a source <strong>of</strong><br />

information for tumour genotype is an inaccurate<br />

method. The underlying reason can only be<br />

identified upon the completion <strong>of</strong> the second step <strong>of</strong><br />

the study, which will provide us the genotype data<br />

obtained directly from tumour tissues <strong>and</strong> thus<br />

enable to perform a cross-comparison between<br />

tumour tissue <strong>and</strong> leukocyte genotype.<br />

Acknowledgements<br />

This study was supported by <strong>Haliç</strong> University <strong>and</strong><br />

CDK Tıbbi Malzeme Tic. Ltd. Şti. (Istanbul,<br />

TURKEY).<br />

References<br />

Gschwind A, Fischer OM <strong>and</strong> Ullrich A. The<br />

discovery <strong>of</strong> receptor tyrosine kinases: targets<br />

for cancer therapy. Nat Rev Cancer. 4 . 361–<br />

370, 2004.<br />

Blehm KN, Spiess PE, Bondaruk JE, Dujka ME,<br />

Villares GJ, Zhao YJ, Bogler O,Aldape KD,<br />

Grossman HB, Adam L, McConkey DJ,<br />

Czerniak BA, Dinney CP <strong>and</strong> Bar-Eli M.<br />

Mutations within the kinase domain <strong>and</strong><br />

truncations <strong>of</strong> the epidermal growth factor<br />

receptor are rare events in bladder cancer:<br />

implications for therapy. Clin Cancer Res.<br />

12(15):4671-7, 2006.<br />

Herbst RS. Review <strong>of</strong> epidermal growth factor<br />

receptor biology. International <strong>Journal</strong> <strong>of</strong><br />

Radiation Oncology .59(2): S21-S26, 2004.<br />

Oda K, Matsuoka Y, Funahashi A <strong>and</strong> Kitano H.<br />

Comprehensive pathway map <strong>of</strong> epidermal<br />

growth factor receptor signaling. Mol Syst Biol.<br />

1: 20050010, Epub 2005, May25.<br />

Lynch TJ, Bell DW, Sordella R, Gurubhagavatula<br />

S, Okimoto RA, Brannigan BW,Harris PL,<br />

Haserlat SM, Supko JG, Haluska FG, Louis<br />

DN, Christiani DC, Settleman J <strong>and</strong> Haber DA.<br />

Activating mutations in the epidermal growth<br />

factor receptor underlying responsiveness <strong>of</strong><br />

non-small-cell lung cancer to gefitinib. N Engl J<br />

Med. 350(21):2129-39, 2004.<br />

Villares GJ, Zigler M, Blehm K, Bogdan C,<br />

McConkey D, Colin D, Bar-Eli M. Targeting<br />

EGFR in bladder cancer.. EGFR in bladder<br />

cancer. World J Urol. 25(6):573-9. 2007<br />

Yarden Y <strong>and</strong> Sliwkowski MX. Untangling the<br />

ErbB signalling network. Nat Rev Mol <strong>Cell</strong><br />

Biol. 2(2):127-37,2001.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> - INSTRUCTIONS for AUTHORS<br />

General<br />

<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />

(J<strong>Cell</strong>MolBiol) is an international journal which<br />

covers original works in the field <strong>of</strong> cell biology,<br />

molecular biology, genetics, microbiology,<br />

neurobiology, bioinforma-tics <strong>and</strong> related topics.<br />

The <strong>of</strong>ficial language <strong>of</strong> the journal is English,<br />

however manuscripts in Turkish are accepted as<br />

well.<br />

Conditions for publication<br />

This journal publishes research articles, review<br />

articles, short communications, book/s<strong>of</strong>tware<br />

reviews, case reports <strong>and</strong> letters to the editor.<br />

Research articles: Only original contributions will<br />

be accepted which have not been published<br />

previously. Manuscripts should not exceed 15<br />

papers <strong>of</strong> printed text, including tables, figures <strong>and</strong><br />

references<br />

Review articles: Reviews <strong>of</strong> recent developments in<br />

a research field <strong>and</strong> ideas will be accepted.<br />

Manuscripts should not exceed 15 papers <strong>of</strong> printed<br />

text. Illustrations are encouraged.<br />

Short communications: These include small-scale<br />

investigations or innovative methods, techniques,<br />

clinical trials <strong>and</strong> epidemiological studies. It should<br />

not exceed 3 pages.<br />

Letters to editor: These include opinions, news <strong>and</strong><br />

suggestions. Letters should not exceed 2 papers <strong>of</strong><br />

printed text.<br />

Case Reports: These include individual<br />

observations based on small numbers <strong>of</strong> subjects.<br />

This type <strong>of</strong> research cannot indicate causality but<br />

may indicate areas for further research.<br />

REVISED<br />

June 30 th , 2011<br />

Manuscripts should be submitted by e-mail to:<br />

<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />

<strong>Haliç</strong> <strong>Üniversitesi</strong><br />

Fen Edebiyat Fakültesi<br />

Moleküler Biyoloji ve Genetik Bölümü<br />

Sıracevizler Cad. No:29<br />

Bomonti-Şişli 34394, İstanbul-TÜRKİYE<br />

Tel: +90 212 343 08 87, Fax: +90 212 231 06 31<br />

E-Mail: jcmb@halic.edu.tr<br />

87<br />

Book/s<strong>of</strong>tware reviews: Short but concise<br />

description <strong>of</strong> the book/s<strong>of</strong>tware, not exceeding a<br />

page. Book/s<strong>of</strong>tware reviews are not peer reviewed.<br />

Presentation<br />

Papers should be typed clearly, double-spaced with<br />

3 cm wide margins.<br />

Manuscripts should be prepared using Word<br />

Processor.<br />

Cover Letter: You may briefly explain your work<br />

<strong>and</strong> its contribution to present knowledge.<br />

Title Page: The first page <strong>of</strong> your manuscript<br />

should be a title page containing the type <strong>of</strong> paper;<br />

the title; all authors' full names, <strong>and</strong> affiliations;<br />

<strong>and</strong> the corresponding author's contact address<br />

(including phone <strong>and</strong> fax numbers) <strong>and</strong> e-mail<br />

address. The title should be as short as possible, but<br />

should give adequate information regarding the<br />

contents. Authors should also state a running title<br />

<strong>of</strong> no more than 50 characters including spaces.<br />

All pages must be numbered.<br />

Full Paper<br />

The full paper should be divided into the following<br />

parts in the order indicated:


88<br />

Abstract: A brief, informative abstract, not<br />

exceeding 200 words, should be provided in<br />

English <strong>and</strong> in Turkish. For authors who are not<br />

native Turkish speakers, J<strong>Cell</strong>MolBiol can provide<br />

the Turkish abstract.<br />

Keywords: Immediately following the abstract,<br />

authors should provide 5 keywords or phrases that<br />

reflect the content <strong>of</strong> the article.<br />

Introduction should include theory, hypotheses,<br />

prior work<br />

Material <strong>and</strong> methods may include subheadings<br />

Results: If the study consists <strong>of</strong> different parts,<br />

subheadings in this section should be consistent<br />

with subheadings in the methods.<br />

Discussion<br />

Acknowledgements should precede the list <strong>of</strong><br />

references<br />

References: Papers cited in the manuscript should<br />

be listed in alphabetical order according to the first<br />

author's surname.<br />

Tables <strong>and</strong> Figures<br />

Tables <strong>and</strong> figures should be embedded within<br />

the text in their appropriate positions.<br />

Each table should be accompanied by a short<br />

instructive title line plus an explanatory caption at<br />

the top. Indicate footnotes within tables by<br />

superscript letters <strong>and</strong> type footnotes below the<br />

table.<br />

Electronically submitted figures are preferred<br />

in *.jpg or *.tiff (min. 300 dpi) formats. Each figure<br />

should be supplied with a short instructive title line.<br />

Do not give magnification on scales in the figure<br />

titles; instead draw bar scales directly on the<br />

figures.<br />

All the tables <strong>and</strong> figures must be referred to<br />

within the text.<br />

Units, Abbreviations <strong>and</strong> Scientific Names<br />

Only SI units should be used. Current<br />

abbreviations can be used without explanation,<br />

others must be explained.<br />

All acronyms/abbreviations must be explained<br />

in parenthesis after their first occurrence. If many<br />

REVISED<br />

June 30 th , 2011<br />

unfamiliar acronyms/abbreviations are used, please<br />

compile them in an "Abbreviations" section at the<br />

end <strong>of</strong> the paper.<br />

Latin expressions should be underlined or typed<br />

in italics.<br />

Referencing<br />

In the text, citations with two authors should<br />

take the form: Smith <strong>and</strong> Robinson,1990. If several<br />

papers are cited by the same author in the same<br />

year, they should be lettered in sequence (1990a),<br />

(1990b), etc. When papers are by more then two<br />

authors they should be cited as Smith et al.,1990.<br />

In the list, references must be placed in<br />

alphabetical order. The following models for the<br />

reference list cover all situations. The punctuation<br />

given must be exactly followed.<br />

Redford IR. Evidence for a general relationship<br />

between the induced level <strong>of</strong> DNA double<br />

str<strong>and</strong> breakage <strong>and</strong> cell killing after Xirradiation<br />

<strong>of</strong> mammalian cells. Int J Radiat<br />

Biol. 49: 611- 620, 1986.<br />

Tccioli CE, Cottlieb TM, Blund T. Product <strong>of</strong> the<br />

XRCCS gene <strong>and</strong> its role in DNA repair <strong>and</strong><br />

V(D)J recombination. Science. 265: 1442-1445,<br />

1994<br />

Ohlrogge JB. Biochemistry <strong>of</strong> plant acyl carrier<br />

proteins. The Biochemistry <strong>of</strong> Plants: A<br />

Comprehensive Treatise. Stumpf PK <strong>and</strong> Conn<br />

EE (Ed). Academic Press, New York. 137-157,<br />

1987.<br />

Brown LA. How to cope with your supervisor. PhD<br />

Thesis. University <strong>of</strong> New Orleans, 2005.<br />

Web document with no author: Leafy seadragons<br />

<strong>and</strong> weedy seadragons 2001. retrieved<br />

November 13, 2002, from http:// www.<br />

windspeed.net.au/jenny/seadragons/<br />

Web document with author: Dawson J, Smith L,<br />

Deubert K. Referencing, not plagiarism.<br />

Retrieved October 31, 2002 from http:<br />

//studytrekk.lis.curtin.edu.au/<br />

Only papers published or in press should be<br />

cited in the literature list. Unpublished results,<br />

including submitted manuscripts <strong>and</strong> those in<br />

preparation, should be indicated as unpublished<br />

data in the text.


Submission Policies <strong>and</strong> Authorship<br />

Upon submission <strong>of</strong> a manuscript, it is accepted<br />

that all co-authors have approved the contents <strong>of</strong><br />

the manuscript <strong>and</strong> its submission by the<br />

corresponding author, <strong>and</strong> that the corresponding<br />

author is authorized to represent all co-authors in<br />

pre-publication discussions with J<strong>Cell</strong>MolBiol.<br />

The corresponding author is responsible for<br />

ensuring that all the contributors to the relevant<br />

work are listed as authors <strong>and</strong> that all authors have<br />

aggreed to the manuscript’s content <strong>and</strong> its<br />

submission to the J<strong>Cell</strong>MolBiol. In case the <strong>Journal</strong><br />

happens to be aware <strong>of</strong> an authorship dispute,<br />

authorship must be approved in writing by all <strong>of</strong> the<br />

parties.<br />

Cost<br />

There are no submission fees or page charges.<br />

Criteria for the Selection <strong>of</strong> Manuscripts<br />

Manuscripts should meet the following criteria: the<br />

study conducted is material is original <strong>and</strong> ethical,<br />

the writing is clear; the study methods are<br />

appropriate, the data are valid, the conclusions are<br />

reasonable <strong>and</strong> supported by the data; the<br />

information is important; <strong>and</strong> the topic is<br />

interesting to our readership.<br />

Editorial Processes<br />

Researchers may request informal feedback from<br />

the editors in a particular manuscript. The<br />

presubmission process aids in the submission<br />

decision for authors<br />

When J<strong>Cell</strong>MolBiol receives a manuscript, the<br />

Editor <strong>and</strong> Associate Editor will first decide<br />

whether the manuscript meets the formal criteria<br />

specified with “Guidelines for Authors” <strong>and</strong><br />

whether it fits within the scope <strong>of</strong> the <strong>Journal</strong>. In<br />

case <strong>of</strong> doubt on the basis <strong>of</strong> initial review, the<br />

editor will consult other members <strong>of</strong> the Editorial<br />

Board.<br />

Manuscripts that are found suitable for peer<br />

review will be assigned to two expert reviewers.<br />

Reviewers may either be Editorial Board members<br />

or external experts selected by the Editorial Board.<br />

The corresponding author is notified by e-mail<br />

when the editor decides to send a paper for review.<br />

The reviewers will have up to three weeks to<br />

review the submitted article. After peer review, the<br />

REVISED<br />

June 30 th , 2011<br />

89<br />

editor will contact the author. If the author is<br />

required to submit a revised version, the revised<br />

version has to be submitted by the author within<br />

two weeks. Otherwise, the manuscript will be<br />

removed from the manuscript submission queue<br />

<strong>and</strong> will be considered rejected.<br />

In cases where the referees have requested welldefined<br />

changes to the manuscript, editors may<br />

request a revised manuscript that addresses to<br />

referees’ concerns. The revised version is sent back<br />

to the original referees for re-review. In cases<br />

where the referees’ concerns are more wideranging,<br />

editors may reject the manuscript. The<br />

revised manuscript should be accompanied by a<br />

cover letter that includes a point-by-point response<br />

to referees’ comments <strong>and</strong> an explanation <strong>of</strong> how<br />

the manuscript has been changed.<br />

As a matter <strong>of</strong> policy, we do not suppress<br />

referees’ reports, any comments directed to authors<br />

are transmitted regardless <strong>of</strong> what we may think <strong>of</strong><br />

the content. On rare occasions, we may edit a report<br />

to remove <strong>of</strong>fensive language or comments to<br />

reveal confidentiality.<br />

The final decision to accept or reject a<br />

manuscript will be made by the Editor. If it<br />

becomes apparent that there are serious problems<br />

with the scientific content or with violations <strong>of</strong> our<br />

publishing policies, the Editor also reserves the<br />

right to reject a paper even after it has been<br />

accepted<br />

After acceptance, the Editor may make further<br />

changes to the text <strong>and</strong> figures so that the<br />

manuscript is readable <strong>and</strong> clear. Page pro<strong>of</strong>s will<br />

be sent to the corresponding author via email for<br />

checking before publication. Corresponding authors<br />

are sent pro<strong>of</strong>s <strong>and</strong> are welcome to discuss<br />

proposed changes with the Editor, but<br />

J<strong>Cell</strong>MolBiol reserves the right to make the final<br />

decision about the style. Corrected pro<strong>of</strong>s should be<br />

sent back to the Editor within three days <strong>of</strong> receipt,<br />

otherwise the Editor reserves the rights to correct<br />

the pro<strong>of</strong>s himself <strong>and</strong> to send the material for<br />

publication.<br />

Appeals<br />

Authors have the right to ask the Editor to<br />

reconsider a rejection decision, which is considered<br />

an appeal. Decisions are reversed only if the Editor<br />

is convinced that the original decision was a serious<br />

mistake. If an appeal merits further consideration,<br />

the Editor may send the author’s response or the<br />

revised paper to one or more referees, or Editor


90<br />

may ask one referee to comment on the concerns<br />

raised by another referee.<br />

Advance Online Publication<br />

J<strong>Cell</strong>MolBiol provides Advance Online Publication<br />

<strong>of</strong> articles, which benefit authors with an earlier<br />

publication date <strong>and</strong> allows the readers’ access to<br />

accepted papers several weeks before they appear<br />

in print<br />

Ethical Issues<br />

For manuscripts reporting experiments on live<br />

vertebrates or higher invertebrates, authors must<br />

declare that the study was approved by the<br />

institutional ethics committee. Papers describing<br />

investigations on human subjects must include a<br />

statement that informed consent was obtained from<br />

all subjects.<br />

Plagiarism<br />

If portions <strong>of</strong> the manuscript have already been<br />

published by the author on other journals or<br />

websites, J<strong>Cell</strong>MolBiol Editorial Board needs to<br />

know which portions <strong>of</strong> the manuscript have been<br />

previously published <strong>and</strong> where. The author should<br />

include a note in the cover letter indicating which<br />

portions have been published elsewhere.<br />

In case <strong>of</strong> any suspicion on scientific misconduct or<br />

dishonesty in research, J<strong>Cell</strong>MolBiol reserves the<br />

right to forward any submitted manuscript to an<br />

appropriate authori-ty for investigation.<br />

Copyright Notice<br />

It is the responsibility <strong>of</strong> the submitting author to<br />

ensure that the authorship <strong>of</strong> the paper reflects the<br />

contributions <strong>of</strong> the authors to the work described,<br />

<strong>and</strong> that all listed authors have agreed to the<br />

submission <strong>of</strong> the manuscript in its current form.<br />

Conditions <strong>of</strong> publication in J<strong>Cell</strong>MolBiol are<br />

that the paper has not already been published<br />

elsewhere; that it is not currently being considered<br />

for publication else-where; all persons designated<br />

as authors should qualify for authorship, <strong>and</strong> all<br />

those who qualify should be listed. If accepted,<br />

<strong>Haliç</strong> University <strong>and</strong> J<strong>Cell</strong>MolBiol have the<br />

exclusive license to publish.<br />

J<strong>Cell</strong>MolBiol is freely available to individuals<br />

<strong>and</strong> institutions. Copies <strong>of</strong> this <strong>Journal</strong> <strong>and</strong> articles<br />

REVISED<br />

June 30 th , 2011<br />

in this journal may be distributed for research or for<br />

educational purposes free <strong>of</strong> charge. However,<br />

commercial use <strong>of</strong> articles contained herein is<br />

prohibited without the written consent <strong>of</strong> the editor.<br />

Publication Agreement<br />

The corresponing author is required to assign the<br />

Publication Agreement Form in order to publish the<br />

submitted manuscript in J<strong>Cell</strong>MolBiol.


<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />

<strong>Vol</strong>ume 9 · No 1 · June 2011<br />

Review Articles<br />

<strong>Molecular</strong> <strong>Biology</strong><br />

Decision making mechanism influences the regulatory function <strong>of</strong> Notch in Apoptosis<br />

A.NAIR<br />

Polymorphisms in the xenobiotic genes <strong>and</strong> susceptibility to bladder cancer<br />

N. ERSOY TUNALI <strong>and</strong> N. O. TİRYAKİOĞLU<br />

Research Articles<br />

Identification <strong>of</strong> silencing suppressors <strong>of</strong> potato virus M<br />

R. KRYLDAKOV, R. AKBERGENOV, T. HOHN <strong>and</strong> B. ISKAKOV<br />

Identification <strong>of</strong> a novel dehydration responsive transcript from tossa jute (Corcohrus olitorius L.)<br />

S. SHARMIN, M. M. MOOSA, Md. S. ISLAM, I. KABIR, A. AKTER <strong>and</strong> H. KHAN<br />

Protective effects <strong>of</strong> curcumin on cadmium chloride induced colon toxicity in Swiss albino mice<br />

P. SINGH, P. MOGRA, V. SANKHLA <strong>and</strong> K. DEORA<br />

In vitro regeneration <strong>of</strong> Cleome viscosa – an important medicinal herb<br />

J.ANBURAJ, C. R. SINGH, S. SUNDARRAJ <strong>and</strong> S. KANNAN<br />

Bio-database compression using enhanced suffix array for pairwise sequence alignment<br />

A.KUNTHAVAI <strong>and</strong> S.VASANTHA RATHNA<br />

Cloning <strong>and</strong> expression <strong>of</strong> Lentinula edodes cellobiohydrolase gene in E. coli <strong>and</strong> characterization <strong>of</strong><br />

the recombinant enzyme<br />

S. TAIPAKOVA, B. SMAILOV, G. STANBEKOVA <strong>and</strong> A. BISSENBAEV<br />

Investigation <strong>of</strong> the MMP1 <strong>and</strong> MMP3 promoter polymorphisms in temporom<strong>and</strong>ibular joint<br />

disorder<br />

N. TASKIN, K. ULUCAN, G. DEGIN, A. AKCAY, B. KARATAS <strong>and</strong> T. AKCAY<br />

Lead induced alterations in blood cell counts <strong>and</strong> hemoglobin during gestation <strong>and</strong> lactation in Swiss<br />

albino mice<br />

I. BARBER, R. SHARMA, S. MOGRA, K. PANWAR <strong>and</strong> U. GARU<br />

The effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> Vernonia amygdalina on some vital organs in<br />

adult Wistar rats<br />

S. NWANGWU, D. A. OFUSORI, S. JOSIAH, O. F. AMEGOR, H. NJOYA <strong>and</strong> A. O. OYAKA<br />

Short Communication<br />

Investigation <strong>of</strong> the EGFR gene variations in bladder cancer patients using INFINITI TM Analyzer<br />

N. O. TİRYAKİOĞLU, Ö. KURNAZ, Ö. O. ÇAKIR <strong>and</strong> N. ERSOY TUNALI<br />

Instructions for Authors<br />

1<br />

5<br />

15<br />

21<br />

31<br />

37<br />

45<br />

53<br />

63<br />

69<br />

75<br />

83<br />

87

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!